DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
down	PSMA7; EREG; MYC; MBP; ARAF; FGFR1; CCL2; NCAM1; HGF; NF1; JAK1; ZFP36; MARK3; PSMB4; MAPK1; YWHAB; CSF2RB; MAP2K2; MAPKAPK2; CCR5; PPP5C; PSMD4; PSME3; GRB2; HSF1; SPTBN1; MAP2K1; ZFP36L1; PSMD2; SPTAN1; PTK2B; RASA3; PEA15; MAPK6; PPM1L; SPRED1; RASGRP3; KSR1; CAMKK2; PSMB7; PSMD1; MAP3K14; NLK; PSMD13; RAPGEF2; MAP4K3;	GO:0000165~MAPK cascade	46	254	18.1102362204724	0	0	0	0	0	0	0
down	ZNF316; ZNF233; BHLHE40; ZNF197; ZNF213; BACH1; ZNF264; GAS7; EDF1; MITF; ZNF217; TULP3; ABL1; RB1; ZNF35; IRF2; TCF3; ZNF182; ZKSCAN1; ZNF43; ATF7; ENG; CALR; AHR; VHL; DNM2; ZNF133; YBX1; UBE2L3; TMF1; TLE3; REST; NFATC2; RUNX3; ZNF267; ZNF460; ZNF846; TRIP4; ZFHX3; HIF1A; RNF20; ARID2; SUPT6H; ERC1; ZNF611; CREBBP; L3MBTL2; HES6; EAF1; ZNF521; PCGF1; SCAND2P; NLK; RNF14; SAP30BP; ZFP69B; TBX21; PHTF1; ATF5; MAFB; LRRFIP2; ZFP37; LIN54; CCAR2; NFX1; HMGB1; GPBP1L1; KDM3B; YY1AP1; GON4L; ZNF646; SBNO2; CTR9; NONO; PHF12; ZFAT;	GO:0006355~regulation of transcription, DNA-templated	76	824	9.22330097087379	0	0	0	0	0	0	0
down	ARID1A; MED7; FOXO3; MYC; SOD2; HMGB1; ANXA4; PRKAR1A; VEGFA; ZSCAN20; UBTF; ATF7; ATP2B4; AHR; PPARG; CUX1; STAT6; SMARCA4; STAT5B; RHOA; SMAD3; MLLT1; ZFP36L1; TFCP2; HLX; BRD3; PKN1; LRRFIP1; GON4L; ZNF704; FOXP4; SMARCC2; THAP3; SMARCC1; MED15; HTATIP2; ABCA2; SMARCAL1; MED11; ZNFX1; RNF14; KDM5B; BAZ1B; IKZF3; ZC3H4; TRAK1; MED16; TSC22D4; AATF; NFE2L1; GTF2H2; RUNX3; ZNF517; MED13; ZNF791; HIF1A; ZNF563; RUNX1; NFKBIZ; MTDH; TBL1X; MED12L; EGR2; TFDP1; RUNX2; TSHZ1; RFX1; GTF2E1; ATF5; KLF6; SPIB; ETV6; ATF3; MED13L; ZMIZ1; PIAS4; MSC; GMEB1; ZMYM1; GTF2H2C; SP2; RXRA; ETS2;	GO:0006357~regulation of transcription by RNA polymerase II	83	747	11.1111111111111	0	0	0	0	0	0	0
down	HIP1; TNFRSF11B; APAF1; MAP2K7; PLSCR1; CFLAR; RIPK2; BCL2L11; TNFSF14; KIF1B; PHLPP1; TLR2; PPP1R15A; STK17B; TNFSF15; RTN3; IL1A; CD2; CD14; PARP1; GZMB; CSNK2A2; NFKB1; C5AR1; DNASE1; NFKBIA; MAPK1; AHR; TGFBR2; FASLG; CXCR3; SERPINB9; DAPK1; PSME3; DAB2; NOTCH2; ZFP36L1; FOXO1; PAK2; ROCK1; C1D; PTK2B; ARL6IP1; PEA15; TRADD; RRAGA; RNF144B; PEG10; PACS2; DRAM1; MZB1; PDCD6IP; PHLDA1; RASSF5; RFFL; RNF34; NLRP3; CIB1; HTATIP2; CARD6; BCL2L13; NUAK2; GHITM; HIPK3; SAV1; NEK6; NLRC4; BCAP29; SAP30BP; DDX41; PLAGL1; CARD8; SH3GLB1; CASP4;	GO:0006915~apoptotic process	74	552	13.4057971014493	0	0	0	0	0	0	0
down	CCL22; SOCS3; EREG; FOXO3; TIMP1; MYC; IL1A; ICAM1; HCK; VIM; CXCL1; CXCL8; CCL4; CCL2; OSM; HGF; IL1R1; VEGFA; PRKACA; TNFRSF1A; ITGAX; JAK1; IL1R2; PTPN6; CCR1; CSF2RB; PTGS2; BCL6; STAT6; IL12RB1; FASLG; CCR5; STAT5B; GRB2; YWHAZ; MCL1; IL10RB; FOXO1; STX4; STX3; IL10RA; RAPGEF1; HIF1A; RHOU; IFNLR1; CNOT9; IL1RL2; GAB2; IRAK3; IRAK2; IFNAR1; IFNGR2;	GO:0019221~cytokine-mediated signaling pathway	52	278	18.705035971223	0	0	0	0	0	0	0
down	KIF3B; DCTN3; SEC24D; AP2A2; SEC24A; HLA-DQA2; HLA-DQB1; HLA-DQB2; CLTA; CANX; HLA-DMB; ACTR1B; CAPZA2; CAPZB; DNM2; RAB7A; ACTR1A; AP2B1; ARF1; CLTC; AP1B1; DYNC1I2; DCTN2; DCTN1; DYNC1H1; AP1S3; TRAF6; FCER1G;	GO:0019886~antigen processing and presentation of exogenous peptide antigen via MHC class II	28	98	28.5714285714286	0	0	0	0	0	0	0
down	TAF4; ARID1A; MAP2K7; ATMIN; FOXO3; EDF1; BRD4; TBL1X; MITF; EOMES; BCL10; MYC; JUN; RB1; ZBTB48; RARA; EGR2; SRC; XRCC6; ETS2; TCF4; TCF3; CREB1; TFE3; NFKB1; F2R; MAPK1; CIITA; AHR; MAP2K2; NUP62; PPARG; VHL; CTCF; DNM2; SMARCA4; NEK4; SMAD3; DAB2; RUNX1; XPC; MAP2K1; PPARA; FOXO1; REST; NFATC2; PICALM; RUNX3; RUNX2; SERTAD2; NCOA6; TRIP4; NCOA1; ZFHX3; HIF1A; HIVEP3; RNF20; CREB3L2; RAI1; SFR1; SMARCC2; ZNF516; CREBBP; TAF15; SMARCC1; DVL3; CAMKK2; KLF6; HNRNPAB; HIPK2; GPBP1L1; CHD8; CALCOCO1; RNF14; MED13; TBX21; ATF5; THRAP3; MED16; MAFB; NFE2L1; SS18;	GO:0045893~positive regulation of transcription, DNA-templated	82	570	14.3859649122807	0	0	0	0	0	0	0
down	EDF1; HMGB1; CALM3; SKI; PPARG; SIRT2; HIPK2;	GO:0043388~positive regulation of DNA binding	7	30	23.3333333333333	0.00010018634044328	0.0014036860386839	0.485202446766838	0.522171206390411	0.285531070263367	0.485002074085951	0.0128241185075192
down	SGPL1; BCR; IQGAP1; PTPRJ; RAPGEF1; PDGFC; PDGFD;	GO:0048008~platelet-derived growth factor receptor signaling pathway	7	30	23.3333333333333	0.00010018634044328	0.0014036860386839	0.485202446766838	0.522171206390411	0.285531070263367	0.485002074085951	0.0128241185075192
down	MYC; ITGAV; MAPK1; MAP2K2; YWHAZ; MAP2K1; ZFP36L1;	GO:0070371~ERK1 and ERK2 cascade	7	30	23.3333333333333	0.00010018634044328	0.0014036860386839	0.485202446766838	0.522171206390411	0.285531070263367	0.485002074085951	0.0128241185075192
down	MAP4K4; MTOR; ADAM9; MAPRE2; IQSEC1;	GO:0051549~positive regulation of keratinocyte migration	5	12	41.6666666666667	0.00010988388570387	0.00152317769225693	0.531618239035354	0.572714812288604	0.298994053000248	0.53150835514965	0.0139157979029463
down	MTSS1; CA2; SRC; PTGS2; PTK2B;	GO:0071498~cellular response to fluid shear stress	5	12	41.6666666666667	0.00010988388570387	0.00152317769225693	0.531618239035354	0.572714812288604	0.298994053000248	0.53150835514965	0.0139157979029463
down	XRCC6; MLH1; LIG4; RNF168; PIAS4; DCLRE1C; POLM; SMARCAL1; PRPF19;	GO:0006303~double-strand break repair via nonhomologous end joining	9	55	16.3636363636364	0.00011904144981778	0.00163274746434282	0.575327326969333	0.620444036450272	0.309983935325501	0.575327326969333	0.0149168306861667
down	SOCS3; SOCS6; CCL2; IFNAR1; CTR9; STAT5B; STAT6;	GO:0007259~receptor signaling pathway via JAK-STAT	7	31	22.5806451612903	0.00011964408246045	0.001636705925942	0.578120206448929	0.623584957783903	0.310715682149807	0.578120206448929	0.0149529953121987
down	RAB27A; DCTN2; RAB11B; BBS4; BLOC1S6; MYO5A;	GO:0032402~melanosome transport	6	21	28.5714285714286	0.00012352745577426	0.00168540601962163	0.596761138845469	0.643825099495463	0.315365594591696	0.596761138845469	0.0153979208549935
down	AHR; TGFBR2; MDM2; FOXO1; RAPGEF1; SPHK1; RAPGEF2; BMPR2;	GO:0001568~blood vessel development	8	43	18.6046511627907	0.00012926905786303	0.00174546717508326	0.624240280420597	0.673750329582139	0.322267761252547	0.62398174230487	0.0159466414051107
down	HOOK3; CHP1; CIB1; TUBGCP2; CAMSAP1; DYNC1H1; CCDC88A; SPAST;	GO:0031122~cytoplasmic microtubule organization	8	43	18.6046511627907	0.00012926905786303	0.00174546717508326	0.624240280420597	0.673750329582139	0.322267761252547	0.62398174230487	0.0159466414051107
down	CFLAR; PDPK1; ZFP36; IQGAP1; STAT5B; PTPN12; ZFP36L1; PPP1R9B;	GO:0071364~cellular response to epidermal growth factor stimulus	8	43	18.6046511627907	0.00012926905786303	0.00174546717508326	0.624240280420597	0.673750329582139	0.322267761252547	0.62398174230487	0.0159466414051107
down	PDPK1; SRC; MTOR; CCDC88A; PARK7; MAPKAP1; OSBPL8;	GO:0032148~activation of protein kinase B activity	7	32	21.875	0.00014206012497919	0.00190829219430813	0.685440103024607	0.740417371391554	0.335253515053614	0.685440103024607	0.0174342157522108
down	TLR4; ABL1; CD180; GAPT;	GO:0002322~B cell proliferation involved in immune response	4	6	66.6666666666667	0.00014586866450982	0.00194441810594688	0.703670437595417	0.760267479425231	0.339072298245321	0.703378700266398	0.0177642631839584
down	BCL10; KDELR1; FASLG; CLC;	GO:0070231~T cell apoptotic process	4	6	66.6666666666667	0.00014586866450982	0.00194441810594688	0.703670437595417	0.760267479425231	0.339072298245321	0.703378700266398	0.0177642631839584
down	TRIP11; FAM91A1; WDR11; LINC00869;	GO:0099041~vesicle tethering to Golgi	4	6	66.6666666666667	0.00014586866450982	0.00194441810594688	0.703670437595417	0.760267479425231	0.339072298245321	0.703378700266398	0.0177642631839584
down	C3AR1; FPR3; CMKLR1; FPR2; C5AR1;	GO:0002430~complement receptor mediated signaling pathway	5	13	38.4615384615385	0.00014839200360627	0.00194839654822558	0.715397849385872	0.773419122795927	0.341598392301655	0.714952673375053	0.0178006103540885
down	ABCA1; ITGAV; NFKBIA; PPARG; PPARA;	GO:0010745~negative regulation of macrophage derived foam cell differentiation	5	13	38.4615384615385	0.00014839200360627	0.00194839654822558	0.715397849385872	0.773419122795927	0.341598392301655	0.714952673375053	0.0178006103540885
down	TNFRSF11B; THBS1; CD14; BMP6; MDM2;	GO:0032026~response to magnesium ion	5	13	38.4615384615385	0.00014839200360627	0.00194839654822558	0.715397849385872	0.773419122795927	0.341598392301655	0.714952673375053	0.0178006103540885
down	UFL1; ARAF; RAD23A; RAD23B; GNA12;	GO:0032434~regulation of proteasomal ubiquitin-dependent protein catabolic process	5	13	38.4615384615385	0.00014839200360627	0.00194839654822558	0.715397849385872	0.773419122795927	0.341598392301655	0.714952673375053	0.0178006103540885
down	B3GAT3; PPP2R5A; PPP1R7; PPP1R3B; PHACTR4; PPP4R1; PPP6R1; TIPRL;	GO:0043666~regulation of phosphoprotein phosphatase activity	8	44	18.1818181818182	0.00014878392674477	0.00194839654822558	0.716692175129594	0.775461826193781	0.342043356430602	0.716394607276105	0.0178006103540885
down	TPP1; ABL1; HEXB; BCR; PAFAH1B1; CNTNAP1; ABR; BLOC1S4;	GO:0050885~neuromuscular process controlling balance	8	44	18.1818181818182	0.00014878392674477	0.00194839654822558	0.716692175129594	0.775461826193781	0.342043356430602	0.716394607276105	0.0178006103540885
down	PDPK1; G0S2; FASLG; SMAD3; TRADD; P2RX7; CIB1; PARP2;	GO:0097191~extrinsic apoptotic signaling pathway	8	44	18.1818181818182	0.00014878392674477	0.00194839654822558	0.716692175129594	0.775461826193781	0.342043356430602	0.716394607276105	0.0178006103540885
down	POU2F2; CCL2; ST6GAL1; TFE3; CD83; NOTCH2; RBPJ; BLNK; TREM1;	GO:0006959~humoral immune response	9	58	15.5172413793103	0.00017056845201546	0.00222371565210312	0.821116528002437	0.889002771904591	0.360581707560688	0.821116528002437	0.0203159340933059
down	CAT; CREB1; BMP6; MTOR; GCLM; HSF1; HDAC5; CAB39;	GO:0014823~response to activity	8	45	17.7777777777778	0.00017066121658504	0.00222371565210312	0.821392435423817	0.88948626084125	0.360667875243762	0.821392435423817	0.0203159340933059
down	ADAM10; MYH9; ADAM9; SPPL2A; HM13; P2RX7;	GO:0006509~membrane protein ectodomain proteolysis	6	23	26.0869565217391	0.00018833067413304	0.00242365302118867	0.906058873254063	0.981579473581412	0.374848064409994	0.905493881231664	0.0221425680018676
down	RAB6A; RAB27A; RAB5B; RAB10; RAB33A; RAB35;	GO:0019882~antigen processing and presentation	6	23	26.0869565217391	0.00018833067413304	0.00242365302118867	0.906058873254063	0.981579473581412	0.374848064409994	0.905493881231664	0.0221425680018676
down	CD14; AP2B1; ARF1; DAB2; PPP3CA; CBLL1;	GO:0045807~positive regulation of endocytosis	6	23	26.0869565217391	0.00018833067413304	0.00242365302118867	0.906058873254063	0.981579473581412	0.374848064409994	0.905493881231664	0.0221425680018676
down	ROCK2; SLC9A1; RHOA; ROCK1; PEAK1; CORO1C;	GO:0051893~regulation of focal adhesion assembly	6	23	26.0869565217391	0.00018833067413304	0.00242365302118867	0.906058873254063	0.981579473581412	0.374848064409994	0.905493881231664	0.0221425680018676
down	JUN; VEGFA; TGFBR2; RBPJ; BMPR2; HIF1A; NIPBL; PLXND1;	GO:0003151~outflow tract morphogenesis	8	46	17.3913043478261	0.00019511513172665	0.00246908469700466	0.937723323078295	1	0.379698348900983	0.937333092814841	0.022557633179267
down	VEGFA; CREB1; STAT5B; DHODH; NCOA1; USF2; HIF1A; NCOR2;	GO:0007595~lactation	8	46	17.3913043478261	0.00019511513172665	0.00246908469700466	0.937723323078295	1	0.379698348900983	0.937333092814841	0.022557633179267
down	SLC9A3R1; PHLPP1; ARRB2; TSC2; PTPRJ; RAPGEF1; BTN2A2; CIB1;	GO:0051898~negative regulation of protein kinase B signaling	8	46	17.3913043478261	0.00019511513172665	0.00246908469700466	0.937723323078295	1	0.379698348900983	0.937333092814841	0.022557633179267
down	RAB29; ANXA2; ECE1; NSF; VAMP3;	GO:0001921~positive regulation of receptor recycling	5	14	35.7142857142857	0.00019642277855092	0.00246908469700466	0.943418605380068	1	0.380667344831683	0.942632914265864	0.022557633179267
down	PRKCSH; GANAB; ST8SIA4; MAN2A2; MAN1A1;	GO:0006491~N-glycan processing	5	14	35.7142857142857	0.00019642277855092	0.00246908469700466	0.943418605380068	1	0.380667344831683	0.942632914265864	0.022557633179267
down	ABL1; DNM2; DPYSL2; TTL; RAB21;	GO:0030516~regulation of axon extension	5	14	35.7142857142857	0.00019642277855092	0.00246908469700466	0.943418605380068	1	0.380667344831683	0.942632914265864	0.022557633179267
down	TLR2; DYSF; CSK; SIRPA; SYT11;	GO:0050765~negative regulation of phagocytosis	5	14	35.7142857142857	0.00019642277855092	0.00246908469700466	0.943418605380068	1	0.380667344831683	0.942632914265864	0.022557633179267
down	ZC3H13; CBLL1; CMTR1; PCIF1; METTL14;	GO:0080009~mRNA methylation	5	14	35.7142857142857	0.00019642277855092	0.00246908469700466	0.943418605380068	1	0.380667344831683	0.942632914265864	0.022557633179267
down	KMO; UGDH; KDM4B; GLUD1; CP; SOD2; MTHFD2; NQO2; TBXAS1; PDIA3; PTGS2; MTHFR; HCCS; ALDH18A1; CTBP2; DHODH; KDSR; LBR; OXA1L; NCF4; PDIA6; COX15; KDM3B; DHFR2; UEVLD; SCCPDH; KDM2B; PYROXD1; HSPBAP1; COQ7; HTATIP2; KDM5B; GSTO1;	GO:0055114~oxidation-reduction process	33	526	6.27376425855513	0.0002113559116067	0.00263537562510559	1	1	0.391431148295614	0.993627075303383	0.0240768721756819
down	CTNS; CREB1; NF1; MTOR; HIF1A; RIC8A; SLC7A11; NPTN;	GO:0008542~visual learning	8	47	17.0212765957447	0.00022237231231314	0.00274425493798431	1	1	0.39895759648234	0.993627075303383	0.0250715969025041
down	TLR4; NRDC; RB1; TFE3; TLE3; RBPJ; IL18R1; ARRDC3;	GO:0120163~negative regulation of cold-induced thermogenesis	8	47	17.0212765957447	0.00022237231231314	0.00274425493798431	1	1	0.39895759648234	0.993627075303383	0.0250715969025041
down	PAFAH1B1; CAP1; WASF2; SGPL1;	GO:0001667~ameboidal-type cell migration	4	7	57.1428571428571	0.00022377366627846	0.00274425493798431	1	1	0.399883541639607	0.993627075303383	0.0250715969025041
down	WDR81; ACBD5; WDFY3; UBQLN1;	GO:0035973~aggrephagy	4	7	57.1428571428571	0.00022377366627846	0.00274425493798431	1	1	0.399883541639607	0.993627075303383	0.0250715969025041
down	NF1; RBPJ; TRPC4AP; MYO5A;	GO:0048820~hair follicle maturation	4	7	57.1428571428571	0.00022377366627846	0.00274425493798431	1	1	0.399883541639607	0.993627075303383	0.0250715969025041
down	MTOR; MAP1A; ITPR1; HIPK2;	GO:0050882~voluntary musculoskeletal movement	4	7	57.1428571428571	0.00022377366627846	0.00274425493798431	1	1	0.399883541639607	0.993627075303383	0.0250715969025041
down	CD63; FLNA; LIMS2; LIMS1;	GO:2001046~positive regulation of integrin-mediated signaling pathway	4	7	57.1428571428571	0.00022377366627846	0.00274425493798431	1	1	0.399883541639607	0.993627075303383	0.0250715969025041
down	LYST; CXCL5; CXCL3; CXCL8; CXCL9; CXCL1;	GO:0030595~leukocyte chemotaxis	6	24	25	0.00022946543191637	0.00279301240529438	1	1	0.403382388839819	0.993627075303383	0.0255170466125383
down	CALM3; SRC; VEGFA; RAP2B; PDGFD; PDGFC;	GO:0031954~positive regulation of protein autophosphorylation	6	24	25	0.00022946543191637	0.00279301240529438	1	1	0.403382388839819	0.993627075303383	0.0255170466125383
down	MTOR; YBX1; CIRBP; ELAVL1; TAF15; THRAP3;	GO:0048255~mRNA stabilization	6	24	25	0.00022946543191637	0.00279301240529438	1	1	0.403382388839819	0.993627075303383	0.0255170466125383
down	BCL2L11; ANKRD17; RARA; CALR; RAD23A; C6orf89; CCPG1;	GO:0045787~positive regulation of cell cycle	7	35	20	0.000230428882248	0.00279301240529438	1	1	0.403941830580747	0.993627075303383	0.0255170466125383
down	TLR4; RIPK2; HK1; NLRP3; P2RX7; CARD8; HMGB1;	GO:0050718~positive regulation of interleukin-1 beta secretion	7	35	20	0.000230428882248	0.00279301240529438	1	1	0.403941830580747	0.993627075303383	0.0255170466125383
down	PPP1R15A; CALM3; MTOR; CD300A; PPP1R15B;	GO:0032516~positive regulation of phosphoprotein phosphatase activity	5	15	33.3333333333333	0.00025544350527118	0.00304661681801691	1	1	0.418416461634193	0.993627075303383	0.0278339842703588
down	JUN; SLC9A1; NFKB1; NFKBIA; SLC8A1;	GO:0035994~response to muscle stretch	5	15	33.3333333333333	0.00025544350527118	0.00304661681801691	1	1	0.418416461634193	0.993627075303383	0.0278339842703588
down	TOR1A; SYNJ1; DNM2; RAB27A; TMEM230;	GO:0048489~synaptic vesicle transport	5	15	33.3333333333333	0.00025544350527118	0.00304661681801691	1	1	0.418416461634193	0.993627075303383	0.0278339842703588
down	CA2; TGFBR2; MDM2; PPP1R9B; ABCA2;	GO:0048545~response to steroid hormone	5	15	33.3333333333333	0.00025544350527118	0.00304661681801691	1	1	0.418416461634193	0.993627075303383	0.0278339842703588
down	TLR4; TLR2; CCL2; NAMPT; AKAP12;	GO:0051770~positive regulation of nitric-oxide synthase biosynthetic process	5	15	33.3333333333333	0.00025544350527118	0.00304661681801691	1	1	0.418416461634193	0.993627075303383	0.0278339842703588
down	MYC; SRC; HGF; ARRB2; PTK2B;	GO:2000573~positive regulation of DNA biosynthetic process	5	15	33.3333333333333	0.00025544350527118	0.00304661681801691	1	1	0.418416461634193	0.993627075303383	0.0278339842703588
down	SHTN1; SRGAP2; DNM2; RHOA; CNTNAP1; DBNL; MAP4K4; ANKRD27; GAS7;	GO:0048812~neuron projection morphogenesis	9	62	14.5161290322581	0.00026698753894693	0.00316979283141559	1	1	0.424510186925633	0.993627075303383	0.0289593240896459
down	SOCS6; VCP; DDI2; PRPF19; PSMB4; PSMB7; PSMA7;	GO:0010498~proteasomal protein catabolic process	7	36	19.4444444444444	0.00026815852378403	0.00317645960445997	1	1	0.425082953926909	0.993627075303383	0.0290202319317329
down	NUDT19; MYO1F; SIPA1L1; SFT2D2; METTL18; SDC2; ZNF142; RBM10; TLE4; TMEM187; TPRG1L; C9orf64; ZNF697; LHFPL2; TRPT1; LIX1L; UEVLD; SLC35F2; EHBP1L1; SLC43A3; FAM3C; TOMM40L; TMEM106A; EMILIN2; ZC3H12C; C6orf62; SCAND2P; MEGF9; GHITM; APMAP; FAM114A2; SIPA1L2; CACFD1; LRRFIP2; WSB1; PXMP4;	GO:0008150~biological_process	36	603	5.97014925373134	0.00027484588364024	0.00324829193998397	1	1	0.428617737340414	0.993627075303383	0.029676494342304
down	BCL10; PTPRC; G0S2; PDIA3; PAK2; ITM2C;	GO:2001238~positive regulation of extrinsic apoptotic signaling pathway	6	25	24	0.00027735243067139	0.00327049970284913	1	1	0.429896267540664	0.993627075303383	0.0298793851418995
down	ROCK2; ABL1; CXCL8; CXCR3; PTPRJ; ROCK1; PTK2B; CBLL1;	GO:0030155~regulation of cell adhesion	8	49	16.3265306122449	0.00028626644937157	0.00333785399133031	1	1	0.434567536646669	0.993627075303383	0.0304947359779612
down	TLR4; RARA; PTPN6; ARRB2; SIRPA; HSF1; NLRC3; IRAK3;	GO:0032720~negative regulation of tumor necrosis factor production	8	49	16.3265306122449	0.00028626644937157	0.00333785399133031	1	1	0.434567536646669	0.993627075303383	0.0304947359779612
down	CTNS; NF1; C5AR1; NIPBL; CYFIP1; METTL23; MAGT1; CHMP2B;	GO:0050890~cognition	8	49	16.3265306122449	0.00028626644937157	0.00333785399133031	1	1	0.434567536646669	0.993627075303383	0.0304947359779612
down	CNOT1; TDRD6; EDF1; CLPTM1; OSM; CUX1; DCAF7; DAB2; NOTCH2; CLC; MCL1; ZNF267; DIP2A; HLX; ZC3H13; SLCO4C1; CBLL1; SPRED2; ERC1; WDFY3; LSM14A; FAM3C; LSM14B; PDGFD; EBF1; TBX21; MERTK; RARA; PPARA; DDR2; FGFR1; PPARG;	GO:0007275~multicellular organism development	32	513	6.23781676413255	0.0002870110449582	0.00333906599625486	1	1	0.43502221723159	0.993627075303383	0.0305058088919575
down	VCP; CREB3L2; ERN1; SERP1; RHBDD2; CALR; HERPUD2; CANX;	GO:0030968~endoplasmic reticulum unfolded protein response	8	50	16	0.0003234206378746	0.00372908736364448	1	1	0.452901298664267	0.993627075303383	0.0340690560127729
down	PTPRC; F2R; CCR7; ITPR1; RASA3; MCOLN2; P2RX7; MCOLN1;	GO:0051209~release of sequestered calcium ion into cytosol	8	50	16	0.0003234206378746	0.00372908736364448	1	1	0.452901298664267	0.993627075303383	0.0340690560127729
down	PPM1G; PPM1F; PPP5C; DUSP4; DUSP10;	GO:0035970~peptidyl-threonine dephosphorylation	5	16	31.25	0.00032701448616978	0.00372908736364448	1	1	0.454550135776002	0.993627075303383	0.0340690560127729
down	AP3B1; AP3D1; BLOC1S4; BLOC1S6; AP3M1;	GO:0048490~anterograde synaptic vesicle transport	5	16	31.25	0.00032701448616978	0.00372908736364448	1	1	0.454550135776002	0.993627075303383	0.0340690560127729
down	ICAM1; NFKB1; SELPLG; PID1; SBNO2;	GO:0071354~cellular response to interleukin-6	5	16	31.25	0.00032701448616978	0.00372908736364448	1	1	0.454550135776002	0.993627075303383	0.0340690560127729
down	IQGAP1; MDM2; DOCK4; SSH1; DOCK5;	GO:1904754~positive regulation of vascular associated smooth muscle cell migration	5	16	31.25	0.00032701448616978	0.00372908736364448	1	1	0.454550135776002	0.993627075303383	0.0340690560127729
down	STK25; SLC9A3R1; YWHAZ; COPG1;	GO:0051683~establishment of Golgi localization	4	8	50	0.00032769033241542	0.00372908736364448	1	1	0.454834181392603	0.993627075303383	0.0340690560127729
down	ABL1; VIM; MAPK1; MAP2K1;	GO:0060020~Bergmann glial cell differentiation	4	8	50	0.00032769033241542	0.00372908736364448	1	1	0.454834181392603	0.993627075303383	0.0340690560127729
down	RNF40; CDK9; RNF20; CTR9;	GO:1900364~negative regulation of mRNA polyadenylation	4	8	50	0.00032769033241542	0.00372908736364448	1	1	0.454834181392603	0.993627075303383	0.0340690560127729
down	UBA6; RARA; ATP2B4; PAFAH1B1; PTPRS; NCOA1; BBS4; PPP1R9B; FEZ1;	GO:0021766~hippocampus development	9	64	14.0625	0.00032995286670944	0.00374665433832167	1	1	0.455916044432201	0.993627075303383	0.0342295484297881
down	GPS1; DUSP4; SPRED2; SPRED1; LAX1; DUSP10;	GO:0000188~inactivation of MAPK activity	6	26	23.0769230769231	0.00033274266208627	0.00375379817054902	1	1	0.457188417706537	0.993627075303383	0.0342948146991365
down	UGDH; CHSY1; XYLT1; CHST11; CHST12; DSE;	GO:0030206~chondroitin sulfate biosynthetic process	6	26	23.0769230769231	0.00033274266208627	0.00375379817054902	1	1	0.457188417706537	0.993627075303383	0.0342948146991365
down	TLR4; RIPK2; TLR2; MAVS; RNF135; TBK1;	GO:0032728~positive regulation of interferon-beta production	6	26	23.0769230769231	0.00033274266208627	0.00375379817054902	1	1	0.457188417706537	0.993627075303383	0.0342948146991365
down	PSMA7; PSMB4; PSMD4; PSME3; PSMD2; PSMB7; PSMD1; PSMD13;	GO:0006521~regulation of cellular amino acid metabolic process	8	51	15.6862745098039	0.00036441285127331	0.00406706591185545	1	1	0.471550229547663	0.993627075303383	0.0371568383485725
down	ICAM1; HCK; CCR7; MTOR; RHOA; GRB2; PTK2B; CDC42EP3;	GO:0030838~positive regulation of actin filament polymerization	8	51	15.6862745098039	0.00036441285127331	0.00406706591185545	1	1	0.471550229547663	0.993627075303383	0.0371568383485725
down	XRCC6; NFKB1; STAT6; LRRFIP1; CREBBP; TBK1; DDX41; CD14;	GO:0032481~positive regulation of type I interferon production	8	51	15.6862745098039	0.00036441285127331	0.00406706591185545	1	1	0.471550229547663	0.993627075303383	0.0371568383485725
down	UFL1; PICALM; RABGAP1L; TBC1D1; PLEKHM2; FBXW7; SWAP70; VPS4A;	GO:0032880~regulation of protein localization	8	51	15.6862745098039	0.00036441285127331	0.00406706591185545	1	1	0.471550229547663	0.993627075303383	0.0371568383485725
down	CAPN2; DNMT1; MTOR; CPEB4; RRAGA; PDGFD; PDGFC; SH3BP4;	GO:0071230~cellular response to amino acid stimulus	8	51	15.6862745098039	0.00036441285127331	0.00406706591185545	1	1	0.471550229547663	0.993627075303383	0.0371568383485725
down	BHLHE40; TOP1; AHR; NAMPT; PPARA; MTA1; ZFHX3; RAI1; HUWE1;	GO:0032922~circadian regulation of gene expression	9	65	13.8461538461538	0.00036575439949027	0.00407331609004976	1	1	0.472188929741939	0.993627075303383	0.0372139401673896
down	MYC; PTPRC; PARP1; LIG4; CCL7; DCUN1D3;	GO:0010332~response to gamma radiation	6	27	22.2222222222222	0.00039642901720293	0.0043775170289443	1	1	0.484713887737544	0.993627075303383	0.0399931292331581
down	PDPK1; BCR; SRC; PTK2B; PEAK1; RCC2;	GO:0048041~focal adhesion assembly	6	27	22.2222222222222	0.00039642901720293	0.0043775170289443	1	1	0.484713887737544	0.993627075303383	0.0399931292331581
down	CCL4; F2R; ARRB2; CCR1; CACNA1D; P2RX4;	GO:0051928~positive regulation of calcium ion transport	6	27	22.2222222222222	0.00039642901720293	0.0043775170289443	1	1	0.484713887737544	0.993627075303383	0.0399931292331581
down	SPTLC2; SGPL1; CSNK1G2; KDSR; PPM1L; CERS2; SPHK1; ELOVL7;	GO:0030148~sphingolipid biosynthetic process	8	52	15.3846153846154	0.00040953456590331	0.00446354085277694	1	1	0.489166450051458	0.993627075303383	0.0407790455142191
down	TIMP1; ANXA5; ANXA4; CCAR2; WDTC1; FAF2; PPP1R12C; FNIP2;	GO:0043086~negative regulation of catalytic activity	8	52	15.3846153846154	0.00040953456590331	0.00446354085277694	1	1	0.489166450051458	0.993627075303383	0.0407790455142191
down	HMGB1; CCR1; CCR7; PIK3CG; CCR5;	GO:0002407~dendritic cell chemotaxis	5	17	29.4117647058824	0.00041278332521843	0.00446354085277694	1	1	0.490134494027021	0.993627075303383	0.0407790455142191
down	CYTH3; IQSEC1; PSD4; GBF1; CYTH4;	GO:0032012~regulation of ARF protein signal transduction	5	17	29.4117647058824	0.00041278332521843	0.00446354085277694	1	1	0.490134494027021	0.993627075303383	0.0407790455142191
down	MLH1; LIG4; EXOSC6; RNF168; SWAP70;	GO:0045190~isotype switching	5	17	29.4117647058824	0.00041278332521843	0.00446354085277694	1	1	0.490134494027021	0.993627075303383	0.0407790455142191
down	ROCK2; ZFP36; RUNX1; ZFP36L1; ROCK1;	GO:0045616~regulation of keratinocyte differentiation	5	17	29.4117647058824	0.00041278332521843	0.00446354085277694	1	1	0.490134494027021	0.993627075303383	0.0407790455142191
down	THBS1; PPM1F; AIF1; STX4; STX3;	GO:0050921~positive regulation of chemotaxis	5	17	29.4117647058824	0.00041278332521843	0.00446354085277694	1	1	0.490134494027021	0.993627075303383	0.0407790455142191
down	NUP62; CLTC; DCTN1; DYNC1H1; NUMA1;	GO:0060236~regulation of mitotic spindle organization	5	17	29.4117647058824	0.00041278332521843	0.00446354085277694	1	1	0.490134494027021	0.993627075303383	0.0407790455142191
down	CHMP2A; PDCD6IP; CHMP4B; VPS4A; CHMP2B;	GO:0061952~midbody abscission	5	17	29.4117647058824	0.00041278332521843	0.00446354085277694	1	1	0.490134494027021	0.993627075303383	0.0407790455142191
down	IL1R2; ABCD1; SIRPA; NLRC3; CHID1;	GO:1900016~negative regulation of cytokine production involved in inflammatory response	5	17	29.4117647058824	0.00041278332521843	0.00446354085277694	1	1	0.490134494027021	0.993627075303383	0.0407790455142191
down	ROCK2; EEF2; REST; CPEB4; P2RX4; P2RX7; CIB1; HYOU1;	GO:0002931~response to ischemia	8	53	15.0943396226415	0.00045909057443438	0.00493356716278765	1	1	0.504081450728954	0.993627075303383	0.0450732202335751
down	MARK3; WWC2; DLG5; WWC3;	GO:0035331~negative regulation of hippo signaling	4	9	44.4444444444444	0.00046210321436279	0.0049455481586425	1	1	0.504962081672889	0.993627075303383	0.0451826789775152
down	RTN3; RAB10; TMEM170A; TMEM33;	GO:0071786~endoplasmic reticulum tubular network organization	4	9	44.4444444444444	0.00046210321436279	0.0049455481586425	1	1	0.504962081672889	0.993627075303383	0.0451826789775152
down	ICAM1; PTPRC; ITGAL; MSN; ROCK1; FERMT3;	GO:0007159~leukocyte cell-cell adhesion	6	28	21.4285714285714	0.00046924539787318	0.00496607946607529	1	1	0.507091642613039	0.993627075303383	0.0453702536290942
down	IL1A; C5AR1; PTGS2; C3AR1; HIF1A; HPSE;	GO:0010575~positive regulation of vascular endothelial growth factor production	6	28	21.4285714285714	0.00046924539787318	0.00496607946607529	1	1	0.507091642613039	0.993627075303383	0.0453702536290942
down	TLR4; TLR2; HMGB1; MAVS; PARK7; TLR7;	GO:0032757~positive regulation of interleukin-8 production	6	28	21.4285714285714	0.00046924539787318	0.00496607946607529	1	1	0.507091642613039	0.993627075303383	0.0453702536290942
down	MYC; SKI; NF1; EMD; NLRC3; CD300A;	GO:0048147~negative regulation of fibroblast proliferation	6	28	21.4285714285714	0.00046924539787318	0.00496607946607529	1	1	0.507091642613039	0.993627075303383	0.0453702536290942
down	CA2; SLC9A1; TM9SF4; CHP1; SLC9A8; SLC9A7;	GO:0051453~regulation of intracellular pH	6	28	21.4285714285714	0.00046924539787318	0.00496607946607529	1	1	0.507091642613039	0.993627075303383	0.0453702536290942
down	HGF; LIMS1; RBPJ; HIF1A; AKNA; DLG5; HNRNPAB;	GO:0001837~epithelial to mesenchymal transition	7	40	17.5	0.00047164415497069	0.00496607946607529	1	1	0.507816113580665	0.993627075303383	0.0453702536290942
down	HEXB; STS; ASAH1; SUMF2; NEU1; ESYT1; GBA2;	GO:0006687~glycosphingolipid metabolic process	7	40	17.5	0.00047164415497069	0.00496607946607529	1	1	0.507816113580665	0.993627075303383	0.0453702536290942
down	CHMP2A; NUP62; DCTN2; PDCD6IP; CHMP4B; VPS4A; CHMP2B;	GO:0007080~mitotic metaphase plate congression	7	40	17.5	0.00047164415497069	0.00496607946607529	1	1	0.507816113580665	0.993627075303383	0.0453702536290942
down	TMED10; ROCK1; PICALM;	GO:1902003~regulation of amyloid-beta formation	3	3	100	0.00050158710240599	0.00520771310306785	1	1	0.515117310985774	0.993627075303383	0.0475778259143475
down	TLR4; REST; TLR6;	GO:1903223~positive regulation of oxidative stress-induced neuron death	3	3	100	0.00050158710240599	0.00520771310306785	1	1	0.515117310985774	0.993627075303383	0.0475778259143475
down	VEGFA; BMP6; RDX;	GO:1903392~negative regulation of adherens junction organization	3	3	100	0.00050158710240599	0.00520771310306785	1	1	0.515117310985774	0.993627075303383	0.0475778259143475
down	ROCK2; PPP3CA; ROCK1;	GO:1905205~positive regulation of connective tissue replacement	3	3	100	0.00050158710240599	0.00520771310306785	1	1	0.515117310985774	0.993627075303383	0.0475778259143475
down	PAK2; RFFL; RNF34;	GO:2001271~negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis	3	3	100	0.00050158710240599	0.00520771310306785	1	1	0.515117310985774	0.993627075303383	0.0475778259143475
down	NRP2; ROCK2; ABL1; THBS1; VEGFA; CALR; BMPR2; PTK2B;	GO:0010595~positive regulation of endothelial cell migration	8	54	14.8148148148148	0.00051339903884095	0.00524748252702227	1	1	0.517664061770123	0.993627075303383	0.0479411605858566
down	AQP9; SLC8A1; AHR; PIK3CG; RAP1B; ZFP36L1; RAPGEF1; RAPGEF2;	GO:0071320~cellular response to cAMP	8	54	14.8148148148148	0.00051339903884095	0.00524748252702227	1	1	0.517664061770123	0.993627075303383	0.0479411605858566
down	CALM3; EIF4G1; SPRED2; SPRED1; SIRT2;	GO:0010801~negative regulation of peptidyl-threonine phosphorylation	5	18	27.7777777777778	0.00051447881260713	0.00524748252702227	1	1	0.517954243565084	0.993627075303383	0.0479411605858566
down	BMPR2; XYLT1; CHST11; CHST10; CHST12;	GO:0030166~proteoglycan biosynthetic process	5	18	27.7777777777778	0.00051447881260713	0.00524748252702227	1	1	0.517954243565084	0.993627075303383	0.0479411605858566
down	TLR4; RIPK2; CD14; NFKBIA; PIK3AP1;	GO:0034142~toll-like receptor 4 signaling pathway	5	18	27.7777777777778	0.00051447881260713	0.00524748252702227	1	1	0.517954243565084	0.993627075303383	0.0479411605858566
down	FLNA; C5AR1; TFCP2; HIF1A; SUPT6H;	GO:0042789~mRNA transcription by RNA polymerase II	5	18	27.7777777777778	0.00051447881260713	0.00524748252702227	1	1	0.517954243565084	0.993627075303383	0.0479411605858566
down	ADA; F2R; PTGS2; PROK2; SPHK1;	GO:0045987~positive regulation of smooth muscle contraction	5	18	27.7777777777778	0.00051447881260713	0.00524748252702227	1	1	0.517954243565084	0.993627075303383	0.0479411605858566
down	SRGAP2; FGD3; FGD5; SPATA13; PPP1R9B;	GO:0046847~filopodium assembly	5	18	27.7777777777778	0.00051447881260713	0.00524748252702227	1	1	0.517954243565084	0.993627075303383	0.0479411605858566
down	HMGB1; FPR2; CCR1; AIF1; PLA2G7;	GO:0090026~positive regulation of monocyte chemotaxis	5	18	27.7777777777778	0.00051447881260713	0.00524748252702227	1	1	0.517954243565084	0.993627075303383	0.0479411605858566
down	FOXO3; ULK1; ZFP36; HMGCL; PPARG; DHODH; PDK4;	GO:0042594~response to starvation	7	41	17.0731707317073	0.00053800855377272	0.00547675894973332	1	1	0.523123807126717	0.993627075303383	0.0500358369841368
down	PARP1; RPA2; RPA1; RAD23B; XPC; GTF2H2;	GO:0006294~nucleotide-excision repair, preincision complex assembly	6	29	20.6896551724138	0.00055206565601151	0.00559798871426461	1	1	0.526118570178972	0.993627075303383	0.0511433958143475
down	MYC; SMARCA4; TLE3; TLE4; BCL9L; CREBBP;	GO:1904837~beta-catenin-TCF complex assembly	6	29	20.6896551724138	0.00055206565601151	0.00559798871426461	1	1	0.526118570178972	0.993627075303383	0.0511433958143475
down	APAF1; TPP1; CXCL1; VEGFA; SMARCA4; NOTCH2; DCTN1; DPYSL2; TMEM41B; SMARCC2; ST8SIA4; SMARCC1; NINJ1; P2RX5; ZBTB45; FEZ1; CRIM1; FEZ2; ARHGAP26; UNC119B; MERTK;	GO:0007399~nervous system development	21	294	7.14285714285714	0.00061681719290207	0.00610889469505176	1	1	0.538184236185684	0.993627075303383	0.0558110484540773
down	CCRL2; ROCK2; TULP3; TRIO; ABCA1; CXCL1; CALM3; CXCL8; IGF2R; SRC; CCL4; RAC2; CXCL3; C5AR1; FPR3; FPR2; F2R; PDE4A; PTPN6; ARRB2; CCR1; CCR7; PPARG; CXCL5; PIK3CG; CXCR3; CCR5; RHOA; GNB1; AKAP12; GNA12; APLP2; CXCL9; SOS2; AKAP13; ABR; ROCK1; C3AR1; CALCRL; FGD3; ADGRG5; PREX1; PIK3R5; CMKLR1; ADGRE3; CXCL16; PLEKHG2; PROK2; ARHGEF12; ADGRE2; VAV3; RAPGEF2; OPN3; CCL2; CCL22; CCL7; RIC8A;	GO:0007186~G protein-coupled receptor signaling pathway	57	1152	4.94791666666667	0.00062293235407107	0.00610889469505176	1	1	0.539211300038553	0.993627075303383	0.0558110484540773
down	HK1; MAN2C1; MAN2B1; MAN2A2;	GO:0006013~mannose metabolic process	4	10	40	0.00063161542274126	0.00610889469505176	1	1	0.540653688250396	0.993627075303383	0.0558110484540773
down	ST3GAL2; GBGT1; B3GNT5; SCCPDH;	GO:0009247~glycolipid biosynthetic process	4	10	40	0.00063161542274126	0.00610889469505176	1	1	0.540653688250396	0.993627075303383	0.0558110484540773
down	AP2A2; CLTA; AP2B1; CLTC;	GO:0032802~low-density lipoprotein particle receptor catabolic process	4	10	40	0.00063161542274126	0.00610889469505176	1	1	0.540653688250396	0.993627075303383	0.0558110484540773
down	MAPK1; MAP2K2; MAP2K1; NBR1;	GO:0032872~regulation of stress-activated MAPK cascade	4	10	40	0.00063161542274126	0.00610889469505176	1	1	0.540653688250396	0.993627075303383	0.0558110484540773
down	HMGB1; LIG3; LIG4; DCLRE1C;	GO:0033151~V(D)J recombination	4	10	40	0.00063161542274126	0.00610889469505176	1	1	0.540653688250396	0.993627075303383	0.0558110484540773
down	DCTN1; HOOK3; BBS4; NINL;	GO:0034454~microtubule anchoring at centrosome	4	10	40	0.00063161542274126	0.00610889469505176	1	1	0.540653688250396	0.993627075303383	0.0558110484540773
down	AP3D1; CD63; ANKRD27; BLOC1S6;	GO:0035646~endosome to melanosome transport	4	10	40	0.00063161542274126	0.00610889469505176	1	1	0.540653688250396	0.993627075303383	0.0558110484540773
down	PTPN6; ZFP36L1; CARD11; IKZF3;	GO:0045577~regulation of B cell differentiation	4	10	40	0.00063161542274126	0.00610889469505176	1	1	0.540653688250396	0.993627075303383	0.0558110484540773
down	ZFP36; STAT5B; ZFP36L1; MAFB;	GO:0045647~negative regulation of erythrocyte differentiation	4	10	40	0.00063161542274126	0.00610889469505176	1	1	0.540653688250396	0.993627075303383	0.0558110484540773
down	MTOR; ELL; BRF1; CHD8;	GO:0045945~positive regulation of transcription by RNA polymerase III	4	10	40	0.00063161542274126	0.00610889469505176	1	1	0.540653688250396	0.993627075303383	0.0558110484540773
down	PTPRC; CD40; MLH1; TBX21;	GO:0048304~positive regulation of isotype switching to IgG isotypes	4	10	40	0.00063161542274126	0.00610889469505176	1	1	0.540653688250396	0.993627075303383	0.0558110484540773
down	ITGAV; PTPRC; HCK; SPHK1;	GO:0050764~regulation of phagocytosis	4	10	40	0.00063161542274126	0.00610889469505176	1	1	0.540653688250396	0.993627075303383	0.0558110484540773
down	TLR4; RIPK2; TLR2; CD14;	GO:0071223~cellular response to lipoteichoic acid	4	10	40	0.00063161542274126	0.00610889469505176	1	1	0.540653688250396	0.993627075303383	0.0558110484540773
down	CHMP2A; CHMP4B; VPS4A; CHMP2B;	GO:1902188~positive regulation of viral release from host cell	4	10	40	0.00063161542274126	0.00610889469505176	1	1	0.540653688250396	0.993627075303383	0.0558110484540773
down	CHMP2A; IST1; VPS4A; CHMP2B;	GO:1904903~ESCRT III complex disassembly	4	10	40	0.00063161542274126	0.00610889469505176	1	1	0.540653688250396	0.993627075303383	0.0558110484540773
down	TOR1A; RAB11B; GBF1; ABCA2;	GO:2000008~regulation of protein localization to cell surface	4	10	40	0.00063161542274126	0.00610889469505176	1	1	0.540653688250396	0.993627075303383	0.0558110484540773
down	ARID1A; SMARCA4; ARID2; SMARCC2; SMARCC1;	GO:0006337~nucleosome disassembly	5	19	26.3157894736842	0.000633904480279	0.00610889469505176	1	1	0.540947161176615	0.993627075303383	0.0558110484540773
down	SCAMP2; RP2; STX4; GBF1; MYO5A;	GO:0006892~post-Golgi vesicle-mediated transport	5	19	26.3157894736842	0.000633904480279	0.00610889469505176	1	1	0.540947161176615	0.993627075303383	0.0558110484540773
down	MAP2K7; AQP9; NFAT5; PTK2B; TSC22D4;	GO:0006970~response to osmotic stress	5	19	26.3157894736842	0.000633904480279	0.00610889469505176	1	1	0.540947161176615	0.993627075303383	0.0558110484540773
down	TLR4; RIPK2; TLR2; HIF1A; TLR7;	GO:0032722~positive regulation of chemokine production	5	19	26.3157894736842	0.000633904480279	0.00610889469505176	1	1	0.540947161176615	0.993627075303383	0.0558110484540773
down	SLC9A3R1; RAC2; TRPT1; SMG8; CAMKK2;	GO:0045859~regulation of protein kinase activity	5	19	26.3157894736842	0.000633904480279	0.00610889469505176	1	1	0.540947161176615	0.993627075303383	0.0558110484540773
down	TNFSF14; CAPN2; CXCL9; NFATC2; EHD1;	GO:1901741~positive regulation of myoblast fusion	5	19	26.3157894736842	0.000633904480279	0.00610889469505176	1	1	0.540947161176615	0.993627075303383	0.0558110484540773
down	STX7; ACTB; SPTBN1; ZDHHC7; VPS4A;	GO:1903076~regulation of protein localization to plasma membrane	5	19	26.3157894736842	0.000633904480279	0.00610889469505176	1	1	0.540947161176615	0.993627075303383	0.0558110484540773
down	FOXO3; THBS1; CCL2; CD40; FASLG;	GO:2000353~positive regulation of endothelial cell apoptotic process	5	19	26.3157894736842	0.000633904480279	0.00610889469505176	1	1	0.540947161176615	0.993627075303383	0.0558110484540773
down	CNOT1; BTG2; MDM2; TFDP1; CNOT9; ARID3A; CNOT11; PLAGL1;	GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest	8	56	14.2857142857143	0.00063761295358943	0.00610889469505176	1	1	0.54153921831369	0.993627075303383	0.0558110484540773
down	CANX; ERP29; PAFAH1B1; ARFGAP3; SEL1L; COPG1; RAB8A; RAB10;	GO:0009306~protein secretion	8	56	14.2857142857143	0.00063761295358943	0.00610889469505176	1	1	0.54153921831369	0.993627075303383	0.0558110484540773
down	PSMA7; PSMB4; PSMD4; PSME3; PSMD2; PSMB7; PSMD1; PSMD13;	GO:0010972~negative regulation of G2/M transition of mitotic cell cycle	8	56	14.2857142857143	0.00063761295358943	0.00610889469505176	1	1	0.54153921831369	0.993627075303383	0.0558110484540773
down	SIPA1L1; FARP2; PLEK; RALA; FLNA; MYH9; RHOA; AUTS2;	GO:0031532~actin cytoskeleton reorganization	8	56	14.2857142857143	0.00063761295358943	0.00610889469505176	1	1	0.54153921831369	0.993627075303383	0.0558110484540773
down	CTDNEP1; HCK; ETS2; VEGFA; EXT1; IKZF3;	GO:0007498~mesoderm development	6	30	20	0.00064580237051681	0.00613100538275706	1	1	0.542896814035725	0.993627075303383	0.0560130523720485
down	RALA; NSF; STX4; RAB21; RAB10; RAB8A;	GO:0017157~regulation of exocytosis	6	30	20	0.00064580237051681	0.00613100538275706	1	1	0.542896814035725	0.993627075303383	0.0560130523720485
down	RPN2; ST6GAL1; DDOST; MGAT5; ALG8; MAGT1;	GO:0018279~protein N-linked glycosylation via asparagine	6	30	20	0.00064580237051681	0.00613100538275706	1	1	0.542896814035725	0.993627075303383	0.0560130523720485
down	CHMP2A; FURIN; PDCD6IP; CHMP4B; VPS4A; CHMP2B;	GO:0019058~viral life cycle	6	30	20	0.00064580237051681	0.00613100538275706	1	1	0.542896814035725	0.993627075303383	0.0560130523720485
down	MAVS; RNF135; NPLOC4; TRAF3IP1; OTUD5; TBK1;	GO:0032480~negative regulation of type I interferon production	6	30	20	0.00064580237051681	0.00613100538275706	1	1	0.542896814035725	0.993627075303383	0.0560130523720485
down	BCR; PRKACA; AKAP12; ABR; PTPRS; EIF4EBP2; PXK; PPP1R9B; SLC7A11;	GO:0050804~modulation of chemical synaptic transmission	9	71	12.6760563380282	0.00065409087833856	0.00619840301436473	1	1	0.544203610777686	0.993627075303383	0.0566287991922371
down	SOCS6; WAS; HSF1; CD83; CXCL9; NLRP3; MICU1; STAT6; STAT5B;	GO:0006952~defense response	9	72	12.5	0.00071653867254928	0.00675334459552778	1	1	0.55425637381755	0.993627075303383	0.06169876242152
down	PAFAH1B1; DCTN1; NUMA1; UBXN2B; ACTR1B; ACTR1A;	GO:0000132~establishment of mitotic spindle orientation	6	31	19.3548387096774	0.0007514054730221	0.00704375058523598	1	1	0.559797077401468	0.993627075303383	0.0643519204103272
down	SRC; CCR7; PTK2B; PIK3R4; AMBRA1; VAV3;	GO:0043552~positive regulation of phosphatidylinositol 3-kinase activity	6	31	19.3548387096774	0.0007514054730221	0.00704375058523598	1	1	0.559797077401468	0.993627075303383	0.0643519204103272
down	SRC; CREB1; RDX; IQGAP1; PDGFD;	GO:0036120~cellular response to platelet-derived growth factor stimulus	5	20	25	0.00077293190252669	0.00719378763565918	1	1	0.563390348205921	0.993627075303383	0.0657226634840062
down	MYH9; TMED10; RAB10; RAB11B; DNAJC5;	GO:0045055~regulated exocytosis	5	20	25	0.00077293190252669	0.00719378763565918	1	1	0.563390348205921	0.993627075303383	0.0657226634840062
down	PRKACA; EMD; MDM2; ANP32B; RBM22;	GO:0046827~positive regulation of protein export from nucleus	5	20	25	0.00077293190252669	0.00719378763565918	1	1	0.563390348205921	0.993627075303383	0.0657226634840062
down	ZFP36; MAPKAPK2; RBM10; HNRNPA0; ELAVL1;	GO:0070935~3'-UTR-mediated mRNA stabilization	5	20	25	0.00077293190252669	0.00719378763565918	1	1	0.563390348205921	0.993627075303383	0.0657226634840062
down	NRP2; DYSF; JUN; VEGFA; NF1; BMP6; MTOR; BMPR2; HIF1A;	GO:0001938~positive regulation of endothelial cell proliferation	9	73	12.3287671232877	0.00078376157797077	0.00725571109126765	1	1	0.56509209771693	0.993627075303383	0.0662883980651256
down	POLR2D; RPA2; TCEA1; RPA1; LIG3; GPS1; GTF2H2; COPS7A; PRPF19;	GO:0006283~transcription-coupled nucleotide-excision repair	9	73	12.3287671232877	0.00078376157797077	0.00725571109126765	1	1	0.56509209771693	0.993627075303383	0.0662883980651256
down	NPC1; ABCA1; CAT; RXRA; HDLBP; APOBR; NFE2L1; STARD3; GBA2;	GO:0008203~cholesterol metabolic process	9	73	12.3287671232877	0.00078376157797077	0.00725571109126765	1	1	0.56509209771693	0.993627075303383	0.0662883980651256
down	PRDM1; RXRA; BMPR2; TMED2;	GO:0001893~maternal placenta development	4	11	36.3636363636364	0.00084090753203125	0.00755543062157543	1	1	0.574339844377347	0.993627075303383	0.0690266448452166
down	MAN2B1; HEXB; NEU1; MAN2C1;	GO:0009313~oligosaccharide catabolic process	4	11	36.3636363636364	0.00084090753203125	0.00755543062157543	1	1	0.574339844377347	0.993627075303383	0.0690266448452166
down	ABL1; CAMSAP1; PRUNE1; GBA2;	GO:0031113~regulation of microtubule polymerization	4	11	36.3636363636364	0.00084090753203125	0.00755543062157543	1	1	0.574339844377347	0.993627075303383	0.0690266448452166
down	RAP1B; RAP2B; RAPGEF1; RAPGEF2;	GO:0032486~Rap protein signal transduction	4	11	36.3636363636364	0.00084090753203125	0.00755543062157543	1	1	0.574339844377347	0.993627075303383	0.0690266448452166
down	CALR; CANX; PDIA3; DNAJC3;	GO:0034975~protein folding in endoplasmic reticulum	4	11	36.3636363636364	0.00084090753203125	0.00755543062157543	1	1	0.574339844377347	0.993627075303383	0.0690266448452166
down	MTOR; TSC2; TFDP1; BMF;	GO:0043276~anoikis	4	11	36.3636363636364	0.00084090753203125	0.00755543062157543	1	1	0.574339844377347	0.993627075303383	0.0690266448452166
down	SRP14; SEC61A1; SRPRA; SPCS3;	GO:0045047~protein targeting to ER	4	11	36.3636363636364	0.00084090753203125	0.00755543062157543	1	1	0.574339844377347	0.993627075303383	0.0690266448452166
down	BTG2; RAPGEF1; LIMS2; KDM2B;	GO:2000178~negative regulation of neural precursor cell proliferation	4	11	36.3636363636364	0.00084090753203125	0.00755543062157543	1	1	0.574339844377347	0.993627075303383	0.0690266448452166
down	ULK1; BCL6; TSC2; IST1; RAB35; MAPRE1; STK11IP; HEATR5A; TRAK1;	GO:0008104~protein localization	9	74	12.1621621621622	0.0008560281103348	0.00755543062157543	1	1	0.576349033667391	0.993627075303383	0.0690266448452166
down	HGF; ARRB2; DOCK4; CCR5; CXCR3; CCRL2; CCR1; CCR7; HMGB1;	GO:0060326~cell chemotaxis	9	74	12.1621621621622	0.0008560281103348	0.00755543062157543	1	1	0.576349033667391	0.993627075303383	0.0690266448452166
down	TNFRSF1A; RBPJ; BMPR2;	GO:0003176~aortic valve development	3	4	75	0.00085817631004847	0.00755543062157543	1	1	0.576694480352575	0.993627075303383	0.0690266448452166
down	TNFRSF1A; RBPJ; BMPR2;	GO:0003177~pulmonary valve development	3	4	75	0.00085817631004847	0.00755543062157543	1	1	0.576694480352575	0.993627075303383	0.0690266448452166
down	PPARA; PDK4; NCOR2;	GO:0010565~regulation of cellular ketone metabolic process	3	4	75	0.00085817631004847	0.00755543062157543	1	1	0.576694480352575	0.993627075303383	0.0690266448452166
down	AHR; MZB1; IKZF3;	GO:0030888~regulation of B cell proliferation	3	4	75	0.00085817631004847	0.00755543062157543	1	1	0.576694480352575	0.993627075303383	0.0690266448452166
down	F2R; SIRPA; SPHK1;	GO:0032651~regulation of interleukin-1 beta production	3	4	75	0.00085817631004847	0.00755543062157543	1	1	0.576694480352575	0.993627075303383	0.0690266448452166
down	TLR2; CD14; TLR6;	GO:0038124~toll-like receptor TLR6:TLR2 signaling pathway	3	4	75	0.00085817631004847	0.00755543062157543	1	1	0.576694480352575	0.993627075303383	0.0690266448452166
down	HMGB1; RUNX1; RUNX3;	GO:0043371~negative regulation of CD4-positive, alpha-beta T cell differentiation	3	4	75	0.00085817631004847	0.00755543062157543	1	1	0.576694480352575	0.993627075303383	0.0690266448452166
down	KEAP1; MAFG; MAFF;	GO:0045604~regulation of epidermal cell differentiation	3	4	75	0.00085817631004847	0.00755543062157543	1	1	0.576694480352575	0.993627075303383	0.0690266448452166
down	PLEK; ITPR1; SLA2;	GO:0050849~negative regulation of calcium-mediated signaling	3	4	75	0.00085817631004847	0.00755543062157543	1	1	0.576694480352575	0.993627075303383	0.0690266448452166
down	AP3B1; AP3D1; TGFBR2;	GO:0051138~positive regulation of NK T cell differentiation	3	4	75	0.00085817631004847	0.00755543062157543	1	1	0.576694480352575	0.993627075303383	0.0690266448452166
down	TLR2; CD14; TLR6;	GO:0071726~cellular response to diacyl bacterial lipopeptide	3	4	75	0.00085817631004847	0.00755543062157543	1	1	0.576694480352575	0.993627075303383	0.0690266448452166
down	MAPK1; MAP2K2; MAP2K1;	GO:0090170~regulation of Golgi inheritance	3	4	75	0.00085817631004847	0.00755543062157543	1	1	0.576694480352575	0.993627075303383	0.0690266448452166
down	SPRED2; SPRED1; CCAR2;	GO:0090311~regulation of protein deacetylation	3	4	75	0.00085817631004847	0.00755543062157543	1	1	0.576694480352575	0.993627075303383	0.0690266448452166
down	ABL1; IL1A; SPTBN1;	GO:1900042~positive regulation of interleukin-2 secretion	3	4	75	0.00085817631004847	0.00755543062157543	1	1	0.576694480352575	0.993627075303383	0.0690266448452166
down	MDM2; RFFL; RNF34;	GO:1901797~negative regulation of signal transduction by p53 class mediator	3	4	75	0.00085817631004847	0.00755543062157543	1	1	0.576694480352575	0.993627075303383	0.0690266448452166
down	MSN; RDX; VPS11;	GO:1902115~regulation of organelle assembly	3	4	75	0.00085817631004847	0.00755543062157543	1	1	0.576694480352575	0.993627075303383	0.0690266448452166
down	NONO; HIF1A; PARK7;	GO:1903377~negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway	3	4	75	0.00085817631004847	0.00755543062157543	1	1	0.576694480352575	0.993627075303383	0.0690266448452166
down	PLEKHM2; SH3GLB1; ASAP1;	GO:1903527~positive regulation of membrane tubulation	3	4	75	0.00085817631004847	0.00755543062157543	1	1	0.576694480352575	0.993627075303383	0.0690266448452166
down	DNM2; DAB2; SCYL2;	GO:2000370~positive regulation of clathrin-dependent endocytosis	3	4	75	0.00085817631004847	0.00755543062157543	1	1	0.576694480352575	0.993627075303383	0.0690266448452166
down	MYC; PDE4A; PPM1F; RAP1B; PPP3CA; REST; EFTUD2; RBM22;	GO:0035690~cellular response to drug	8	59	13.5593220338983	0.00086830054571662	0.00759416104626483	1	1	0.578186314181668	0.993627075303383	0.0693804871877173
down	JUN; VIM; SKI; BMP6; SMAD3; HIPK2; ZMIZ1; BTBD11;	GO:0060395~SMAD protein signal transduction	8	59	13.5593220338983	0.00086830054571662	0.00759416104626483	1	1	0.578186314181668	0.993627075303383	0.0693804871877173
down	CLIP1; NUMA1; MAPRE1; CHP1; CCSER2; SPAST;	GO:0001578~microtubule bundle formation	6	32	18.75	0.00086986073381045	0.00759416104626483	1	1	0.578419918789041	0.993627075303383	0.0693804871877173
down	MYH9; CNN2; EPB41L2; EPB41; ROCK1; ROCK2;	GO:0031032~actomyosin structure organization	6	32	18.75	0.00086986073381045	0.00759416104626483	1	1	0.578419918789041	0.993627075303383	0.0693804871877173
down	N4BP1; MAP1A; UBXN1; CCAR2; SMARCC1; PARK7;	GO:0032435~negative regulation of proteasomal ubiquitin-dependent protein catabolic process	6	32	18.75	0.00086986073381045	0.00759416104626483	1	1	0.578419918789041	0.993627075303383	0.0693804871877173
down	BCL2L11; ABL1; TNFRSF1A; MLH1; FNIP2; MCL1; BCL2A1;	GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage	7	45	15.5555555555556	0.00088119805576103	0.00766745286582055	1	1	0.579840487347393	0.993627075303383	0.070050083488964
down	ICAM1; MTA1; RNF168; LZIC; USP28; DCLRE1C; NABP2;	GO:0010212~response to ionizing radiation	7	45	15.5555555555556	0.00088119805576103	0.00766745286582055	1	1	0.579840487347393	0.993627075303383	0.070050083488964
down	CHMP2A; PDCD6IP; CHMP4B; VPS4A; CHMP2B;	GO:0039702~viral budding via host ESCRT complex	5	21	23.8095238095238	0.00093349380915075	0.00802866292622728	1	1	0.587198006029301	0.993627075303383	0.0733501096295012
down	TLR4; TYROBP; THBS1; MAPKAPK2; AKAP12;	GO:0042535~positive regulation of tumor necrosis factor biosynthetic process	5	21	23.8095238095238	0.00093349380915075	0.00802866292622728	1	1	0.587198006029301	0.993627075303383	0.0733501096295012
down	TYROBP; ITGAV; HMGB1; RARA; MERTK;	GO:0043277~apoptotic cell clearance	5	21	23.8095238095238	0.00093349380915075	0.00802866292622728	1	1	0.587198006029301	0.993627075303383	0.0733501096295012
down	THBS1; HMGB1; ATP2B4; PPARG; VASH1;	GO:0043537~negative regulation of blood vessel endothelial cell migration	5	21	23.8095238095238	0.00093349380915075	0.00802866292622728	1	1	0.587198006029301	0.993627075303383	0.0733501096295012
down	RPS2; UBE2L3; FBXW7; ARRDC3; DCUN1D3;	GO:0051443~positive regulation of ubiquitin-protein transferase activity	5	21	23.8095238095238	0.00093349380915075	0.00802866292622728	1	1	0.587198006029301	0.993627075303383	0.0733501096295012
down	ABL1; RB1; SLC8A1; YWHAG; CIB1;	GO:0071901~negative regulation of protein serine/threonine kinase activity	5	21	23.8095238095238	0.00093349380915075	0.00802866292622728	1	1	0.587198006029301	0.993627075303383	0.0733501096295012
down	ABL1; VEGFA; PTGS2; HDAC7; CIB1;	GO:0090050~positive regulation of cell migration involved in sprouting angiogenesis	5	21	23.8095238095238	0.00093349380915075	0.00802866292622728	1	1	0.587198006029301	0.993627075303383	0.0733501096295012
down	TULP3; PAPSS2; ENG; AKAP13; ANKRD11; MIGA2; PDGFC;	GO:0060348~bone development	7	46	15.2173913043478	0.00098932322685052	0.00849481492313828	1	1	0.5951801625827	0.993627075303383	0.0776088885060856
down	CAT; GK; CPT1A; SEL1L; APOBR; GK5;	GO:0006641~triglyceride metabolic process	6	33	18.1818181818182	0.00100218811723296	0.00856295814265277	1	1	0.597018439453004	0.993627075303383	0.0782314470401557
down	IRAK2; SRC; IL1R1; MTHFR; TRAF6; IRAK3;	GO:0070555~response to interleukin-1	6	33	18.1818181818182	0.00100218811723296	0.00856295814265277	1	1	0.597018439453004	0.993627075303383	0.0782314470401557
down	BCL2L11; FOXO3; IL1A; ITGAV; MCL1; BCL2A1;	GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand	6	33	18.1818181818182	0.00100218811723296	0.00856295814265277	1	1	0.597018439453004	0.993627075303383	0.0782314470401557
down	SASH3; PTPRC; HLA-DMB; AIF1; LILRB2; CARD11; CD274; TRAF6;	GO:0042102~positive regulation of T cell proliferation	8	61	13.1147540983607	0.00105615890164978	0.00900932928870487	1	1	0.604538211696767	0.993627075303383	0.0823095074593335
down	SLC9A1; CLCN3; PDK4; SLC9A7;	GO:0006885~regulation of pH	4	12	33.3333333333333	0.00109470026133129	0.00915823075771863	1	1	0.609889316437011	0.993627075303383	0.0836698758265835
down	TLR4; TLR2; ERC1; TLR7;	GO:0007252~I-kappaB phosphorylation	4	12	33.3333333333333	0.00109470026133129	0.00915823075771863	1	1	0.609889316437011	0.993627075303383	0.0836698758265835
down	GNA12; RFFL; RCC2; CORO1C;	GO:0010762~regulation of fibroblast migration	4	12	33.3333333333333	0.00109470026133129	0.00915823075771863	1	1	0.609889316437011	0.993627075303383	0.0836698758265835
down	JUN; PTPRC; ENG; CHP1;	GO:0031953~negative regulation of protein autophosphorylation	4	12	33.3333333333333	0.00109470026133129	0.00915823075771863	1	1	0.609889316437011	0.993627075303383	0.0836698758265835
down	SIRPA; PTPRS; NLRC3; TRAF3IP1;	GO:0032688~negative regulation of interferon-beta production	4	12	33.3333333333333	0.00109470026133129	0.00915823075771863	1	1	0.609889316437011	0.993627075303383	0.0836698758265835
down	THBS1; ARRB2; CMKLR1; IRAK3;	GO:0032695~negative regulation of interleukin-12 production	4	12	33.3333333333333	0.00109470026133129	0.00915823075771863	1	1	0.609889316437011	0.993627075303383	0.0836698758265835
down	RING1; RNF168; KDM2B; PCGF1;	GO:0035518~histone H2A monoubiquitination	4	12	33.3333333333333	0.00109470026133129	0.00915823075771863	1	1	0.609889316437011	0.993627075303383	0.0836698758265835
down	SPTLC2; ASAH1; ABCA2; SPHK1;	GO:0046512~sphingosine biosynthetic process	4	12	33.3333333333333	0.00109470026133129	0.00915823075771863	1	1	0.609889316437011	0.993627075303383	0.0836698758265835
down	ARID1A; SOCS3; MAP2K1; NOTCH2;	GO:0060674~placenta blood vessel development	4	12	33.3333333333333	0.00109470026133129	0.00915823075771863	1	1	0.609889316437011	0.993627075303383	0.0836698758265835
down	SRC; MSN; RHOA; ASAP1;	GO:0071803~positive regulation of podosome assembly	4	12	33.3333333333333	0.00109470026133129	0.00915823075771863	1	1	0.609889316437011	0.993627075303383	0.0836698758265835
down	CFLAR; ABCD1; RHOA; PARK7;	GO:1903427~negative regulation of reactive oxygen species biosynthetic process	4	12	33.3333333333333	0.00109470026133129	0.00915823075771863	1	1	0.609889316437011	0.993627075303383	0.0836698758265835
down	NFAT5; ICAM1; RHOA; TRAF6;	GO:1904996~positive regulation of leukocyte adhesion to vascular endothelial cell	4	12	33.3333333333333	0.00109470026133129	0.00915823075771863	1	1	0.609889316437011	0.993627075303383	0.0836698758265835
down	GTF2F1; TMBIM6; ACTB; DAB2; PPARA; GOLGA2; ROCK1; PARK7; GNL3L;	GO:0032091~negative regulation of protein binding	9	77	11.6883116883117	0.00110590648781794	0.00923108034101592	1	1	0.611566287763322	0.993627075303383	0.0843354318438706
down	CNOT1; ZFP36; MLH1; CNOT9; CNOT11;	GO:0000289~nuclear-transcribed mRNA poly(A) tail shortening	5	22	22.7272727272727	0.00111757707121662	0.00923108034101592	1	1	0.613288841801402	0.993627075303383	0.0843354318438706
down	UROS; ALAS1; NFE2L1; COX15; SRRD;	GO:0006783~heme biosynthetic process	5	22	22.7272727272727	0.00111757707121662	0.00923108034101592	1	1	0.613288841801402	0.993627075303383	0.0843354318438706
down	PRDM1; DNM2; AP2B1; TAB1; PLXND1;	GO:0035904~aorta development	5	22	22.7272727272727	0.00111757707121662	0.00923108034101592	1	1	0.613288841801402	0.993627075303383	0.0843354318438706
down	WDR91; RAB7A; WDR81; HOOK3; ANKRD27;	GO:0045022~early endosome to late endosome transport	5	22	22.7272727272727	0.00111757707121662	0.00923108034101592	1	1	0.613288841801402	0.993627075303383	0.0843354318438706
down	HIP1; NUP62; FASLG; CCDC88A; CNOT9;	GO:0045742~positive regulation of epidermal growth factor receptor signaling pathway	5	22	22.7272727272727	0.00111757707121662	0.00923108034101592	1	1	0.613288841801402	0.993627075303383	0.0843354318438706
down	RPA2; RPA1; VCP; NPLOC4; POLDIP2;	GO:0070987~error-free translesion synthesis	5	22	22.7272727272727	0.00111757707121662	0.00923108034101592	1	1	0.613288841801402	0.993627075303383	0.0843354318438706
down	BCR; HIF1A; SIRT2; SIRT3; AATF;	GO:2000378~negative regulation of reactive oxygen species metabolic process	5	22	22.7272727272727	0.00111757707121662	0.00923108034101592	1	1	0.613288841801402	0.993627075303383	0.0843354318438706
down	RPA2; RPA1; SMUG1; HUWE1; PARP2; POLM;	GO:0006284~base-excision repair	6	34	17.6470588235294	0.00114944002014683	0.00941962481919069	1	1	0.617653135909003	0.993627075303383	0.0860579799532175
down	EIF4G1; NSRP1; MSC; NUDCD2; HMGB1; NUDC;	GO:0032502~developmental process	6	34	17.6470588235294	0.00114944002014683	0.00941962481919069	1	1	0.617653135909003	0.993627075303383	0.0860579799532175
down	TOR1A; CTDNEP1; CALR; MDM2; TOR1AIP1; PIKFYVE;	GO:0034504~protein localization to nucleus	6	34	17.6470588235294	0.00114944002014683	0.00941962481919069	1	1	0.617653135909003	0.993627075303383	0.0860579799532175
down	APAF1; PPP1R15A; CASP4; TMBIM6; ITPR1; ERN1;	GO:0070059~intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress	6	34	17.6470588235294	0.00114944002014683	0.00941962481919069	1	1	0.617653135909003	0.993627075303383	0.0860579799532175
down	ABHD2; F2R; ZFP36; CCR1; ZFP36L1; CREB3L2; VASH1; NMNAT1;	GO:0009611~response to wounding	8	62	12.9032258064516	0.00116154050596662	0.00947409877480128	1	1	0.619300725079395	0.993627075303383	0.0865556556749042
down	TFEC; IL1A; THBS1; PRKACA; NF1; PTGS2; VCP; HSF1;	GO:0034605~cellular response to heat	8	63	12.6984126984127	0.00127513453362393	0.0103520267745295	1	1	0.635016997744719	0.993627075303383	0.0945764326857949
down	POLR2D; FGFR1; MAPK1; GTF2F1; IQGAP1; HNRNPM; GRB2; SPRED2; SPRED1;	GO:0008543~fibroblast growth factor receptor signaling pathway	9	79	11.3924050632911	0.00130302745399258	0.0104276358082294	1	1	0.638551777937624	0.993627075303383	0.0952671991262127
down	DYSF; FLNA; SMAD3; SIRT2; SNX12; IRAK3;	GO:0042177~negative regulation of protein catabolic process	6	35	17.1428571428571	0.00131269940278012	0.0104276358082294	1	1	0.639938991576049	0.993627075303383	0.0952671991262127
down	MTOR; DNM2; MDM2; PTK2B; EFTUD2; HDAC5;	GO:0042220~response to cocaine	6	35	17.1428571428571	0.00131269940278012	0.0104276358082294	1	1	0.639938991576049	0.993627075303383	0.0952671991262127
down	PARP1; RAD23B; XPC; GPS1; COPS7A;	GO:0000715~nucleotide-excision repair, DNA damage recognition	5	23	21.7391304347826	0.00132721561481342	0.0104276358082294	1	1	0.641824978657504	0.993627075303383	0.0952671991262127
down	SLC9A3R1; MTSS1; SPTBN1; SERP1; DYSF;	GO:0007009~plasma membrane organization	5	23	21.7391304347826	0.00132721561481342	0.0104276358082294	1	1	0.641824978657504	0.993627075303383	0.0952671991262127
down	TPP1; SRC; RAC2; PTK2B; TRAF6;	GO:0045453~bone resorption	5	23	21.7391304347826	0.00132721561481342	0.0104276358082294	1	1	0.641824978657504	0.993627075303383	0.0952671991262127
down	CA2; CREB1; CCR1; NOTCH2; TRAF6;	GO:0045672~positive regulation of osteoclast differentiation	5	23	21.7391304347826	0.00132721561481342	0.0104276358082294	1	1	0.641824978657504	0.993627075303383	0.0952671991262127
down	SMAD3; EIF4H; NIPBL; CHST11; ZMIZ1;	GO:0048589~developmental growth	5	23	21.7391304347826	0.00132721561481342	0.0104276358082294	1	1	0.641824978657504	0.993627075303383	0.0952671991262127
down	PRDM1; VEGFA; ENG; NF1; ZMIZ1;	GO:0048844~artery morphogenesis	5	23	21.7391304347826	0.00132721561481342	0.0104276358082294	1	1	0.641824978657504	0.993627075303383	0.0952671991262127
down	BCL2L11; ZFP36; UBE2L3; ZFP36L1; REST;	GO:0071385~cellular response to glucocorticoid stimulus	5	23	21.7391304347826	0.00132721561481342	0.0104276358082294	1	1	0.641824978657504	0.993627075303383	0.0952671991262127
down	FOXO3; FOXO1; REST; SS18; HOOK3;	GO:0097150~neuronal stem cell population maintenance	5	23	21.7391304347826	0.00132721561481342	0.0104276358082294	1	1	0.641824978657504	0.993627075303383	0.0952671991262127
down	BCL6; PKN1; RC3H1;	GO:0002634~regulation of germinal center formation	3	5	60	0.00134246807891825	0.0104276358082294	1	1	0.643753829081719	0.993627075303383	0.0952671991262127
down	PPARG; PPARA; OSBPL8;	GO:0010891~negative regulation of sequestering of triglyceride	3	5	60	0.00134246807891825	0.0104276358082294	1	1	0.643753829081719	0.993627075303383	0.0952671991262127
down	ICAM1; MSN; ROCK1;	GO:0022614~membrane to membrane docking	3	5	60	0.00134246807891825	0.0104276358082294	1	1	0.643753829081719	0.993627075303383	0.0952671991262127
down	RAB10; DLG5; ZDHHC7;	GO:0030859~polarized epithelial cell differentiation	3	5	60	0.00134246807891825	0.0104276358082294	1	1	0.643753829081719	0.993627075303383	0.0952671991262127
down	ABCA1; ITGAV; RHOA;	GO:0038027~apolipoprotein A-I-mediated signaling pathway	3	5	60	0.00134246807891825	0.0104276358082294	1	1	0.643753829081719	0.993627075303383	0.0952671991262127
down	AHCYL1; CA2; RAB11B;	GO:0044070~regulation of anion transport	3	5	60	0.00134246807891825	0.0104276358082294	1	1	0.643753829081719	0.993627075303383	0.0952671991262127
down	BCL10; RC3H1; CD300A;	GO:0050856~regulation of T cell receptor signaling pathway	3	5	60	0.00134246807891825	0.0104276358082294	1	1	0.643753829081719	0.993627075303383	0.0952671991262127
down	GOLGA2; ALG10B; CHP1;	GO:0060050~positive regulation of protein glycosylation	3	5	60	0.00134246807891825	0.0104276358082294	1	1	0.643753829081719	0.993627075303383	0.0952671991262127
down	TOR1A; TOR1AIP1; TMEM43;	GO:0071763~nuclear membrane organization	3	5	60	0.00134246807891825	0.0104276358082294	1	1	0.643753829081719	0.993627075303383	0.0952671991262127
down	DYNC1H1; NUMA1; TTL;	GO:0090235~regulation of metaphase plate congression	3	5	60	0.00134246807891825	0.0104276358082294	1	1	0.643753829081719	0.993627075303383	0.0952671991262127
down	ROCK2; PTGS2; AIF1;	GO:0090271~positive regulation of fibroblast growth factor production	3	5	60	0.00134246807891825	0.0104276358082294	1	1	0.643753829081719	0.993627075303383	0.0952671991262127
down	PDCD6IP; CHMP4B; VPS4A;	GO:0090611~ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway	3	5	60	0.00134246807891825	0.0104276358082294	1	1	0.643753829081719	0.993627075303383	0.0952671991262127
down	ADAM10; RPL18A; ADAM9;	GO:0097327~response to antineoplastic agent	3	5	60	0.00134246807891825	0.0104276358082294	1	1	0.643753829081719	0.993627075303383	0.0952671991262127
down	MAP4K4; MAPRE2; IQSEC1;	GO:0120183~positive regulation of focal adhesion disassembly	3	5	60	0.00134246807891825	0.0104276358082294	1	1	0.643753829081719	0.993627075303383	0.0952671991262127
down	EPB41L2; EPB41; NUMA1;	GO:1904778~positive regulation of protein localization to cell cortex	3	5	60	0.00134246807891825	0.0104276358082294	1	1	0.643753829081719	0.993627075303383	0.0952671991262127
down	PTPRC; PTPRJ; RAPGEF1;	GO:1905451~positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis	3	5	60	0.00134246807891825	0.0104276358082294	1	1	0.643753829081719	0.993627075303383	0.0952671991262127
down	SRC; RAD23A; MDM2; CREBBP; FBXW7; CHFR; GGA3;	GO:0031648~protein destabilization	7	49	14.2857142857143	0.00137728300439899	0.0106349200117139	1	1	0.64825822905197	0.993627075303383	0.0971609539381608
down	ARRB2; GRK4; DNM2; GTF2H2;	GO:0002031~G protein-coupled receptor internalization	4	13	30.7692307692308	0.00139772068457866	0.0106349200117139	1	1	0.650864325024239	0.993627075303383	0.0971609539381608
down	SLC9A3R1; FHOD1; DYNC1H1; PAFAH1B1;	GO:0007097~nuclear migration	4	13	30.7692307692308	0.00139772068457866	0.0106349200117139	1	1	0.650864325024239	0.993627075303383	0.0971609539381608
down	CCL2; MCL1; NFE2L1; RHOT1;	GO:0019725~cellular homeostasis	4	13	30.7692307692308	0.00139772068457866	0.0106349200117139	1	1	0.650864325024239	0.993627075303383	0.0971609539381608
down	TLR4; RIPK2; MAVS; TBK1;	GO:0032727~positive regulation of interferon-alpha production	4	13	30.7692307692308	0.00139772068457866	0.0106349200117139	1	1	0.650864325024239	0.993627075303383	0.0971609539381608
down	SURF4; RAB6A; TMED9; TRAPPC10;	GO:0034498~early endosome to Golgi transport	4	13	30.7692307692308	0.00139772068457866	0.0106349200117139	1	1	0.650864325024239	0.993627075303383	0.0971609539381608
down	RDX; ACTB; DLG5; GOPC;	GO:0045176~apical protein localization	4	13	30.7692307692308	0.00139772068457866	0.0106349200117139	1	1	0.650864325024239	0.993627075303383	0.0971609539381608
down	ABL1; CD2; CARD11; TBX21;	GO:0045580~regulation of T cell differentiation	4	13	30.7692307692308	0.00139772068457866	0.0106349200117139	1	1	0.650864325024239	0.993627075303383	0.0971609539381608
down	MGRN1; PLEK; CXCL8; YWHAB;	GO:0045744~negative regulation of G protein-coupled receptor signaling pathway	4	13	30.7692307692308	0.00139772068457866	0.0106349200117139	1	1	0.650864325024239	0.993627075303383	0.0971609539381608
down	PRKAR1A; RC3H1; BTN2A2; CD274;	GO:0046007~negative regulation of activated T cell proliferation	4	13	30.7692307692308	0.00139772068457866	0.0106349200117139	1	1	0.650864325024239	0.993627075303383	0.0971609539381608
down	SOCS3; JAK1; IFNGR2; CDC37;	GO:0060334~regulation of interferon-gamma-mediated signaling pathway	4	13	30.7692307692308	0.00139772068457866	0.0106349200117139	1	1	0.650864325024239	0.993627075303383	0.0971609539381608
down	PRKACA; SLC9A1; ATP2B4; SIRT2;	GO:0071872~cellular response to epinephrine stimulus	4	13	30.7692307692308	0.00139772068457866	0.0106349200117139	1	1	0.650864325024239	0.993627075303383	0.0971609539381608
down	SMCR8; FEZ1; CHMP4B; FEZ2;	GO:1902902~negative regulation of autophagosome assembly	4	13	30.7692307692308	0.00139772068457866	0.0106349200117139	1	1	0.650864325024239	0.993627075303383	0.0971609539381608
down	DNM2; PDE4DIP; STX18; MYO5A;	GO:1903358~regulation of Golgi organization	4	13	30.7692307692308	0.00139772068457866	0.0106349200117139	1	1	0.650864325024239	0.993627075303383	0.0971609539381608
down	MGRN1; KLHL12; UBE2R2; HUWE1; ZNF598; KLHL21;	GO:0006513~protein monoubiquitination	6	36	16.6666666666667	0.00149307782292107	0.0113109325771288	1	1	0.662926553376957	0.993627075303383	0.103337025376174
down	ARID1A; RB1; RHOA; NCOA1; RNF14; ZMIZ1;	GO:0030521~androgen receptor signaling pathway	6	36	16.6666666666667	0.00149307782292107	0.0113109325771288	1	1	0.662926553376957	0.993627075303383	0.103337025376174
down	PTBP3; FGFR1; RUNX3; RUNX2; BCL6; RUNX1;	GO:0045595~regulation of cell differentiation	6	36	16.6666666666667	0.00149307782292107	0.0113109325771288	1	1	0.662926553376957	0.993627075303383	0.103337025376174
down	PSMA7; PSMB4; PSMD4; PSME3; CDC16; PSMD2; PSMB7; PSMD1; PSMD13;	GO:0031145~anaphase-promoting complex-dependent catabolic process	9	81	11.1111111111111	0.00152750922121381	0.0115405093762293	1	1	0.66599402044922	0.993627075303383	0.105434446022319
down	EREG; PDPK1; ABL1; SRC; IQGAP1; GRB2; PTK2B;	GO:0007173~epidermal growth factor receptor signaling pathway	7	50	14	0.00153002532213631	0.0115405093762293	1	1	0.666397479918218	0.993627075303383	0.105434446022319
down	SIPA1L1; RARA; YWHAG; MAP1A; EIF4EBP2; PTK2B; RAPGEF2;	GO:0048167~regulation of synaptic plasticity	7	50	14	0.00153002532213631	0.0115405093762293	1	1	0.666397479918218	0.993627075303383	0.105434446022319
down	ARHGAP18; PREX1; PLEKHG2; GBA2; DBNL;	GO:0030833~regulation of actin filament polymerization	5	24	20.8333333333333	0.00156448331074488	0.0117324993030249	1	1	0.669598856998809	0.993627075303383	0.107188471855464
down	CD40; CIITA; SEC61A1; KYNU; CXCL16;	GO:0034341~response to interferon-gamma	5	24	20.8333333333333	0.00156448331074488	0.0117324993030249	1	1	0.669598856998809	0.993627075303383	0.107188471855464
down	PHLPP1; GRB2; SPRED1; VRK2; STK40;	GO:0043408~regulation of MAPK cascade	5	24	20.8333333333333	0.00156448331074488	0.0117324993030249	1	1	0.669598856998809	0.993627075303383	0.107188471855464
down	SRC; CREB1; CPT1A; PDK4; PID1;	GO:0071398~cellular response to fatty acid	5	24	20.8333333333333	0.00156448331074488	0.0117324993030249	1	1	0.669598856998809	0.993627075303383	0.107188471855464
down	HIP1; APAF1; TDRD6; CLPTM1; PTPN6; GNA12; SLFN5; HLX; SLCO4C1; HUWE1; PEG10; PURB; MMP19; HTATIP2; AMBRA1; YY1AP1; DDX41; RARA; HES6; RXRA; PPARA; ETS2; PRRC2A; ETV6; PRRC2B; POU2F2; SPIB; SRC; HCK; BHLHE40; PPARG; RB1;	GO:0030154~cell differentiation	32	572	5.59440559440559	0.00157422752436753	0.0117886118635109	1	1	0.670620925380569	0.993627075303383	0.107701117921324
down	PARP1; RPA2; RPA1; LIG3; SFR1; SLX4; HELQ; NABP2; NSMCE1;	GO:0000724~double-strand break repair via homologous recombination	9	82	10.9756097560976	0.00165083816317102	0.0123268889777183	1	1	0.678201473145602	0.993627075303383	0.112618834071691
down	EREG; SERPINB2; NF1; TGFBR2; MTOR; SMAD3; NOTCH2; PPARA; C6orf89;	GO:0042060~wound healing	9	82	10.9756097560976	0.00165083816317102	0.0123268889777183	1	1	0.678201473145602	0.993627075303383	0.112618834071691
down	EGR2; NUP62; UBE2I; MDM2; PIAS4; POM121; SENP6; ZMIZ1;	GO:0016925~protein sumoylation	8	66	12.1212121212121	0.00166973758182531	0.0124323889663908	1	1	0.679745481005698	0.993627075303383	0.113582685189386
down	ROCK2; PPARG; MTOR; CCAR2; CREBBP; USP9X; FBXW7; KDM5B;	GO:0048511~rhythmic process	8	66	12.1212121212121	0.00166973758182531	0.0124323889663908	1	1	0.679745481005698	0.993627075303383	0.113582685189386
down	N4BP1; MYC; PARP1; PTGS2; CREBBP; BMF; USP28;	GO:0034644~cellular response to UV	7	51	13.7254901960784	0.00169563772976056	0.012607223748234	1	1	0.682386104470133	0.993627075303383	0.115179981094456
down	WIPF1; WAS; ABI1; CAP1;	GO:0008154~actin polymerization or depolymerization	4	14	28.5714285714286	0.00175467173631172	0.0128445914180571	1	1	0.687934982155533	0.993627075303383	0.117348579373398
down	SLC9A3R1; TSC2; NLRC3; BTN2A2;	GO:0014067~negative regulation of phosphatidylinositol 3-kinase signaling	4	14	28.5714285714286	0.00175467173631172	0.0128445914180571	1	1	0.687934982155533	0.993627075303383	0.117348579373398
down	NPC1; MTOR; SMCR8; POLDIP2;	GO:0016242~negative regulation of macroautophagy	4	14	28.5714285714286	0.00175467173631172	0.0128445914180571	1	1	0.687934982155533	0.993627075303383	0.117348579373398
down	PLEK; CCR7; MTOR; CYFIP1;	GO:0031529~ruffle organization	4	14	28.5714285714286	0.00175467173631172	0.0128445914180571	1	1	0.687934982155533	0.993627075303383	0.117348579373398
down	ULK1; ICAM1; MTOR; EIF4G1;	GO:0031669~cellular response to nutrient levels	4	14	28.5714285714286	0.00175467173631172	0.0128445914180571	1	1	0.687934982155533	0.993627075303383	0.117348579373398
down	TMED10; PICALM; TMED2; KIF13A;	GO:0035459~vesicle cargo loading	4	14	28.5714285714286	0.00175467173631172	0.0128445914180571	1	1	0.687934982155533	0.993627075303383	0.117348579373398
down	IL1A; PTPRC; STAT5B; CARD11;	GO:0045086~positive regulation of interleukin-2 biosynthetic process	4	14	28.5714285714286	0.00175467173631172	0.0128445914180571	1	1	0.687934982155533	0.993627075303383	0.117348579373398
down	ICAM1; PTGS2; LILRB2; LILRB1;	GO:0051926~negative regulation of calcium ion transport	4	14	28.5714285714286	0.00175467173631172	0.0128445914180571	1	1	0.687934982155533	0.993627075303383	0.117348579373398
down	UBA6; ACSL4; SRGAP2; PAK2;	GO:0060996~dendritic spine development	4	14	28.5714285714286	0.00175467173631172	0.0128445914180571	1	1	0.687934982155533	0.993627075303383	0.117348579373398
down	ICAM1; RAP2B; PTPRS; RAPGEF2;	GO:0090557~establishment of endothelial intestinal barrier	4	14	28.5714285714286	0.00175467173631172	0.0128445914180571	1	1	0.687934982155533	0.993627075303383	0.117348579373398
down	CNOT1; ELAVL1; ZC3H13; SAV1;	GO:2000036~regulation of stem cell population maintenance	4	14	28.5714285714286	0.00175467173631172	0.0128445914180571	1	1	0.687934982155533	0.993627075303383	0.117348579373398
down	SKAP2; CNTNAP1; KHDRBS1; LASP1; SH2D3C; BLNK; SLA2; VAV3;	GO:0009967~positive regulation of signal transduction	8	67	11.9402985074627	0.00182078716113621	0.0132726471102684	1	1	0.694488498748185	0.993627075303383	0.121259309247069
down	TLR2; CAT; ICAM1; EGR2; HADHA; MTOR; GCNT1; PPARA;	GO:0032868~response to insulin	8	67	11.9402985074627	0.00182078716113621	0.0132726471102684	1	1	0.694488498748185	0.993627075303383	0.121259309247069
down	TPP1; CFLAR; TBL1X; CTSB; MME; GZMB; HGF; CPA3; CAPN2; PDIA3; VHL; PREP; CASP4; SPCS3; ADAM8; RHBDF2; VASH1; DPP9; AMZ2; TANK; CNDP2; PARK7; MMP19; NRIP3; ADAM28; PGPEP1;	GO:0006508~proteolysis	26	436	5.96330275229358	0.00182984379567019	0.0132763694747593	1	1	0.695340642354674	0.993627075303383	0.121293316882711
down	FUCA1; GNS; SDC2; HGSNAT; HPSE;	GO:0006027~glycosaminoglycan catabolic process	5	25	20	0.00183148688648349	0.0132763694747593	1	1	0.695734782661725	0.993627075303383	0.121293316882711
down	ICAM1; NUP62; MTOR; LIMS1; ZMIZ1;	GO:0007569~cell aging	5	25	20	0.00183148688648349	0.0132763694747593	1	1	0.695734782661725	0.993627075303383	0.121293316882711
down	EREG; PLSCR1; FPR2; ADAM8; HMGB1;	GO:0045089~positive regulation of innate immune response	5	25	20	0.00183148688648349	0.0132763694747593	1	1	0.695734782661725	0.993627075303383	0.121293316882711
down	BCL2L11; FOXO3; JUN; NQO2; NF1; FASLG; RHOA;	GO:0043525~positive regulation of neuron apoptotic process	7	52	13.4615384615385	0.00187484107875735	0.0135341713330794	1	1	0.699581615680052	0.993627075303383	0.123648602531669
down	CREB1; ZFP36; PPARG; ZFP36L1; CCDC71L; CMKLR1; SAV1;	GO:0045600~positive regulation of fat cell differentiation	7	52	13.4615384615385	0.00187484107875735	0.0135341713330794	1	1	0.699581615680052	0.993627075303383	0.123648602531669
down	VEGFA; MTOR; TAB1; ARID2; NIPBL; ZMIZ1;	GO:0003007~heart morphogenesis	6	38	15.7894736842105	0.00190976861451131	0.0137292607156316	1	1	0.702610653298098	0.993627075303383	0.125430945087242
down	B3GAT3; SDC2; EXT1; XYLT1; HS3ST3B1; UGDH;	GO:0006024~glycosaminoglycan biosynthetic process	6	38	15.7894736842105	0.00190976861451131	0.0137292607156316	1	1	0.702610653298098	0.993627075303383	0.125430945087242
down	CCL2; CD40; TSC2; ZFP36L1; MERTK; SIRT2;	GO:0043491~protein kinase B signaling	6	38	15.7894736842105	0.00190976861451131	0.0137292607156316	1	1	0.702610653298098	0.993627075303383	0.125430945087242
down	WAS; WIPF1; WIPF2;	GO:0000147~actin cortical patch assembly	3	6	50	0.00196887488405251	0.0137557317636483	1	1	0.706128063283697	0.993627075303383	0.125672785390151
down	EREG; HSF1; HIPK3;	GO:0009299~mRNA transcription	3	6	50	0.00196887488405251	0.0137557317636483	1	1	0.706128063283697	0.993627075303383	0.125672785390151
down	SRC; ARSB; CORO1C;	GO:0010632~regulation of epithelial cell migration	3	6	50	0.00196887488405251	0.0137557317636483	1	1	0.706128063283697	0.993627075303383	0.125672785390151
down	RAB7A; IST1; VPS4A;	GO:0019076~viral release from host cell	3	6	50	0.00196887488405251	0.0137557317636483	1	1	0.706128063283697	0.993627075303383	0.125672785390151
down	SHTN1; WAS; RHOU;	GO:0032488~Cdc42 protein signal transduction	3	6	50	0.00196887488405251	0.0137557317636483	1	1	0.706128063283697	0.993627075303383	0.125672785390151
down	RIPK2; TLR2; PIK3AP1;	GO:0034134~toll-like receptor 2 signaling pathway	3	6	50	0.00196887488405251	0.0137557317636483	1	1	0.706128063283697	0.993627075303383	0.125672785390151
down	ANXA2; PAFAH1B1; SRC;	GO:0036035~osteoclast development	3	6	50	0.00196887488405251	0.0137557317636483	1	1	0.706128063283697	0.993627075303383	0.125672785390151
down	PARP1; MGME1; LIG3;	GO:0043504~mitochondrial DNA repair	3	6	50	0.00196887488405251	0.0137557317636483	1	1	0.706128063283697	0.993627075303383	0.125672785390151
down	FBL; PRPF31; PIH1D1;	GO:0048254~snoRNA localization	3	6	50	0.00196887488405251	0.0137557317636483	1	1	0.706128063283697	0.993627075303383	0.125672785390151
down	SLA2; SPG21; LAX1;	GO:0050851~antigen receptor-mediated signaling pathway	3	6	50	0.00196887488405251	0.0137557317636483	1	1	0.706128063283697	0.993627075303383	0.125672785390151
down	RARA; S100A10; DPH3;	GO:0051099~positive regulation of binding	3	6	50	0.00196887488405251	0.0137557317636483	1	1	0.706128063283697	0.993627075303383	0.125672785390151
down	RAB8A; GAPVD1; SLC7A11;	GO:0051223~regulation of protein transport	3	6	50	0.00196887488405251	0.0137557317636483	1	1	0.706128063283697	0.993627075303383	0.125672785390151
down	WWP2; PPM1F; SNX12;	GO:0051224~negative regulation of protein transport	3	6	50	0.00196887488405251	0.0137557317636483	1	1	0.706128063283697	0.993627075303383	0.125672785390151
down	MAPK1; TGFBR2; MAP2K1;	GO:0060440~trachea formation	3	6	50	0.00196887488405251	0.0137557317636483	1	1	0.706128063283697	0.993627075303383	0.125672785390151
down	VEGFA; RBPJ; HIF1A;	GO:0061419~positive regulation of transcription from RNA polymerase II promoter in response to hypoxia	3	6	50	0.00196887488405251	0.0137557317636483	1	1	0.706128063283697	0.993627075303383	0.125672785390151
down	CD14; SIRT2; FAM49B;	GO:0071219~cellular response to molecule of bacterial origin	3	6	50	0.00196887488405251	0.0137557317636483	1	1	0.706128063283697	0.993627075303383	0.125672785390151
down	PLEKHO1; ABI1; WASF2;	GO:0072673~lamellipodium morphogenesis	3	6	50	0.00196887488405251	0.0137557317636483	1	1	0.706128063283697	0.993627075303383	0.125672785390151
down	TULP3; PRKACA; TRAF3IP1;	GO:1901621~negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning	3	6	50	0.00196887488405251	0.0137557317636483	1	1	0.706128063283697	0.993627075303383	0.125672785390151
down	UFL1; CREB1; TMBIM6;	GO:1902065~response to L-glutamate	3	6	50	0.00196887488405251	0.0137557317636483	1	1	0.706128063283697	0.993627075303383	0.125672785390151
down	ATP2B4; SMAD3; FOXO1;	GO:1903243~negative regulation of cardiac muscle hypertrophy in response to stress	3	6	50	0.00196887488405251	0.0137557317636483	1	1	0.706128063283697	0.993627075303383	0.125672785390151
down	TAPBP; CALR; STX4;	GO:1990668~vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane	3	6	50	0.00196887488405251	0.0137557317636483	1	1	0.706128063283697	0.993627075303383	0.125672785390151
down	GALNT2; TET2; GALNT7; GALNT10; TRAK1; B3GNT5; B3GNT7;	GO:0006493~protein O-linked glycosylation	7	53	13.2075471698113	0.00206837212762656	0.0143165412074232	1	1	0.712042706522391	0.993627075303383	0.130796357591415
down	STK25; CCL4; ACTB; CAP1; RHOU; RHOA; RAC2;	GO:0007163~establishment or maintenance of cell polarity	7	53	13.2075471698113	0.00206837212762656	0.0143165412074232	1	1	0.712042706522391	0.993627075303383	0.130796357591415
down	MME; CCL2; MAPK1; PTGS2; P2RX4; P2RX7; PROK2;	GO:0019233~sensory perception of pain	7	53	13.2075471698113	0.00206837212762656	0.0143165412074232	1	1	0.712042706522391	0.993627075303383	0.130796357591415
down	SGPL1; RUNX1; NOTCH2; PICALM; GFI1; RUNX3; RUNX2;	GO:0030097~hemopoiesis	7	53	13.2075471698113	0.00206837212762656	0.0143165412074232	1	1	0.712042706522391	0.993627075303383	0.130796357591415
down	EREG; BCR; MAP2K1; RBPJ; ADAM9; ASAH1; SAV1;	GO:0030216~keratinocyte differentiation	7	53	13.2075471698113	0.00206837212762656	0.0143165412074232	1	1	0.712042706522391	0.993627075303383	0.130796357591415
down	ATRN; HEXB; EGR2; QKI; MYO5A; MBP; ZNF18;	GO:0042552~myelination	7	53	13.2075471698113	0.00206837212762656	0.0143165412074232	1	1	0.712042706522391	0.993627075303383	0.130796357591415
down	AHCYL1; ATP1A1; PRKACA; ATP2B4; SLC8A1; ASPH; ITPR1;	GO:1903779~regulation of cardiac conduction	7	53	13.2075471698113	0.00206837212762656	0.0143165412074232	1	1	0.712042706522391	0.993627075303383	0.130796357591415
down	ADA; MTOR; PPP5C; MDM2; PEA15;	GO:0043278~response to morphine	5	26	19.2307692307692	0.00213035889720836	0.014670696983799	1	1	0.715653810706161	0.993627075303383	0.134031935577661
down	ATRN; NF1; HPS3; LYST; HPS5;	GO:0043473~pigmentation	5	26	19.2307692307692	0.00213035889720836	0.014670696983799	1	1	0.715653810706161	0.993627075303383	0.134031935577661
down	NF1; PTPN6; NUP62; PTPRJ; CD300A; IRAK3;	GO:0043407~negative regulation of MAP kinase activity	6	39	15.3846153846154	0.00214842826838113	0.014670696983799	1	1	0.716283272207151	0.993627075303383	0.134031935577661
down	WWP2; BHLHE40; EOMES; RB1; FLNA; KEAP1; TRIB1; MED13;	GO:0043433~negative regulation of DNA-binding transcription factor activity	8	69	11.5942028985507	0.00215511368659971	0.014670696983799	1	1	0.716601258792995	0.993627075303383	0.134031935577661
down	WWP2; MDM2; NFX1; RNFT1; RNF19B; RNF185; TRAF6; RNF115;	GO:0051865~protein autoubiquitination	8	69	11.5942028985507	0.00215511368659971	0.014670696983799	1	1	0.716601258792995	0.993627075303383	0.134031935577661
down	GFPT2; MYC; MTOR; PID1;	GO:0006112~energy reserve metabolic process	4	15	26.6666666666667	0.00217020479173236	0.014670696983799	1	1	0.717243856685223	0.993627075303383	0.134031935577661
down	THBS1; C5AR1; C3AR1; CMKLR1;	GO:0010759~positive regulation of macrophage chemotaxis	4	15	26.6666666666667	0.00217020479173236	0.014670696983799	1	1	0.717243856685223	0.993627075303383	0.134031935577661
down	IL1R2; MDM2; GLG1; SNX12;	GO:0010955~negative regulation of protein processing	4	15	26.6666666666667	0.00217020479173236	0.014670696983799	1	1	0.717243856685223	0.993627075303383	0.134031935577661
down	EREG; TYROBP; TLR6; TRAF6;	GO:0045410~positive regulation of interleukin-6 biosynthetic process	4	15	26.6666666666667	0.00217020479173236	0.014670696983799	1	1	0.717243856685223	0.993627075303383	0.134031935577661
down	RAB29; ADA; CCR7; CARD11;	GO:0050862~positive regulation of T cell receptor signaling pathway	4	15	26.6666666666667	0.00217020479173236	0.014670696983799	1	1	0.717243856685223	0.993627075303383	0.134031935577661
down	RDX; TRIOBP; CAPZB; CAPZA2;	GO:0051016~barbed-end actin filament capping	4	15	26.6666666666667	0.00217020479173236	0.014670696983799	1	1	0.717243856685223	0.993627075303383	0.134031935577661
down	NRDC; FURIN; ADAM8; ADAM9;	GO:0051044~positive regulation of membrane protein ectodomain proteolysis	4	15	26.6666666666667	0.00217020479173236	0.014670696983799	1	1	0.717243856685223	0.993627075303383	0.134031935577661
down	PPM1F; PPP5C; PPP3CA; PPP1R15B;	GO:0070262~peptidyl-serine dephosphorylation	4	15	26.6666666666667	0.00217020479173236	0.014670696983799	1	1	0.717243856685223	0.993627075303383	0.134031935577661
down	TLR2; CAT; PTGS2; HMGCL;	GO:0070542~response to fatty acid	4	15	26.6666666666667	0.00217020479173236	0.014670696983799	1	1	0.717243856685223	0.993627075303383	0.134031935577661
down	RARA; SERPINB9; MDM2; SFR1;	GO:0071391~cellular response to estrogen stimulus	4	15	26.6666666666667	0.00217020479173236	0.014670696983799	1	1	0.717243856685223	0.993627075303383	0.134031935577661
down	THBS1; RHOA; SPRED1; HDAC5;	GO:0090051~negative regulation of cell migration involved in sprouting angiogenesis	4	15	26.6666666666667	0.00217020479173236	0.014670696983799	1	1	0.717243856685223	0.993627075303383	0.134031935577661
down	CHMP2A; RAB7A; PDCD6IP; VPS4A;	GO:1903543~positive regulation of exosomal secretion	4	15	26.6666666666667	0.00217020479173236	0.014670696983799	1	1	0.717243856685223	0.993627075303383	0.134031935577661
down	SHTN1; FLNA; NIPBL; RAPGEF2;	GO:2001224~positive regulation of neuron migration	4	15	26.6666666666667	0.00217020479173236	0.014670696983799	1	1	0.717243856685223	0.993627075303383	0.134031935577661
down	POLR2D; POU2F2; GTF2E1; GTF2F1; CDK9; GTF2A1; ELL; NABP2;	GO:0042795~snRNA transcription by RNA polymerase II	8	70	11.4285714285714	0.00233941346255628	0.0157940712005743	1	1	0.724572360737032	0.993627075303383	0.144295116721591
down	WWP2; NPC1; ICAM1; ITGAV; CTSB; LAMP1; NCAM1; SCARB2; SELPLG;	GO:0046718~viral entry into host cell	9	87	10.3448275862069	0.0023924216911908	0.0161310502645362	1	1	0.726882825068637	0.993627075303383	0.147373767738774
down	ARID1A; RXRA; PTGS2; TGFBR2; UBE2Q1; VMP1;	GO:0007566~embryo implantation	6	40	15	0.00240889708949887	0.0161793448846239	1	1	0.72748692102866	0.993627075303383	0.147814988862453
down	SRC; MTOR; CHSY1; MBD2; PPARG; PPARA;	GO:0031667~response to nutrient levels	6	40	15	0.00240889708949887	0.0161793448846239	1	1	0.72748692102866	0.993627075303383	0.147814988862453
down	FLNA; MAPK1; PTGS2; SMAD3; MAVS; RBM22;	GO:0042307~positive regulation of protein import into nucleus	6	40	15	0.00240889708949887	0.0161793448846239	1	1	0.72748692102866	0.993627075303383	0.147814988862453
down	AP3B1; FLNA; USP4; GGA3; GGA2;	GO:0034394~protein localization to cell surface	5	27	18.5185185185185	0.00246325079261434	0.0164384931256158	1	1	0.729716327585546	0.993627075303383	0.150182575104609
down	MGRN1; TULP3; RB1; VCP; RUNX2;	GO:0045879~negative regulation of smoothened signaling pathway	5	27	18.5185185185185	0.00246325079261434	0.0164384931256158	1	1	0.729716327585546	0.993627075303383	0.150182575104609
down	RAPH1; CYFIP1; AUTS2; USP9X; ULK1;	GO:0048675~axon extension	5	27	18.5185185185185	0.00246325079261434	0.0164384931256158	1	1	0.729716327585546	0.993627075303383	0.150182575104609
down	PRDM1; DNM2; AP2B1; TAB1; PLXND1;	GO:0060976~coronary vasculature development	5	27	18.5185185185185	0.00246325079261434	0.0164384931256158	1	1	0.729716327585546	0.993627075303383	0.150182575104609
down	THBS1; NQO2; TGFBR2; GRB2; PID1;	GO:2000379~positive regulation of reactive oxygen species metabolic process	5	27	18.5185185185185	0.00246325079261434	0.0164384931256158	1	1	0.729716327585546	0.993627075303383	0.150182575104609
down	ADAM10; FURIN; ECE1; METAP2; DDI2; P2RX7; CPD;	GO:0016485~protein processing	7	55	12.7272727272727	0.0025014388017145	0.0166719936503017	1	1	0.73140671422992	0.993627075303383	0.152315843027505
down	EIF3D; EIF3G; EIF3I; EIF2S2;	GO:0001732~formation of cytoplasmic translation initiation complex	4	16	25	0.00264889511329947	0.0173660897239205	1	1	0.737113189725578	0.993627075303383	0.158657125948603
down	ANP32B; FBXW7; RIC8A; BMPR2;	GO:0001944~vasculature development	4	16	25	0.00264889511329947	0.0173660897239205	1	1	0.737113189725578	0.993627075303383	0.158657125948603
down	GRAMD1B; OSBPL11; OSBPL8; OSBPL7;	GO:0015918~sterol transport	4	16	25	0.00264889511329947	0.0173660897239205	1	1	0.737113189725578	0.993627075303383	0.158657125948603
down	HEXB; CD44; SLC9A1; CHP1;	GO:0030214~hyaluronan catabolic process	4	16	25	0.00264889511329947	0.0173660897239205	1	1	0.737113189725578	0.993627075303383	0.158657125948603
down	TYROBP; PKN1; RC3H1; CD300A;	GO:0030889~negative regulation of B cell proliferation	4	16	25	0.00264889511329947	0.0173660897239205	1	1	0.737113189725578	0.993627075303383	0.158657125948603
down	HGF; CREB1; GCLM; SIRT2;	GO:0035729~cellular response to hepatocyte growth factor stimulus	4	16	25	0.00264889511329947	0.0173660897239205	1	1	0.737113189725578	0.993627075303383	0.158657125948603
down	VCP; ERLEC1; RNF185; SEL1L;	GO:0036503~ERAD pathway	4	16	25	0.00264889511329947	0.0173660897239205	1	1	0.737113189725578	0.993627075303383	0.158657125948603
down	FURIN; MDM2; PSMD2; PSMD1;	GO:0042176~regulation of protein catabolic process	4	16	25	0.00264889511329947	0.0173660897239205	1	1	0.737113189725578	0.993627075303383	0.158657125948603
down	TOR1A; CD44; FLNA; RHOA;	GO:0044319~wound healing, spreading of cells	4	16	25	0.00264889511329947	0.0173660897239205	1	1	0.737113189725578	0.993627075303383	0.158657125948603
down	DNMT1; CTR9; AUTS2; RTF1;	GO:0051571~positive regulation of histone H3-K4 methylation	4	16	25	0.00264889511329947	0.0173660897239205	1	1	0.737113189725578	0.993627075303383	0.158657125948603
down	ACTB; ARF1; WASF2; DBNL;	GO:0098974~postsynaptic actin cytoskeleton organization	4	16	25	0.00264889511329947	0.0173660897239205	1	1	0.737113189725578	0.993627075303383	0.158657125948603
down	RB1; PARP1; PARK7; TRAF6;	GO:2000679~positive regulation of transcription regulatory region DNA binding	4	16	25	0.00264889511329947	0.0173660897239205	1	1	0.737113189725578	0.993627075303383	0.158657125948603
down	XRCC6; LIG4; LIG3;	GO:0006266~DNA ligation	3	7	42.8571428571429	0.00275016326389332	0.0175875471551068	1	1	0.740197345331124	0.993627075303383	0.160680367801579
down	BRF1; GTF3C5; GTF3C1;	GO:0006384~transcription initiation from RNA polymerase III promoter	3	7	42.8571428571429	0.00275016326389332	0.0175875471551068	1	1	0.740197345331124	0.993627075303383	0.160680367801579
down	RXRA; RRAGA; HIPK2;	GO:0019048~modulation by virus of host process	3	7	42.8571428571429	0.00275016326389332	0.0175875471551068	1	1	0.740197345331124	0.993627075303383	0.160680367801579
down	GK; GK5; TKFC;	GO:0019563~glycerol catabolic process	3	7	42.8571428571429	0.00275016326389332	0.0175875471551068	1	1	0.740197345331124	0.993627075303383	0.160680367801579
down	RARA; IL1RL1; NLRP3;	GO:0032754~positive regulation of interleukin-5 production	3	7	42.8571428571429	0.00275016326389332	0.0175875471551068	1	1	0.740197345331124	0.993627075303383	0.160680367801579
down	PLEK; SRC; RAP1B;	GO:0033625~positive regulation of integrin activation	3	7	42.8571428571429	0.00275016326389332	0.0175875471551068	1	1	0.740197345331124	0.993627075303383	0.160680367801579
down	ACTN4; RXRA; PPARG;	GO:0035357~peroxisome proliferator activated receptor signaling pathway	3	7	42.8571428571429	0.00275016326389332	0.0175875471551068	1	1	0.740197345331124	0.993627075303383	0.160680367801579
down	RHOA; SPIRE1; SNX18;	GO:0036089~cleavage furrow formation	3	7	42.8571428571429	0.00275016326389332	0.0175875471551068	1	1	0.740197345331124	0.993627075303383	0.160680367801579
down	ZFP36; MAPKAPK2; ZFP36L1;	GO:0038066~p38MAPK cascade	3	7	42.8571428571429	0.00275016326389332	0.0175875471551068	1	1	0.740197345331124	0.993627075303383	0.160680367801579
down	EOMES; ZFP36L1; SSBP3;	GO:0048382~mesendoderm development	3	7	42.8571428571429	0.00275016326389332	0.0175875471551068	1	1	0.740197345331124	0.993627075303383	0.160680367801579
down	HMGB1; LIG4; LIG3;	GO:0051103~DNA ligation involved in DNA repair	3	7	42.8571428571429	0.00275016326389332	0.0175875471551068	1	1	0.740197345331124	0.993627075303383	0.160680367801579
down	WAS; WIPF2; WIPF1;	GO:0051666~actin cortical patch localization	3	7	42.8571428571429	0.00275016326389332	0.0175875471551068	1	1	0.740197345331124	0.993627075303383	0.160680367801579
down	NUMA1; TRADD; HPSE;	GO:0051798~positive regulation of hair follicle development	3	7	42.8571428571429	0.00275016326389332	0.0175875471551068	1	1	0.740197345331124	0.993627075303383	0.160680367801579
down	RIPK2; NFKBIA; OTULIN;	GO:0070431~nucleotide-binding oligomerization domain containing 2 signaling pathway	3	7	42.8571428571429	0.00275016326389332	0.0175875471551068	1	1	0.740197345331124	0.993627075303383	0.160680367801579
down	KIF3B; FYCO1; KIF13A;	GO:0072383~plus-end-directed vesicle transport along microtubule	3	7	42.8571428571429	0.00275016326389332	0.0175875471551068	1	1	0.740197345331124	0.993627075303383	0.160680367801579
down	CLTC; PICALM; RAB11B;	GO:0150093~amyloid-beta clearance by transcytosis	3	7	42.8571428571429	0.00275016326389332	0.0175875471551068	1	1	0.740197345331124	0.993627075303383	0.160680367801579
down	HIF1A; CAMKK2; PARK7;	GO:1903599~positive regulation of autophagy of mitochondrion	3	7	42.8571428571429	0.00275016326389332	0.0175875471551068	1	1	0.740197345331124	0.993627075303383	0.160680367801579
down	IQGAP1; MAP1A; NPTN;	GO:1903829~positive regulation of cellular protein localization	3	7	42.8571428571429	0.00275016326389332	0.0175875471551068	1	1	0.740197345331124	0.993627075303383	0.160680367801579
down	E2F3; SOD2; PPARG;	GO:1905461~positive regulation of vascular associated smooth muscle cell apoptotic process	3	7	42.8571428571429	0.00275016326389332	0.0175875471551068	1	1	0.740197345331124	0.993627075303383	0.160680367801579
down	WDR1; MCOLN2; IRAK4;	GO:1990266~neutrophil migration	3	7	42.8571428571429	0.00275016326389332	0.0175875471551068	1	1	0.740197345331124	0.993627075303383	0.160680367801579
down	NRP2; RARA; ENG; TGFBR2; BMPR2;	GO:0003148~outflow tract septum morphogenesis	5	28	17.8571428571429	0.00283232610968631	0.017958739274556	1	1	0.742761566658341	0.993627075303383	0.164071590338307
down	CAPZB; CAMSAP1; BCL9L; AGO4; ZMYM1;	GO:0022604~regulation of cell morphogenesis	5	28	17.8571428571429	0.00283232610968631	0.017958739274556	1	1	0.742761566658341	0.993627075303383	0.164071590338307
down	SPAG9; KIF1B; MYH9; PLEKHM2; ARL8B;	GO:0032418~lysosome localization	5	28	17.8571428571429	0.00283232610968631	0.017958739274556	1	1	0.742761566658341	0.993627075303383	0.164071590338307
down	BCL2L11; TNFSF14; STAT5B; RC3H1; P2RX7;	GO:0043029~T cell homeostasis	5	28	17.8571428571429	0.00283232610968631	0.017958739274556	1	1	0.742761566658341	0.993627075303383	0.164071590338307
down	COBL; RB1; TGFBR2; CHD8; PDGFC;	GO:0048565~digestive tract development	5	28	17.8571428571429	0.00283232610968631	0.017958739274556	1	1	0.742761566658341	0.993627075303383	0.164071590338307
down	MME; SERPINF1; NUMB; LIG4; NAP1L1;	GO:0050769~positive regulation of neurogenesis	5	28	17.8571428571429	0.00283232610968631	0.017958739274556	1	1	0.742761566658341	0.993627075303383	0.164071590338307
down	ATP6V1B2; ATP6V1C1; ATP6V1A; RAB7A; ATP6V0D1;	GO:0090383~phagosome acidification	5	28	17.8571428571429	0.00283232610968631	0.017958739274556	1	1	0.742761566658341	0.993627075303383	0.164071590338307
down	TGFBR2; MTOR; SMAD3; DAB2; BCL9L; GLIPR2;	GO:0010718~positive regulation of epithelial to mesenchymal transition	6	42	14.2857142857143	0.0030001673713278	0.0189767868196122	1	1	0.747958589269992	0.993627075303383	0.17337250379352
down	BMPR2; RUNX2; CHSY1; CHST11;	GO:0002063~chondrocyte development	4	17	23.5294117647059	0.0031952199667804	0.0199682091928771	1	1	0.754071912160176	0.993627075303383	0.182430168866313
down	TOR1A; CTDNEP1; TMEM170A; VPS4A;	GO:0006998~nuclear envelope organization	4	17	23.5294117647059	0.0031952199667804	0.0199682091928771	1	1	0.754071912160176	0.993627075303383	0.182430168866313
down	JUN; VEGFA; MYH9; PPARG;	GO:0030224~monocyte differentiation	4	17	23.5294117647059	0.0031952199667804	0.0199682091928771	1	1	0.754071912160176	0.993627075303383	0.182430168866313
down	TLR4; THBS1; IL1RL1; TLR6;	GO:0043032~positive regulation of macrophage activation	4	17	23.5294117647059	0.0031952199667804	0.0199682091928771	1	1	0.754071912160176	0.993627075303383	0.182430168866313
down	ADA; CCL4; P2RX5; P2RX4;	GO:0050850~positive regulation of calcium-mediated signaling	4	17	23.5294117647059	0.0031952199667804	0.0199682091928771	1	1	0.754071912160176	0.993627075303383	0.182430168866313
down	BCL10; CCL2; FAM49B; SIRPA;	GO:0050870~positive regulation of T cell activation	4	17	23.5294117647059	0.0031952199667804	0.0199682091928771	1	1	0.754071912160176	0.993627075303383	0.182430168866313
down	RARA; MAPK1; MAP2K1; BBS4;	GO:0060324~face development	4	17	23.5294117647059	0.0031952199667804	0.0199682091928771	1	1	0.754071912160176	0.993627075303383	0.182430168866313
down	NPC1; ABCA1; FCER1G; PPARG;	GO:0071404~cellular response to low-density lipoprotein particle stimulus	4	17	23.5294117647059	0.0031952199667804	0.0199682091928771	1	1	0.754071912160176	0.993627075303383	0.182430168866313
down	GSAP; ROCK2; PICALM; ABCA2;	GO:1902004~positive regulation of amyloid-beta formation	4	17	23.5294117647059	0.0031952199667804	0.0199682091928771	1	1	0.754071912160176	0.993627075303383	0.182430168866313
down	CFLAR; FASLG; STX4; TRADD;	GO:1902041~regulation of extrinsic apoptotic signaling pathway via death domain receptors	4	17	23.5294117647059	0.0031952199667804	0.0199682091928771	1	1	0.754071912160176	0.993627075303383	0.182430168866313
down	STX7; PTPRC; IL12RB1; P2RX7; FAM49B;	GO:0001916~positive regulation of T cell mediated cytotoxicity	5	29	17.2413793103448	0.00323975381860975	0.020125860432174	1	1	0.755268687009459	0.993627075303383	0.183870475402023
down	TNFRSF1A; TRADD; SPPL2A; OTULIN; SPHK1;	GO:0010803~regulation of tumor necrosis factor-mediated signaling pathway	5	29	17.2413793103448	0.00323975381860975	0.020125860432174	1	1	0.755268687009459	0.993627075303383	0.183870475402023
down	TSC2; HIF1A; TNFAIP8L1; TBC1D7; SH3BP4;	GO:0032007~negative regulation of TOR signaling	5	29	17.2413793103448	0.00323975381860975	0.020125860432174	1	1	0.755268687009459	0.993627075303383	0.183870475402023
down	LIG4; STAT5B; ZFP36L1; NKAP; MAFB;	GO:0033077~T cell differentiation in thymus	5	29	17.2413793103448	0.00323975381860975	0.020125860432174	1	1	0.755268687009459	0.993627075303383	0.183870475402023
down	TLR4; CD14; TANK; TBK1; TLR6;	GO:0035666~TRIF-dependent toll-like receptor signaling pathway	5	29	17.2413793103448	0.00323975381860975	0.020125860432174	1	1	0.755268687009459	0.993627075303383	0.183870475402023
down	ABCD1; HADHA; ACAA2; ACADVL; CPT1A; ECH1;	GO:0006635~fatty acid beta-oxidation	6	43	13.953488372093	0.00333345748455827	0.020609703925881	1	1	0.758316107196533	0.993627075303383	0.188290884333502
down	SEC24A; IL1A; BMP6; ADAM8; ARF1; ADAM9;	GO:0050714~positive regulation of protein secretion	6	43	13.953488372093	0.00333345748455827	0.020609703925881	1	1	0.758316107196533	0.993627075303383	0.188290884333502
down	MAN2B1; MME; EGR2; MAPK1; PAFAH1B1; PICALM; LILRB2;	GO:0007611~learning or memory	7	59	11.864406779661	0.00357348305975858	0.0220675280894096	1	1	0.765600655995165	0.993627075303383	0.201609610402576
down	RIPK2; CALM3; MAPK1; SPHK1; CAB39;	GO:0010800~positive regulation of peptidyl-threonine phosphorylation	5	30	16.6666666666667	0.00368770184571898	0.0222536713624301	1	1	0.769321631224198	0.993627075303383	0.203310221028319
down	F2R; MAPK1; MAP3K8; ADAM9; RAPGEF1; MAP3K14;	GO:0000186~activation of MAPKK activity	6	44	13.6363636363636	0.0036935293537449	0.0222536713624301	1	1	0.769321631224198	0.993627075303383	0.203310221028319
down	RPL8; RPL18A; RPL18; RPL36; DRG2; RPLP1;	GO:0002181~cytoplasmic translation	6	44	13.6363636363636	0.0036935293537449	0.0222536713624301	1	1	0.769321631224198	0.993627075303383	0.203310221028319
down	BCL2L11; ABL1; MAPK1; MAP2K1; JARID2; MAFB;	GO:0048538~thymus development	6	44	13.6363636363636	0.0036935293537449	0.0222536713624301	1	1	0.769321631224198	0.993627075303383	0.203310221028319
down	WWP2; RNF135; RNF168; PRPF19; TRAF6; RNF115;	GO:0070534~protein K63-linked ubiquitination	6	44	13.6363636363636	0.0036935293537449	0.0222536713624301	1	1	0.769321631224198	0.993627075303383	0.203310221028319
down	BCL2L11; BCL10; PKN1;	GO:0001783~B cell apoptotic process	3	8	37.5	0.00369755936298244	0.0222536713624301	1	1	0.769321631224198	0.993627075303383	0.203310221028319
down	ERN1; CPSF2; CPSF3;	GO:0006379~mRNA cleavage	3	8	37.5	0.00369755936298244	0.0222536713624301	1	1	0.769321631224198	0.993627075303383	0.203310221028319
down	ARPC5; SLC9A1; DLG5;	GO:0030011~maintenance of cell polarity	3	8	37.5	0.00369755936298244	0.0222536713624301	1	1	0.769321631224198	0.993627075303383	0.203310221028319
down	CAPN2; MAPKAPK2; SIRPA;	GO:0032675~regulation of interleukin-6 production	3	8	37.5	0.00369755936298244	0.0222536713624301	1	1	0.769321631224198	0.993627075303383	0.203310221028319
down	VPS39; VPS11; VPS4A;	GO:0034058~endosomal vesicle fusion	3	8	37.5	0.00369755936298244	0.0222536713624301	1	1	0.769321631224198	0.993627075303383	0.203310221028319
down	UGDH; LETM1; SPAST;	GO:0034214~protein hexamerization	3	8	37.5	0.00369755936298244	0.0222536713624301	1	1	0.769321631224198	0.993627075303383	0.203310221028319
down	P2RX5; P2RX4; P2RX7;	GO:0035590~purinergic nucleotide receptor signaling pathway	3	8	37.5	0.00369755936298244	0.0222536713624301	1	1	0.769321631224198	0.993627075303383	0.203310221028319
down	SRC; GRB2; CBLL1;	GO:0035635~entry of bacterium into host cell	3	8	37.5	0.00369755936298244	0.0222536713624301	1	1	0.769321631224198	0.993627075303383	0.203310221028319
down	ERN1; MARK3; MAP2K2;	GO:0036289~peptidyl-serine autophosphorylation	3	8	37.5	0.00369755936298244	0.0222536713624301	1	1	0.769321631224198	0.993627075303383	0.203310221028319
down	PPM1F; CORO1C; DUSP10;	GO:0044387~negative regulation of protein kinase activity by regulation of protein phosphorylation	3	8	37.5	0.00369755936298244	0.0222536713624301	1	1	0.769321631224198	0.993627075303383	0.203310221028319
down	TLR4; TLR7; TBK1;	GO:0045359~positive regulation of interferon-beta biosynthetic process	3	8	37.5	0.00369755936298244	0.0222536713624301	1	1	0.769321631224198	0.993627075303383	0.203310221028319
down	RAB5C; RAB5B; RAB35;	GO:0048227~plasma membrane to endosome transport	3	8	37.5	0.00369755936298244	0.0222536713624301	1	1	0.769321631224198	0.993627075303383	0.203310221028319
down	GFI1; PIH1D1; CTR9;	GO:0051569~regulation of histone H3-K4 methylation	3	8	37.5	0.00369755936298244	0.0222536713624301	1	1	0.769321631224198	0.993627075303383	0.203310221028319
down	NRDC; FURIN; ABCA2;	GO:0052548~regulation of endopeptidase activity	3	8	37.5	0.00369755936298244	0.0222536713624301	1	1	0.769321631224198	0.993627075303383	0.203310221028319
down	ROCK2; MSN; RDX;	GO:1902966~positive regulation of protein localization to early endosome	3	8	37.5	0.00369755936298244	0.0222536713624301	1	1	0.769321631224198	0.993627075303383	0.203310221028319
down	ROCK2; TNFRSF1A; ROCK1;	GO:1903140~regulation of establishment of endothelial barrier	3	8	37.5	0.00369755936298244	0.0222536713624301	1	1	0.769321631224198	0.993627075303383	0.203310221028319
down	WAS; CYFIP1; BRK1;	GO:2000601~positive regulation of Arp2/3 complex-mediated actin nucleation	3	8	37.5	0.00369755936298244	0.0222536713624301	1	1	0.769321631224198	0.993627075303383	0.203310221028319
down	ATP1A1; SLC8A1; P2RX4; P2RX7;	GO:0002028~regulation of sodium ion transport	4	18	22.2222222222222	0.00381353922045902	0.022509814741826	1	1	0.773302209376187	0.993627075303383	0.205650354763189
down	TAF4; TCF4; NCOA6; BRF1;	GO:0006352~DNA-templated transcription, initiation	4	18	22.2222222222222	0.00381353922045902	0.022509814741826	1	1	0.773302209376187	0.993627075303383	0.205650354763189
down	RBPJ; CREBBP; MAML3; PLXND1;	GO:0007221~positive regulation of transcription of Notch receptor target	4	18	22.2222222222222	0.00381353922045902	0.022509814741826	1	1	0.773302209376187	0.993627075303383	0.205650354763189
down	S100A11; TERF1; TTF1; PDS5A;	GO:0008156~negative regulation of DNA replication	4	18	22.2222222222222	0.00381353922045902	0.022509814741826	1	1	0.773302209376187	0.993627075303383	0.205650354763189
down	ACSL4; GK; ACSL1; GPAT3;	GO:0019432~triglyceride biosynthetic process	4	18	22.2222222222222	0.00381353922045902	0.022509814741826	1	1	0.773302209376187	0.993627075303383	0.205650354763189
down	SKI; NF1; CNTNAP1; SIRT2;	GO:0022011~myelination in peripheral nervous system	4	18	22.2222222222222	0.00381353922045902	0.022509814741826	1	1	0.773302209376187	0.993627075303383	0.205650354763189
down	ARAF; GNA12; GPAT3; RFFL;	GO:0032006~regulation of TOR signaling	4	18	22.2222222222222	0.00381353922045902	0.022509814741826	1	1	0.773302209376187	0.993627075303383	0.205650354763189
down	SLC8A1; P2RX5; P2RX4; P2RX7;	GO:0033198~response to ATP	4	18	22.2222222222222	0.00381353922045902	0.022509814741826	1	1	0.773302209376187	0.993627075303383	0.205650354763189
down	GZMB; PTPN6; LYST; SLAMF7;	GO:0042267~natural killer cell mediated cytotoxicity	4	18	22.2222222222222	0.00381353922045902	0.022509814741826	1	1	0.773302209376187	0.993627075303383	0.205650354763189
down	TGFBR2; NOTCH2; RBPJ; TRAF6;	GO:0043011~myeloid dendritic cell differentiation	4	18	22.2222222222222	0.00381353922045902	0.022509814741826	1	1	0.773302209376187	0.993627075303383	0.205650354763189
down	CFLAR; DYSF; MTPN; PPP3CA;	GO:0043403~skeletal muscle tissue regeneration	4	18	22.2222222222222	0.00381353922045902	0.022509814741826	1	1	0.773302209376187	0.993627075303383	0.205650354763189
down	SKI; VEGFA; NF1; RING1;	GO:0048593~camera-type eye morphogenesis	4	18	22.2222222222222	0.00381353922045902	0.022509814741826	1	1	0.773302209376187	0.993627075303383	0.205650354763189
down	THBS1; SRC; RCC2; CORO1C;	GO:0051895~negative regulation of focal adhesion assembly	4	18	22.2222222222222	0.00381353922045902	0.022509814741826	1	1	0.773302209376187	0.993627075303383	0.205650354763189
down	PRKACA; PSME3; TMF1; NFE2L1;	GO:0061136~regulation of proteasomal protein catabolic process	4	18	22.2222222222222	0.00381353922045902	0.022509814741826	1	1	0.773302209376187	0.993627075303383	0.205650354763189
down	EGR2; TBX21; MAPK6; MAPK1;	GO:0071310~cellular response to organic substance	4	18	22.2222222222222	0.00381353922045902	0.022509814741826	1	1	0.773302209376187	0.993627075303383	0.205650354763189
down	PTGS2; SSH1; P2RX4; P2RX7;	GO:0071318~cellular response to ATP	4	18	22.2222222222222	0.00381353922045902	0.022509814741826	1	1	0.773302209376187	0.993627075303383	0.205650354763189
down	ABCA1; NFE2L1; GRAMD1B; OSBPL7;	GO:0071397~cellular response to cholesterol	4	18	22.2222222222222	0.00381353922045902	0.022509814741826	1	1	0.773302209376187	0.993627075303383	0.205650354763189
down	F2R; GNB1; C5AR1; FPR3; CMKLR1; C3AR1; FPR2;	GO:0007200~phospholipase C-activating G protein-coupled receptor signaling pathway	7	60	11.6666666666667	0.00388908768640295	0.0228780192116616	1	1	0.775398490178122	0.993627075303383	0.209014282041825
down	EREG; MTSS1; RB1; RUNX3; NLRC3; SAV1; DUSP10;	GO:0050680~negative regulation of epithelial cell proliferation	7	60	11.6666666666667	0.00388908768640295	0.0228780192116616	1	1	0.775398490178122	0.993627075303383	0.209014282041825
down	FOXO3; ERN1; ICAM1; PRKACA; SERPINF1; GCLM; PPP3CA;	GO:0071333~cellular response to glucose stimulus	7	60	11.6666666666667	0.00388908768640295	0.0228780192116616	1	1	0.775398490178122	0.993627075303383	0.209014282041825
down	ACTN4; MARCKS; AIF1; NEDD9; SWAP70; RHOA;	GO:0051017~actin filament bundle assembly	6	45	13.3333333333333	0.00408165275477101	0.0239837363673805	1	1	0.781370503394401	0.993627075303383	0.219116147736829
down	PSMA7; PSMB4; PSMD4; PSME3; PSMD2; FBXW7; PSMB7; PSMD1; PSMD13;	GO:0031146~SCF-dependent proteasomal ubiquitin-dependent protein catabolic process	9	95	9.47368421052632	0.00410468025387634	0.0240918845531571	1	1	0.782158995764363	0.993627075303383	0.220104192864122
down	PGK1; OGDH; DHTKD1; HK1; GAPDH;	GO:0006096~glycolytic process	5	31	16.1290322580645	0.00417833079336072	0.02438685340985	1	1	0.784584739806984	0.993627075303383	0.222799037345018
down	EREG; SRC; GRB2; PTPN12; CDC37;	GO:0038128~ERBB2 signaling pathway	5	31	16.1290322580645	0.00417833079336072	0.02438685340985	1	1	0.784584739806984	0.993627075303383	0.222799037345018
down	RAD23B; ARID2; PDGFC; MBD2; RARA;	GO:0048568~embryonic organ development	5	31	16.1290322580645	0.00417833079336072	0.02438685340985	1	1	0.784584739806984	0.993627075303383	0.222799037345018
down	RBM3; HNRNPA1L2; HNRNPA0; HNRNPAB; CIRBP;	GO:0051252~regulation of RNA metabolic process	5	31	16.1290322580645	0.00417833079336072	0.02438685340985	1	1	0.784584739806984	0.993627075303383	0.222799037345018
down	SGPL1; SKI; ASPH; NIPBL; ANKRD11;	GO:0060325~face morphogenesis	5	31	16.1290322580645	0.00417833079336072	0.02438685340985	1	1	0.784584739806984	0.993627075303383	0.222799037345018
down	CTNS; SLC9A1; SLC8A1; LASP1; SLC15A3; SLC15A4; TOMM40L; SLC9A7; SLC9A8;	GO:0006811~ion transport	9	96	9.375	0.00437275981696728	0.0254930919083148	1	1	0.790622147201953	0.993627075303383	0.232905666043266
down	RPN2; DDOST; MGAT5; ALG8; MAGT1; GFPT2;	GO:0006487~protein N-linked glycosylation	6	46	13.0434782608696	0.00449910336774495	0.0258767663635207	1	1	0.794332021804732	0.993627075303383	0.236410927580584
down	POLR2D; GTF2F1; HNRNPM; HNRNPA0; DDX54; METTL14;	GO:0016070~RNA metabolic process	6	46	13.0434782608696	0.00449910336774495	0.0258767663635207	1	1	0.794332021804732	0.993627075303383	0.236410927580584
down	RARA; IGF2R; RXRA; BMP6; PPARG; NCOA1;	GO:0032526~response to retinoic acid	6	46	13.0434782608696	0.00449910336774495	0.0258767663635207	1	1	0.794332021804732	0.993627075303383	0.236410927580584
down	HMGB1; HGF; VEGFA; FPR2; TSC2; PTPRJ;	GO:0050918~positive chemotaxis	6	46	13.0434782608696	0.00449910336774495	0.0258767663635207	1	1	0.794332021804732	0.993627075303383	0.236410927580584
down	MAP4K4; THBS1; NF1; BCL6;	GO:0001953~negative regulation of cell-matrix adhesion	4	19	21.0526315789474	0.00450807825366017	0.0258767663635207	1	1	0.794332021804732	0.993627075303383	0.236410927580584
down	CHMP2A; PDCD6IP; CHMP4B; CHMP2B;	GO:0010824~regulation of centrosome duplication	4	19	21.0526315789474	0.00450807825366017	0.0258767663635207	1	1	0.794332021804732	0.993627075303383	0.236410927580584
down	ACTN4; MYO5A; MYO1F; MYO1G;	GO:0030050~vesicle transport along actin filament	4	19	21.0526315789474	0.00450807825366017	0.0258767663635207	1	1	0.794332021804732	0.993627075303383	0.236410927580584
down	WDR1; PTPN6; MYH9; CIB1;	GO:0030220~platelet formation	4	19	21.0526315789474	0.00450807825366017	0.0258767663635207	1	1	0.794332021804732	0.993627075303383	0.236410927580584
down	NFKB1; SPPL2A; HM13; TRAF6;	GO:0031293~membrane protein intracellular domain proteolysis	4	19	21.0526315789474	0.00450807825366017	0.0258767663635207	1	1	0.794332021804732	0.993627075303383	0.236410927580584
down	MTOR; EIF4EBP2; CCDC88A; TIPRL;	GO:0031929~TOR signaling	4	19	21.0526315789474	0.00450807825366017	0.0258767663635207	1	1	0.794332021804732	0.993627075303383	0.236410927580584
down	ELOVL7; ACSL4; ACSL1; ACSL5;	GO:0035338~long-chain fatty-acyl-CoA biosynthetic process	4	19	21.0526315789474	0.00450807825366017	0.0258767663635207	1	1	0.794332021804732	0.993627075303383	0.236410927580584
down	SRC; CSK; MDM2; ZFP36L1;	GO:0071375~cellular response to peptide hormone stimulus	4	19	21.0526315789474	0.00450807825366017	0.0258767663635207	1	1	0.794332021804732	0.993627075303383	0.236410927580584
down	DCTN2; KIAA0753; HOOK3; BBS4;	GO:0071539~protein localization to centrosome	4	19	21.0526315789474	0.00450807825366017	0.0258767663635207	1	1	0.794332021804732	0.993627075303383	0.236410927580584
down	ABL1; BCL6; NAMPT; YBX1;	GO:2000773~negative regulation of cellular senescence	4	19	21.0526315789474	0.00450807825366017	0.0258767663635207	1	1	0.794332021804732	0.993627075303383	0.236410927580584
down	UBA6; SYNJ1; TLR2; JUN; PTGS2; PPP1R9B; SYT11;	GO:0007612~learning	7	62	11.2903225806452	0.00458319361377413	0.0262501155109789	1	1	0.797250629446779	0.993627075303383	0.23982185679106
down	GAPDH; GNLY; CXCL5; CXCL9; CXCL1; CXCL3; CXCL8;	GO:0061844~antimicrobial humoral immune response mediated by antimicrobial peptide	7	62	11.2903225806452	0.00458319361377413	0.0262501155109789	1	1	0.797250629446779	0.993627075303383	0.23982185679106
down	VEGFA; G0S2; ACSL1; STAT6; HSF1; DYNC1H1; ZNF516; CMKLR1; PDGFC;	GO:0120162~positive regulation of cold-induced thermogenesis	9	97	9.27835051546392	0.00465428299018766	0.0265886404186353	1	1	0.799265365691406	0.993627075303383	0.242914630683435
down	EOMES; PRKAR1A; PRKACA; SMAD3; BMPR2;	GO:0001707~mesoderm formation	5	32	15.625	0.0047137878745771	0.0265886404186353	1	1	0.801338079957462	0.993627075303383	0.242914630683435
down	THBS1; ENG; PTK2B; OTULIN; VEGFA;	GO:0002040~sprouting angiogenesis	5	32	15.625	0.0047137878745771	0.0265886404186353	1	1	0.801338079957462	0.993627075303383	0.242914630683435
down	ABL1; RPA2; RPA1; MLH1; XPC;	GO:0006298~mismatch repair	5	32	15.625	0.0047137878745771	0.0265886404186353	1	1	0.801338079957462	0.993627075303383	0.242914630683435
down	CAT; OXA1L; SIRT3; UQCR10; NDUFS8;	GO:0009060~aerobic respiration	5	32	15.625	0.0047137878745771	0.0265886404186353	1	1	0.801338079957462	0.993627075303383	0.242914630683435
down	AQP9; ANXA5; CREB1; JUN; TIMP1;	GO:0010033~response to organic substance	5	32	15.625	0.0047137878745771	0.0265886404186353	1	1	0.801338079957462	0.993627075303383	0.242914630683435
down	NF1; HTATIP2; PLXND1; VASH1; PROK2;	GO:0045765~regulation of angiogenesis	5	32	15.625	0.0047137878745771	0.0265886404186353	1	1	0.801338079957462	0.993627075303383	0.242914630683435
down	CTSB; CAPN2; MDM2; DNAJC3; NRDC;	GO:0051603~proteolysis involved in cellular protein catabolic process	5	32	15.625	0.0047137878745771	0.0265886404186353	1	1	0.801338079957462	0.993627075303383	0.242914630683435
down	PAFAH1B1; RHOA; ROCK1; DIXDC1; TRAF3IP1;	GO:0070507~regulation of microtubule cytoskeleton organization	5	32	15.625	0.0047137878745771	0.0265886404186353	1	1	0.801338079957462	0.993627075303383	0.242914630683435
down	"NAMPT; LIG4; GRB2; TANK; RAD9A;"	GO:0071479~cellular response to ionizing radiation	5	32	15.625	0.0047137878745771	0.0265886404186353	1	1	0.801338079957462	0.993627075303383	0.242914630683435
down	ANKRD17; RDX; AIF1; EIF4G1; TFDP1;	GO:1900087~positive regulation of G1/S transition of mitotic cell cycle	5	32	15.625	0.0047137878745771	0.0265886404186353	1	1	0.801338079957462	0.993627075303383	0.242914630683435
down	UBTF; SMARCA4; PIH1D1;	GO:0001188~RNA polymerase I preinitiation complex assembly	3	9	33.3333333333333	0.00482084903983315	0.0265886404186353	1	1	0.804259663403306	0.993627075303383	0.242914630683435
down	HMGB1; TOP1; TOP3A;	GO:0006265~DNA topological change	3	9	33.3333333333333	0.00482084903983315	0.0265886404186353	1	1	0.804259663403306	0.993627075303383	0.242914630683435
down	OS9; KDELR1; KDELR2;	GO:0006621~protein retention in ER lumen	3	9	33.3333333333333	0.00482084903983315	0.0265886404186353	1	1	0.804259663403306	0.993627075303383	0.242914630683435
down	EREG; PRKAR1A; HSF1;	GO:0007143~female meiotic nuclear division	3	9	33.3333333333333	0.00482084903983315	0.0265886404186353	1	1	0.804259663403306	0.993627075303383	0.242914630683435
down	PTGS2; PTK2B; ARL13B;	GO:0010226~response to lithium ion	3	9	33.3333333333333	0.00482084903983315	0.0265886404186353	1	1	0.804259663403306	0.993627075303383	0.242914630683435
down	ABCA1; PPARG; PPARA;	GO:0010887~negative regulation of cholesterol storage	3	9	33.3333333333333	0.00482084903983315	0.0265886404186353	1	1	0.804259663403306	0.993627075303383	0.242914630683435
down	CHST10; CHST11; CHST12;	GO:0016051~carbohydrate biosynthetic process	3	9	33.3333333333333	0.00482084903983315	0.0265886404186353	1	1	0.804259663403306	0.993627075303383	0.242914630683435
down	EREG; PTGS2; TNFAIP6;	GO:0030728~ovulation	3	9	33.3333333333333	0.00482084903983315	0.0265886404186353	1	1	0.804259663403306	0.993627075303383	0.242914630683435
down	BMP6; CD180; TRAF6;	GO:0031666~positive regulation of lipopolysaccharide-mediated signaling pathway	3	9	33.3333333333333	0.00482084903983315	0.0265886404186353	1	1	0.804259663403306	0.993627075303383	0.242914630683435
down	ZFP36; MAPKAPK2; SIRPA;	GO:0032680~regulation of tumor necrosis factor production	3	9	33.3333333333333	0.00482084903983315	0.0265886404186353	1	1	0.804259663403306	0.993627075303383	0.242914630683435
down	RNF40; RNF20; CTR9;	GO:0033523~histone H2B ubiquitination	3	9	33.3333333333333	0.00482084903983315	0.0265886404186353	1	1	0.804259663403306	0.993627075303383	0.242914630683435
down	FERMT3; MZB1; TLN1;	GO:0033622~integrin activation	3	9	33.3333333333333	0.00482084903983315	0.0265886404186353	1	1	0.804259663403306	0.993627075303383	0.242914630683435
down	PDPK1; RAC2; ADGRE2;	GO:0043304~regulation of mast cell degranulation	3	9	33.3333333333333	0.00482084903983315	0.0265886404186353	1	1	0.804259663403306	0.993627075303383	0.242914630683435
down	SRC; NF1; PDK4;	GO:0045124~regulation of bone resorption	3	9	33.3333333333333	0.00482084903983315	0.0265886404186353	1	1	0.804259663403306	0.993627075303383	0.242914630683435
down	PIK3R4; CHMP2A; CHMP2B;	GO:0045324~late endosome to vacuole transport	3	9	33.3333333333333	0.00482084903983315	0.0265886404186353	1	1	0.804259663403306	0.993627075303383	0.242914630683435
down	NF1; CACNA1D; AKAP5;	GO:0045762~positive regulation of adenylate cyclase activity	3	9	33.3333333333333	0.00482084903983315	0.0265886404186353	1	1	0.804259663403306	0.993627075303383	0.242914630683435
down	CYTH3; GOLGA5; CUX1;	GO:0048193~Golgi vesicle transport	3	9	33.3333333333333	0.00482084903983315	0.0265886404186353	1	1	0.804259663403306	0.993627075303383	0.242914630683435
down	FLNA; MARCKS; AIF1;	GO:0051764~actin crosslink formation	3	9	33.3333333333333	0.00482084903983315	0.0265886404186353	1	1	0.804259663403306	0.993627075303383	0.242914630683435
down	AP3B1; ABCA1; F2R;	GO:0060155~platelet dense granule organization	3	9	33.3333333333333	0.00482084903983315	0.0265886404186353	1	1	0.804259663403306	0.993627075303383	0.242914630683435
down	TGFBR2; CCR5; ABCA2;	GO:0070723~response to cholesterol	3	9	33.3333333333333	0.00482084903983315	0.0265886404186353	1	1	0.804259663403306	0.993627075303383	0.242914630683435
down	SLC9A1; RAB11B; CHP1;	GO:0071468~cellular response to acidic pH	3	9	33.3333333333333	0.00482084903983315	0.0265886404186353	1	1	0.804259663403306	0.993627075303383	0.242914630683435
down	NPC1; RAB10; RAB11B;	GO:0090150~establishment of protein localization to membrane	3	9	33.3333333333333	0.00482084903983315	0.0265886404186353	1	1	0.804259663403306	0.993627075303383	0.242914630683435
down	PARP1; TERF1; SLX4;	GO:1904357~negative regulation of telomere maintenance via telomere lengthening	3	9	33.3333333333333	0.00482084903983315	0.0265886404186353	1	1	0.804259663403306	0.993627075303383	0.242914630683435
down	FOXO3; RHOA; FOXO1;	GO:2000177~regulation of neural precursor cell proliferation	3	9	33.3333333333333	0.00482084903983315	0.0265886404186353	1	1	0.804259663403306	0.993627075303383	0.242914630683435
down	EREG; RNF40; TIMP1; BTG2; STAT6; STAT5B;	GO:0043434~response to peptide hormone	6	47	12.7659574468085	0.00494716040692067	0.0272564482461634	1	1	0.806387146328069	0.993627075303383	0.249015743385602
down	CALM3; PRKACA; SLC8A1; GSTO1;	GO:0010881~regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion	4	20	20	0.00528291300835371	0.0275212363084626	1	1	0.813071024541502	0.993627075303383	0.25143485520742
down	SPIRE1; BBS4; AFTPH; BLOC1S6;	GO:0046907~intracellular transport	4	20	20	0.00528291300835371	0.0275212363084626	1	1	0.813071024541502	0.993627075303383	0.25143485520742
down	PTPN6; PTPRJ; LILRB4; BTN2A2;	GO:0050860~negative regulation of T cell receptor signaling pathway	4	20	20	0.00528291300835371	0.0275212363084626	1	1	0.813071024541502	0.993627075303383	0.25143485520742
down	KIF3B; KIF1B; DYNC1I2; DNAH17; DYNC1H1; KIF21B; KIF13A; KIF21A;	GO:0007018~microtubule-based movement	8	81	9.87654320987654	0.00528906989160349	0.0275212363084626	1	1	0.813071024541502	0.993627075303383	0.25143485520742
down	TIPRL; PEA15; USP28; RAD9A; DOT1L;	GO:0000077~DNA damage checkpoint	5	33	15.1515151515152	0.00529620107777973	0.0275212363084626	1	1	0.813071024541502	0.993627075303383	0.25143485520742
down	PRDM1; DNM2; AP2B1; MDM2; TRIP11;	GO:0003281~ventricular septum development	5	33	15.1515151515152	0.00529620107777973	0.0275212363084626	1	1	0.813071024541502	0.993627075303383	0.25143485520742
down	POLR2D; GTF2F1; GTF2H2; NCBP3; CMTR1;	GO:0006370~7-methylguanosine mRNA capping	5	33	15.1515151515152	0.00529620107777973	0.0275212363084626	1	1	0.813071024541502	0.993627075303383	0.25143485520742
down	AHCYL1; TUT1; CPSF2; FIP1L1; CPSF3;	GO:0006378~mRNA polyadenylation	5	33	15.1515151515152	0.00529620107777973	0.0275212363084626	1	1	0.813071024541502	0.993627075303383	0.25143485520742
down	CSNK2A2; SLC44A2; LPCAT1; PHOSPHO1; SLC44A1;	GO:0006656~phosphatidylcholine biosynthetic process	5	33	15.1515151515152	0.00529620107777973	0.0275212363084626	1	1	0.813071024541502	0.993627075303383	0.25143485520742
down	PLEK; RAB8A; VAMP3; RAB10; VPS11;	GO:0006904~vesicle docking involved in exocytosis	5	33	15.1515151515152	0.00529620107777973	0.0275212363084626	1	1	0.813071024541502	0.993627075303383	0.25143485520742
down	TNFRSF1A; NF1; FASLG; DAPK1; TRADD;	GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors	5	33	15.1515151515152	0.00529620107777973	0.0275212363084626	1	1	0.813071024541502	0.993627075303383	0.25143485520742
down	NF1; PIK3CG; ZFP36L1; SIRT2; PIK3R5;	GO:0014065~phosphatidylinositol 3-kinase signaling	5	33	15.1515151515152	0.00529620107777973	0.0275212363084626	1	1	0.813071024541502	0.993627075303383	0.25143485520742
down	CCDC88A; CYFIP1; SPATA13; VAV3; WASF2;	GO:0030032~lamellipodium assembly	5	33	15.1515151515152	0.00529620107777973	0.0275212363084626	1	1	0.813071024541502	0.993627075303383	0.25143485520742
down	CREB1; STAT5B; HSF1; NIPBL; BBS4;	GO:0040018~positive regulation of multicellular organism growth	5	33	15.1515151515152	0.00529620107777973	0.0275212363084626	1	1	0.813071024541502	0.993627075303383	0.25143485520742
down	ADAM8; CCL22; CCL4; CCL2; CCL7;	GO:0048247~lymphocyte chemotaxis	5	33	15.1515151515152	0.00529620107777973	0.0275212363084626	1	1	0.813071024541502	0.993627075303383	0.25143485520742
down	BCL2L11; ABL1; PKN1; RC3H1; JARID2;	GO:0048536~spleen development	5	33	15.1515151515152	0.00529620107777973	0.0275212363084626	1	1	0.813071024541502	0.993627075303383	0.25143485520742
down	STK25; RHOA; MAP2K1; TRAK1; PLXND1;	GO:0050772~positive regulation of axonogenesis	5	33	15.1515151515152	0.00529620107777973	0.0275212363084626	1	1	0.813071024541502	0.993627075303383	0.25143485520742
down	ERN1; JUN; NQO2; DNMT1; MDM2;	GO:1904707~positive regulation of vascular smooth muscle cell proliferation	5	33	15.1515151515152	0.00529620107777973	0.0275212363084626	1	1	0.813071024541502	0.993627075303383	0.25143485520742
down	PTPRC; KDELR1; RUNX2; PREX1; TBX21;	GO:0030217~T cell differentiation	5	34	14.7058823529412	0.00592767357197632	0.0306802727479053	1	1	0.822617963232679	0.993627075303383	0.280295908571582
down	ENG; NOTCH2; RBPJ; BMPR2; NUMA1;	GO:0030513~positive regulation of BMP signaling pathway	5	34	14.7058823529412	0.00592767357197632	0.0306802727479053	1	1	0.822617963232679	0.993627075303383	0.280295908571582
down	ADA; BMPR2; TNS3; STK40; SLC7A11;	GO:0048286~lung alveolus development	5	34	14.7058823529412	0.00592767357197632	0.0306802727479053	1	1	0.822617963232679	0.993627075303383	0.280295908571582
down	TOR1A; GPS1; COPS7A;	GO:0000338~protein deneddylation	3	10	30	0.00612847278750051	0.0309293526885278	1	1	0.825140438411833	0.993627075303383	0.282571510514153
down	TLR2; TIMP1; TLR6;	GO:0001775~cell activation	3	10	30	0.00612847278750051	0.0309293526885278	1	1	0.825140438411833	0.993627075303383	0.282571510514153
down	PDS5A; NIPBL; NAA50;	GO:0007064~mitotic sister chromatid cohesion	3	10	30	0.00612847278750051	0.0309293526885278	1	1	0.825140438411833	0.993627075303383	0.282571510514153
down	ABCD1; CPT1A; PPARA;	GO:0032000~positive regulation of fatty acid beta-oxidation	3	10	30	0.00612847278750051	0.0309293526885278	1	1	0.825140438411833	0.993627075303383	0.282571510514153
down	EMP3; ROCK1; P2RX7;	GO:0032060~bleb assembly	3	10	30	0.00612847278750051	0.0309293526885278	1	1	0.825140438411833	0.993627075303383	0.282571510514153
down	FURIN; MERTK; USE1;	GO:0032940~secretion by cell	3	10	30	0.00612847278750051	0.0309293526885278	1	1	0.825140438411833	0.993627075303383	0.282571510514153
down	IVD; ETFB; ACADVL;	GO:0033539~fatty acid beta-oxidation using acyl-CoA dehydrogenase	3	10	30	0.00612847278750051	0.0309293526885278	1	1	0.825140438411833	0.993627075303383	0.282571510514153
down	BCL2L11; VEGFA; YWHAZ;	GO:0035148~tube formation	3	10	30	0.00612847278750051	0.0309293526885278	1	1	0.825140438411833	0.993627075303383	0.282571510514153
down	ATG2A; ATG12; WIPI1;	GO:0044804~autophagy of nucleus	3	10	30	0.00612847278750051	0.0309293526885278	1	1	0.825140438411833	0.993627075303383	0.282571510514153
down	TLR4; CIITA; TMEM106A;	GO:0045348~positive regulation of MHC class II biosynthetic process	3	10	30	0.00612847278750051	0.0309293526885278	1	1	0.825140438411833	0.993627075303383	0.282571510514153
down	RUNX1; CREBBP; PURB;	GO:0045637~regulation of myeloid cell differentiation	3	10	30	0.00612847278750051	0.0309293526885278	1	1	0.825140438411833	0.993627075303383	0.282571510514153
down	RDX; MTOR; RHOA;	GO:0045792~negative regulation of cell size	3	10	30	0.00612847278750051	0.0309293526885278	1	1	0.825140438411833	0.993627075303383	0.282571510514153
down	ADA; RHOA; NKAP;	GO:0046638~positive regulation of alpha-beta T cell differentiation	3	10	30	0.00612847278750051	0.0309293526885278	1	1	0.825140438411833	0.993627075303383	0.282571510514153
down	ACTN4; VEGFA; BCL6;	GO:0051272~positive regulation of cellular component movement	3	10	30	0.00612847278750051	0.0309293526885278	1	1	0.825140438411833	0.993627075303383	0.282571510514153
down	DNM2; NIPBL; XRCC6;	GO:0071481~cellular response to X-ray	3	10	30	0.00612847278750051	0.0309293526885278	1	1	0.825140438411833	0.993627075303383	0.282571510514153
down	MTOR; SMARCA4; PIH1D1;	GO:1901838~positive regulation of transcription of nucleolar large rRNA by RNA polymerase I	3	10	30	0.00612847278750051	0.0309293526885278	1	1	0.825140438411833	0.993627075303383	0.282571510514153
down	ABCD1; MAP1A; DCTN1;	GO:1990535~neuron projection maintenance	3	10	30	0.00612847278750051	0.0309293526885278	1	1	0.825140438411833	0.993627075303383	0.282571510514153
down	VEGFA; BMP6; PPM1F;	GO:2000048~negative regulation of cell-cell adhesion mediated by cadherin	3	10	30	0.00612847278750051	0.0309293526885278	1	1	0.825140438411833	0.993627075303383	0.282571510514153
down	BCL2L11; PKN1; RC3H1; GAPT;	GO:0001782~B cell homeostasis	4	21	19.047619047619	0.00614195702851617	0.0309293526885278	1	1	0.825140438411833	0.993627075303383	0.282571510514153
down	PARP1; RPA2; RPA1; GTF2H2;	GO:0006293~nucleotide-excision repair, preincision complex stabilization	4	21	19.047619047619	0.00614195702851617	0.0309293526885278	1	1	0.825140438411833	0.993627075303383	0.282571510514153
down	CFLAR; PDPK1; HSF1; AMBRA1;	GO:0010667~negative regulation of cardiac muscle cell apoptotic process	4	21	19.047619047619	0.00614195702851617	0.0309293526885278	1	1	0.825140438411833	0.993627075303383	0.282571510514153
down	MITF; RAB27A; HPS4; MYO5A;	GO:0030318~melanocyte differentiation	4	21	19.047619047619	0.00614195702851617	0.0309293526885278	1	1	0.825140438411833	0.993627075303383	0.282571510514153
down	KIF1B; MYO10; HOOK3; CCDC88A;	GO:0030705~cytoskeleton-dependent intracellular transport	4	21	19.047619047619	0.00614195702851617	0.0309293526885278	1	1	0.825140438411833	0.993627075303383	0.282571510514153
down	SASH3; RARA; FCER1G; NLRP3;	GO:0032753~positive regulation of interleukin-4 production	4	21	19.047619047619	0.00614195702851617	0.0309293526885278	1	1	0.825140438411833	0.993627075303383	0.282571510514153
down	RAB6A; COG7; PACS1; GBF1;	GO:0034067~protein localization to Golgi apparatus	4	21	19.047619047619	0.00614195702851617	0.0309293526885278	1	1	0.825140438411833	0.993627075303383	0.282571510514153
down	ARID1A; SLC9A1; CALR; AKAP13;	GO:0055007~cardiac muscle cell differentiation	4	21	19.047619047619	0.00614195702851617	0.0309293526885278	1	1	0.825140438411833	0.993627075303383	0.282571510514153
down	MAPK1; RBPJ; TMED2; VASH1;	GO:0060716~labyrinthine layer blood vessel development	4	21	19.047619047619	0.00614195702851617	0.0309293526885278	1	1	0.825140438411833	0.993627075303383	0.282571510514153
down	AP3D1; RAB29; TM9SF4; TM9SF2;	GO:0072657~protein localization to membrane	4	21	19.047619047619	0.00614195702851617	0.0309293526885278	1	1	0.825140438411833	0.993627075303383	0.282571510514153
down	ADAM10; TIMP1; FURIN; CD44; CAPN2; ADAM8; MMP19;	GO:0022617~extracellular matrix disassembly	7	66	10.6060606060606	0.00624665146779635	0.0314262041024658	1	1	0.826464737880889	0.993627075303383	0.287110760202027
down	CFLAR; NF1; MYL6; RHOA; HLX; MSC;	GO:0007519~skeletal muscle tissue development	6	50	12	0.00648776592050937	0.0326077492552506	1	1	0.829977010385777	0.993627075303383	0.297905392793446
down	BCL10; NUP62; EMP3; RRAGA; SUSD6;	GO:0008219~cell death	5	35	14.2857142857143	0.00661027836496664	0.0331276642675059	1	1	0.831468949148915	0.993627075303383	0.302655352219738
down	SIRT2; SIRT3; HDAC5; MTA1; TBL1X;	GO:0016575~histone deacetylation	5	35	14.2857142857143	0.00661027836496664	0.0331276642675059	1	1	0.831468949148915	0.993627075303383	0.302655352219738
down	FOXO3; JUN; SMARCA4; SMAD3; HIF1A;	GO:1902895~positive regulation of pri-miRNA transcription by RNA polymerase II	5	35	14.2857142857143	0.00661027836496664	0.0331276642675059	1	1	0.831468949148915	0.993627075303383	0.302655352219738
down	CAT; RARA; EEF2; CALR; PTGS2; STAT5B; NCOA1; MBD2; NCOR2;	GO:0032355~response to estradiol	9	103	8.7378640776699	0.00665090540901592	0.0332992497519606	1	1	0.831468949148915	0.993627075303383	0.304222962444657
down	SKI; ZNF8; ENG; BMP6; BMPR2; RUNX2; ZFYVE16; USP9X;	GO:0030509~BMP signaling pathway	8	85	9.41176470588235	0.00687383370771377	0.0343823620773553	1	1	0.834617076814253	0.993627075303383	0.314118309719635
down	PARP1; RAD23B; XPC; GTF2H2;	GO:0000717~nucleotide-excision repair, DNA duplex unwinding	4	22	18.1818181818182	0.00708895034112833	0.0351213014999628	1	1	0.837134093980643	0.993627075303383	0.320869282846277
down	AHCYL1; DHFR2; MTHFR; MTHFD2;	GO:0006730~one-carbon metabolic process	4	22	18.1818181818182	0.00708895034112833	0.0351213014999628	1	1	0.837134093980643	0.993627075303383	0.320869282846277
down	PARP1; VEGFA; GAB3; EIF2AK1;	GO:0030225~macrophage differentiation	4	22	18.1818181818182	0.00708895034112833	0.0351213014999628	1	1	0.837134093980643	0.993627075303383	0.320869282846277
down	HSF1; PDE4DIP; MBD2; SAMM50;	GO:0034622~cellular protein-containing complex assembly	4	22	18.1818181818182	0.00708895034112833	0.0351213014999628	1	1	0.837134093980643	0.993627075303383	0.320869282846277
down	SLC8A1; PPARG; PTK2B; PPP1R9B;	GO:0035902~response to immobilization stress	4	22	18.1818181818182	0.00708895034112833	0.0351213014999628	1	1	0.837134093980643	0.993627075303383	0.320869282846277
down	JUN; PARK7; P2RX4; P2RX7;	GO:0051899~membrane depolarization	4	22	18.1818181818182	0.00708895034112833	0.0351213014999628	1	1	0.837134093980643	0.993627075303383	0.320869282846277
down	DCTN3; IST1; SPAST; VPS4A;	GO:0061640~cytoskeleton-dependent cytokinesis	4	22	18.1818181818182	0.00708895034112833	0.0351213014999628	1	1	0.837134093980643	0.993627075303383	0.320869282846277
down	IRAK2; RIPK2; TAB1; TRAF6;	GO:0070423~nucleotide-binding oligomerization domain containing signaling pathway	4	22	18.1818181818182	0.00708895034112833	0.0351213014999628	1	1	0.837134093980643	0.993627075303383	0.320869282846277
down	MME; CREB1; AKAP5; NPTN;	GO:1900273~positive regulation of long-term synaptic potentiation	4	22	18.1818181818182	0.00708895034112833	0.0351213014999628	1	1	0.837134093980643	0.993627075303383	0.320869282846277
down	IL1A; AKAP12; MAVS; FRMD8;	GO:1904469~positive regulation of tumor necrosis factor secretion	4	22	18.1818181818182	0.00708895034112833	0.0351213014999628	1	1	0.837134093980643	0.993627075303383	0.320869282846277
down	PPARG; ACADVL; CIRBP; METRNL; ZNF516;	GO:0009409~response to cold	5	36	13.8888888888889	0.00734605322075865	0.0362572247979111	1	1	0.839217280483464	0.993627075303383	0.331247112778958
down	TLR2; SKI; SMARCA4; DIXDC1; MBD2;	GO:0030177~positive regulation of Wnt signaling pathway	5	36	13.8888888888889	0.00734605322075865	0.0362572247979111	1	1	0.839217280483464	0.993627075303383	0.331247112778958
down	SOCS3; VHL; PA2G4; JUN; FGFR1;	GO:0045597~positive regulation of cell differentiation	5	36	13.8888888888889	0.00734605322075865	0.0362572247979111	1	1	0.839217280483464	0.993627075303383	0.331247112778958
down	SHTN1; GDI1; PAFAH1B1; CYFIP1; DBNL;	GO:0045773~positive regulation of axon extension	5	36	13.8888888888889	0.00734605322075865	0.0362572247979111	1	1	0.839217280483464	0.993627075303383	0.331247112778958
down	OSM; PIK3CG; ADAM8;	GO:0002675~positive regulation of acute inflammatory response	3	11	27.2727272727273	0.00762761570513093	0.0367422671489301	1	1	0.841182003213693	0.993627075303383	0.335678474507444
down	PARK7; MAN2A2; MAN2B1;	GO:0006517~protein deglycosylation	3	11	27.2727272727273	0.00762761570513093	0.0367422671489301	1	1	0.841182003213693	0.993627075303383	0.335678474507444
down	TOR1A; HPS5; HPS3;	GO:0006996~organelle organization	3	11	27.2727272727273	0.00762761570513093	0.0367422671489301	1	1	0.841182003213693	0.993627075303383	0.335678474507444
down	SLC9A3R1; GNB1; GNAL;	GO:0007191~adenylate cyclase-activating dopamine receptor signaling pathway	3	11	27.2727272727273	0.00762761570513093	0.0367422671489301	1	1	0.841182003213693	0.993627075303383	0.335678474507444
down	CHMP2A; CHMP4B; SPAST;	GO:0010458~exit from mitosis	3	11	27.2727272727273	0.00762761570513093	0.0367422671489301	1	1	0.841182003213693	0.993627075303383	0.335678474507444
down	AKAP5; PDE4A; AKAP12;	GO:0010738~regulation of protein kinase A signaling	3	11	27.2727272727273	0.00762761570513093	0.0367422671489301	1	1	0.841182003213693	0.993627075303383	0.335678474507444
down	PIK3CG; CXCR3; CXCL16;	GO:0010818~T cell chemotaxis	3	11	27.2727272727273	0.00762761570513093	0.0367422671489301	1	1	0.841182003213693	0.993627075303383	0.335678474507444
down	CTBP2; STX3; BLOC1S6;	GO:0016081~synaptic vesicle docking	3	11	27.2727272727273	0.00762761570513093	0.0367422671489301	1	1	0.841182003213693	0.993627075303383	0.335678474507444
down	B4GALT5; B3GNT7; B3GNT5;	GO:0030311~poly-N-acetyllactosamine biosynthetic process	3	11	27.2727272727273	0.00762761570513093	0.0367422671489301	1	1	0.841182003213693	0.993627075303383	0.335678474507444
down	NPC1; ABCA1; VPS4A;	GO:0032367~intracellular cholesterol transport	3	11	27.2727272727273	0.00762761570513093	0.0367422671489301	1	1	0.841182003213693	0.993627075303383	0.335678474507444
down	ACTB; PAK2; TBCD;	GO:0034333~adherens junction assembly	3	11	27.2727272727273	0.00762761570513093	0.0367422671489301	1	1	0.841182003213693	0.993627075303383	0.335678474507444
down	JAK1; STAT5B; PTK2B;	GO:0038110~interleukin-2-mediated signaling pathway	3	11	27.2727272727273	0.00762761570513093	0.0367422671489301	1	1	0.841182003213693	0.993627075303383	0.335678474507444
down	BCR; SRC; ABR;	GO:0043114~regulation of vascular permeability	3	11	27.2727272727273	0.00762761570513093	0.0367422671489301	1	1	0.841182003213693	0.993627075303383	0.335678474507444
down	SLC9A3R1; WDR1; PDCD6IP;	GO:0045199~maintenance of epithelial cell apical/basal polarity	3	11	27.2727272727273	0.00762761570513093	0.0367422671489301	1	1	0.841182003213693	0.993627075303383	0.335678474507444
down	MITF; TFE3; MTOR;	GO:0045670~regulation of osteoclast differentiation	3	11	27.2727272727273	0.00762761570513093	0.0367422671489301	1	1	0.841182003213693	0.993627075303383	0.335678474507444
down	SASH3; HLX; SERP1;	GO:0046622~positive regulation of organ growth	3	11	27.2727272727273	0.00762761570513093	0.0367422671489301	1	1	0.841182003213693	0.993627075303383	0.335678474507444
down	ARID1A; ZMIZ1; ELOF1;	GO:0048096~chromatin-mediated maintenance of transcription	3	11	27.2727272727273	0.00762761570513093	0.0367422671489301	1	1	0.841182003213693	0.993627075303383	0.335678474507444
down	THBS1; CAPN2; P2RX4;	GO:0048266~behavioral response to pain	3	11	27.2727272727273	0.00762761570513093	0.0367422671489301	1	1	0.841182003213693	0.993627075303383	0.335678474507444
down	SRC; PPARG; TERF1;	GO:0051974~negative regulation of telomerase activity	3	11	27.2727272727273	0.00762761570513093	0.0367422671489301	1	1	0.841182003213693	0.993627075303383	0.335678474507444
down	ARRB2; PARK7; RNF14;	GO:0060765~regulation of androgen receptor signaling pathway	3	11	27.2727272727273	0.00762761570513093	0.0367422671489301	1	1	0.841182003213693	0.993627075303383	0.335678474507444
down	APOBEC3A; APOBEC3F; CDADC1;	GO:0070383~DNA cytosine deamination	3	11	27.2727272727273	0.00762761570513093	0.0367422671489301	1	1	0.841182003213693	0.993627075303383	0.335678474507444
down	TOR1A; VCP; RNF185;	GO:0071712~ER-associated misfolded protein catabolic process	3	11	27.2727272727273	0.00762761570513093	0.0367422671489301	1	1	0.841182003213693	0.993627075303383	0.335678474507444
down	DNMT1; MPHOSPH8; SETDB2;	GO:0090309~positive regulation of DNA methylation-dependent heterochromatin assembly	3	11	27.2727272727273	0.00762761570513093	0.0367422671489301	1	1	0.841182003213693	0.993627075303383	0.335678474507444
down	TERF1; SLX4; SMARCAL1;	GO:0090656~t-circle formation	3	11	27.2727272727273	0.00762761570513093	0.0367422671489301	1	1	0.841182003213693	0.993627075303383	0.335678474507444
down	PARP1; WAS; ARID2;	GO:1905168~positive regulation of double-strand break repair via homologous recombination	3	11	27.2727272727273	0.00762761570513093	0.0367422671489301	1	1	0.841182003213693	0.993627075303383	0.335678474507444
down	ABL1; NEK4; MCL1;	GO:2001020~regulation of response to DNA damage stimulus	3	11	27.2727272727273	0.00762761570513093	0.0367422671489301	1	1	0.841182003213693	0.993627075303383	0.335678474507444
down	RBM25; RBM10; KHDRBS1; REST; NSRP1; THRAP3; IK;	GO:0000381~regulation of alternative mRNA splicing, via spliceosome	7	69	10.1449275362319	0.00776199528964916	0.0372861930411534	1	1	0.842222150541461	0.993627075303383	0.340647798066236
down	ABCA1; RARA; ZNF35; CREB1; SERPINF1; PPARG; PTK2B;	GO:0071300~cellular response to retinoic acid	7	69	10.1449275362319	0.00776199528964916	0.0372861930411534	1	1	0.842222150541461	0.993627075303383	0.340647798066236
down	BACH1; BRD4; TFDP1; GFI1;	GO:0000083~regulation of transcription involved in G1/S transition of mitotic cell cycle	4	23	17.3913043478261	0.00812745004018156	0.0384069746007571	1	1	0.845010174306613	0.993627075303383	0.350887292615086
down	ACSL4; ACSL1; CPT1A; ACSL5;	GO:0001676~long-chain fatty acid metabolic process	4	23	17.3913043478261	0.00812745004018156	0.0384069746007571	1	1	0.845010174306613	0.993627075303383	0.350887292615086
down	MYC; FGFR1; VEGFA; TGFBR2;	GO:0002053~positive regulation of mesenchymal cell proliferation	4	23	17.3913043478261	0.00812745004018156	0.0384069746007571	1	1	0.845010174306613	0.993627075303383	0.350887292615086
down	PARP1; RPA2; RPA1; GTF2H2;	GO:0006295~nucleotide-excision repair, DNA incision, 3'-to lesion	4	23	17.3913043478261	0.00812745004018156	0.0384069746007571	1	1	0.845010174306613	0.993627075303383	0.350887292615086
down	DNMT1; CTCF; GATAD2A; EHMT2;	GO:0006306~DNA methylation	4	23	17.3913043478261	0.00812745004018156	0.0384069746007571	1	1	0.845010174306613	0.993627075303383	0.350887292615086
down	DYSF; HEXB; STAT5B; PLIN2;	GO:0019915~lipid storage	4	23	17.3913043478261	0.00812745004018156	0.0384069746007571	1	1	0.845010174306613	0.993627075303383	0.350887292615086
down	ARPC2; ARPC5; ARPC4; WHAMMP3;	GO:0034314~Arp2/3 complex-mediated actin nucleation	4	23	17.3913043478261	0.00812745004018156	0.0384069746007571	1	1	0.845010174306613	0.993627075303383	0.350887292615086
down	PRPF19; THRAP3; RBM3; CIRBP;	GO:0048026~positive regulation of mRNA splicing, via spliceosome	4	23	17.3913043478261	0.00812745004018156	0.0384069746007571	1	1	0.845010174306613	0.993627075303383	0.350887292615086
down	MTOR; ARF1; MAPK6; DLG5;	GO:0060999~positive regulation of dendritic spine development	4	23	17.3913043478261	0.00812745004018156	0.0384069746007571	1	1	0.845010174306613	0.993627075303383	0.350887292615086
down	CHMP2A; PDCD6IP; CHMP4B; CHMP2B;	GO:1901673~regulation of mitotic spindle assembly	4	23	17.3913043478261	0.00812745004018156	0.0384069746007571	1	1	0.845010174306613	0.993627075303383	0.350887292615086
down	SRC; VDAC2; IVNS1ABP; MCL1;	GO:2001243~negative regulation of intrinsic apoptotic signaling pathway	4	23	17.3913043478261	0.00812745004018156	0.0384069746007571	1	1	0.845010174306613	0.993627075303383	0.350887292615086
down	FGFR1; CREB3L2; RUNX2; RUNX3; RUNX1;	GO:0002062~chondrocyte differentiation	5	37	13.5135135135135	0.00813699584213867	0.0384069746007571	1	1	0.845010174306613	0.993627075303383	0.350887292615086
down	GNAO1; GNB1; PPP3CA; AGO4; NLK;	GO:0007223~Wnt signaling pathway, calcium modulating pathway	5	37	13.5135135135135	0.00813699584213867	0.0384069746007571	1	1	0.845010174306613	0.993627075303383	0.350887292615086
down	POU2F2; FGFR1; VEGFA; PPARG; RUNX2;	GO:0048469~cell maturation	5	37	13.5135135135135	0.00813699584213867	0.0384069746007571	1	1	0.845010174306613	0.993627075303383	0.350887292615086
down	SYNJ1; CANX; AMPH; PICALM; ACTB;	GO:0048488~synaptic vesicle endocytosis	5	37	13.5135135135135	0.00813699584213867	0.0384069746007571	1	1	0.845010174306613	0.993627075303383	0.350887292615086
down	FLNA; RHOA; ROCK1; SPATA13; FAM49B; RCC2; ABI3; PLXND1;	GO:0030334~regulation of cell migration	8	89	8.98876404494382	0.0087932404636496	0.0399567299882665	1	1	0.849433838680654	0.993627075303383	0.365045905153344
down	AMBRA1; MAP1LC3B; ATG12; WIPI1; ATG2A;	GO:0000422~autophagy of mitochondrion	5	38	13.1578947368421	0.00898505932337512	0.0407218514725488	1	1	0.850827005707543	0.993627075303383	0.37203607839485
down	MAP2K7; ERN1; PKN1; DBNL; SPAG9;	GO:0007257~activation of JUN kinase activity	5	38	13.1578947368421	0.00898505932337512	0.0407218514725488	1	1	0.850827005707543	0.993627075303383	0.37203607839485
down	ACTN4; PAK2; MTDH; PDCD6IP; TBCD;	GO:0070830~bicellular tight junction assembly	5	38	13.1578947368421	0.00898505932337512	0.0407218514725488	1	1	0.850827005707543	0.993627075303383	0.37203607839485
down	EFR3A; PIKFYVE; PIK3CG; SOCS3; SLA2; SOCS6;	GO:0046854~phosphatidylinositol phosphorylation	6	54	11.1111111111111	0.00904765904177651	0.0409699382499906	1	1	0.850827005707543	0.993627075303383	0.374302606768279
down	CD63; VEGFA; ARRB2; SCYL2;	GO:0002092~positive regulation of receptor internalization	4	24	16.6666666666667	0.00926082244448601	0.041184926953137	1	1	0.8522849712008	0.993627075303383	0.376266750124376
down	RPA2; RPA1; LIG3; LIG4;	GO:0006297~nucleotide-excision repair, DNA gap filling	4	24	16.6666666666667	0.00926082244448601	0.041184926953137	1	1	0.8522849712008	0.993627075303383	0.376266750124376
down	TLR4; NF1; LILRB4; MAFB;	GO:0045671~negative regulation of osteoclast differentiation	4	24	16.6666666666667	0.00926082244448601	0.041184926953137	1	1	0.8522849712008	0.993627075303383	0.376266750124376
down	UROS; JAK1; CIITA; MDM2;	GO:0046677~response to antibiotic	4	24	16.6666666666667	0.00926082244448601	0.041184926953137	1	1	0.8522849712008	0.993627075303383	0.376266750124376
down	TAB1; MAP4K3; KSR1;	GO:0000185~activation of MAPKKK activity	3	12	25	0.00932429274840785	0.041184926953137	1	1	0.85303968275025	0.993627075303383	0.376266750124376
down	MYH9; SYT11; DYSF;	GO:0001778~plasma membrane repair	3	12	25	0.00932429274840785	0.041184926953137	1	1	0.85303968275025	0.993627075303383	0.376266750124376
down	PTPRC; STAT5B; MERTK;	GO:0001779~natural killer cell differentiation	3	12	25	0.00932429274840785	0.041184926953137	1	1	0.85303968275025	0.993627075303383	0.376266750124376
down	HK1; NFE2L1; GFPT2;	GO:0006002~fructose 6-phosphate metabolic process	3	12	25	0.00932429274840785	0.041184926953137	1	1	0.85303968275025	0.993627075303383	0.376266750124376
down	FURIN; HM13; SPCS3;	GO:0006465~signal peptide processing	3	12	25	0.00932429274840785	0.041184926953137	1	1	0.85303968275025	0.993627075303383	0.376266750124376
down	CTDNEP1; NEK9; NEK6;	GO:0007077~mitotic nuclear envelope disassembly	3	12	25	0.00932429274840785	0.041184926953137	1	1	0.85303968275025	0.993627075303383	0.376266750124376
down	APOBEC3A; APOBEC3F; CDADC1;	GO:0009972~cytidine deamination	3	12	25	0.00932429274840785	0.041184926953137	1	1	0.85303968275025	0.993627075303383	0.376266750124376
down	RNF40; RNF20; CTR9;	GO:0010390~histone monoubiquitination	3	12	25	0.00932429274840785	0.041184926953137	1	1	0.85303968275025	0.993627075303383	0.376266750124376
down	P2RX5; P2RX4; P2RX7;	GO:0010524~positive regulation of calcium ion transport into cytosol	3	12	25	0.00932429274840785	0.041184926953137	1	1	0.85303968275025	0.993627075303383	0.376266750124376
down	ST3GAL2; GBA2; GBGT1;	GO:0030259~lipid glycosylation	3	12	25	0.00932429274840785	0.041184926953137	1	1	0.85303968275025	0.993627075303383	0.376266750124376
down	TULP3; RARA; TRAF3IP1;	GO:0031076~embryonic camera-type eye development	3	12	25	0.00932429274840785	0.041184926953137	1	1	0.85303968275025	0.993627075303383	0.376266750124376
down	PPP3CA; NFATC2; NFAT5;	GO:0033173~calcineurin-NFAT signaling cascade	3	12	25	0.00932429274840785	0.041184926953137	1	1	0.85303968275025	0.993627075303383	0.376266750124376
down	ABL1; ITGAV; HPSE;	GO:0033690~positive regulation of osteoblast proliferation	3	12	25	0.00932429274840785	0.041184926953137	1	1	0.85303968275025	0.993627075303383	0.376266750124376
down	CXCL8; CCL2; ATF3;	GO:0036499~PERK-mediated unfolded protein response	3	12	25	0.00932429274840785	0.041184926953137	1	1	0.85303968275025	0.993627075303383	0.376266750124376
down	IL18RAP; CXCL8; PREX1;	GO:0042119~neutrophil activation	3	12	25	0.00932429274840785	0.041184926953137	1	1	0.85303968275025	0.993627075303383	0.376266750124376
down	JUN; CCL4; REST;	GO:0043922~negative regulation by host of viral transcription	3	12	25	0.00932429274840785	0.041184926953137	1	1	0.85303968275025	0.993627075303383	0.376266750124376
down	YBX1; ROCK1; ROCK2;	GO:0048598~embryonic morphogenesis	3	12	25	0.00932429274840785	0.041184926953137	1	1	0.85303968275025	0.993627075303383	0.376266750124376
down	WAS; WIPF1; WIPF2;	GO:0051127~positive regulation of actin nucleation	3	12	25	0.00932429274840785	0.041184926953137	1	1	0.85303968275025	0.993627075303383	0.376266750124376
down	ATP1A1; SLC8A1; P2RX4;	GO:0055119~relaxation of cardiac muscle	3	12	25	0.00932429274840785	0.041184926953137	1	1	0.85303968275025	0.993627075303383	0.376266750124376
down	CNOT1; ZFP36; BTG2;	GO:0060213~positive regulation of nuclear-transcribed mRNA poly(A) tail shortening	3	12	25	0.00932429274840785	0.041184926953137	1	1	0.85303968275025	0.993627075303383	0.376266750124376
down	SMAD3; KDM5B; SLC7A11;	GO:0070306~lens fiber cell differentiation	3	12	25	0.00932429274840785	0.041184926953137	1	1	0.85303968275025	0.993627075303383	0.376266750124376
down	PDIA3; RAD23B; YBX1;	GO:0098761~cellular response to interleukin-7	3	12	25	0.00932429274840785	0.041184926953137	1	1	0.85303968275025	0.993627075303383	0.376266750124376
down	TUT1; FIP1L1; CSTF2T;	GO:0098789~pre-mRNA cleavage required for polyadenylation	3	12	25	0.00932429274840785	0.041184926953137	1	1	0.85303968275025	0.993627075303383	0.376266750124376
down	SLC8A1; ITPR1; MYO5A;	GO:0099566~regulation of postsynaptic cytosolic calcium ion concentration	3	12	25	0.00932429274840785	0.041184926953137	1	1	0.85303968275025	0.993627075303383	0.376266750124376
down	NEK4; VASH1; NEK6;	GO:2000772~regulation of cellular senescence	3	12	25	0.00932429274840785	0.041184926953137	1	1	0.85303968275025	0.993627075303383	0.376266750124376
down	TULP3; ECE1; GNA12; TRAF3IP1; CREBBP; CHST11;	GO:0042733~embryonic digit morphogenesis	6	55	10.9090909090909	0.00978627827919565	0.0431888927952309	1	1	0.85624487747878	0.993627075303383	0.394575043243917
down	DNAJC13; RAB5B; HOOK3; CHMP2B; VPS11;	GO:0007032~endosome organization	5	39	12.8205128205128	0.00989214787573278	0.0435087550449951	1	1	0.857096257328546	0.993627075303383	0.397497314523971
down	BMP6; SLC8A1; SMAD3; BMPR2; P2RX7;	GO:0030501~positive regulation of bone mineralization	5	39	12.8205128205128	0.00989214787573278	0.0435087550449951	1	1	0.857096257328546	0.993627075303383	0.397497314523971
down	FOXO3; CPEB4; PIK3R4; NUAK2; SH3GLB1;	GO:0042149~cellular response to glucose starvation	5	39	12.8205128205128	0.00989214787573278	0.0435087550449951	1	1	0.857096257328546	0.993627075303383	0.397497314523971
down	APAF1; RING1; TFDP1; L3MBTL2; EHMT2;	GO:0070317~negative regulation of G0 to G1 transition	5	39	12.8205128205128	0.00989214787573278	0.0435087550449951	1	1	0.857096257328546	0.993627075303383	0.397497314523971
down	TDP2; TATDN3; TSEN15; DCLRE1C; RAD9A; MGME1; ZC3H12C;	GO:0090305~nucleic acid phosphodiester bond hydrolysis	7	73	9.58904109589041	0.0101834129854919	0.0447520644859895	1	1	0.858864507785752	0.993627075303383	0.408856227538293
down	HMGB1; NOTCH2; RBPJ; IL1A;	GO:0002437~inflammatory response to antigenic stimulus	4	25	16	0.0104922367058429	0.0458771289520579	1	1	0.860725824056495	0.993627075303383	0.419134850851372
down	GTF3C1; BRF1; GTF3C5; IVNS1ABP;	GO:0006383~transcription by RNA polymerase III	4	25	16	0.0104922367058429	0.0458771289520579	1	1	0.860725824056495	0.993627075303383	0.419134850851372
down	PARP1; SIRT2; SIRT3; PARP2;	GO:0006471~protein ADP-ribosylation	4	25	16	0.0104922367058429	0.0458771289520579	1	1	0.860725824056495	0.993627075303383	0.419134850851372
down	VIM; ENG; F2R; ARRB2;	GO:0032967~positive regulation of collagen biosynthetic process	4	25	16	0.0104922367058429	0.0458771289520579	1	1	0.860725824056495	0.993627075303383	0.419134850851372
down	APAF1; PPM1F; CASP4; HIPK2;	GO:0097193~intrinsic apoptotic signaling pathway	4	25	16	0.0104922367058429	0.0458771289520579	1	1	0.860725824056495	0.993627075303383	0.419134850851372
down	IGHA1; ACTB; LYZ; POC1B; BBS4;	GO:0001895~retina homeostasis	5	40	12.5	0.0108601128267449	0.0473526193260788	1	1	0.863709029586316	0.993627075303383	0.432614975958899
down	CSTF1; FIP1L1; CSTF2T; CPSF2; CPSF3;	GO:0006369~termination of RNA polymerase II transcription	5	40	12.5	0.0108601128267449	0.0473526193260788	1	1	0.863709029586316	0.993627075303383	0.432614975958899
down	APAF1; GAPDH; RB1; LIG4; XIAP;	GO:0051402~neuron apoptotic process	5	40	12.5	0.0108601128267449	0.0473526193260788	1	1	0.863709029586316	0.993627075303383	0.432614975958899
down	NSF; RAB7A; VCP; FOXO1; LPCAT1; GGA3; WWP2;	GO:0045732~positive regulation of protein catabolic process	7	74	9.45945945945946	0.0108660269980795	0.0473526193260788	1	1	0.863709029586316	0.993627075303383	0.432614975958899
down	DHX34; RC3H1; THRAP3;	GO:0000956~nuclear-transcribed mRNA catabolic process	3	13	23.0769230769231	0.0112234294762119	0.0480266949343321	1	1	0.865837889870508	0.993627075303383	0.438773351297143
down	EOMES; ADA; CTR9;	GO:0001829~trophectodermal cell differentiation	3	13	23.0769230769231	0.0112234294762119	0.0480266949343321	1	1	0.865837889870508	0.993627075303383	0.438773351297143
down	TGFBR2; MDM2; BMPR2;	GO:0003181~atrioventricular valve morphogenesis	3	13	23.0769230769231	0.0112234294762119	0.0480266949343321	1	1	0.865837889870508	0.993627075303383	0.438773351297143
down	DYSF; GK; GK5;	GO:0006071~glycerol metabolic process	3	13	23.0769230769231	0.0112234294762119	0.0480266949343321	1	1	0.865837889870508	0.993627075303383	0.438773351297143
down	SIRT2; SIRT3; HDAC5;	GO:0006476~protein deacetylation	3	13	23.0769230769231	0.0112234294762119	0.0480266949343321	1	1	0.865837889870508	0.993627075303383	0.438773351297143
down	TNFRSF1A; JARID2; P2RX4;	GO:0010614~negative regulation of cardiac muscle hypertrophy	3	13	23.0769230769231	0.0112234294762119	0.0480266949343321	1	1	0.865837889870508	0.993627075303383	0.438773351297143
down	THBS1; SLC8A1; DDR2;	GO:0010763~positive regulation of fibroblast migration	3	13	23.0769230769231	0.0112234294762119	0.0480266949343321	1	1	0.865837889870508	0.993627075303383	0.438773351297143
down	RBM47; APOBEC3F; APOBEC3A;	GO:0016554~cytidine to uridine editing	3	13	23.0769230769231	0.0112234294762119	0.0480266949343321	1	1	0.865837889870508	0.993627075303383	0.438773351297143
down	STX3; STX4; SNAP29;	GO:0031629~synaptic vesicle fusion to presynaptic active zone membrane	3	13	23.0769230769231	0.0112234294762119	0.0480266949343321	1	1	0.865837889870508	0.993627075303383	0.438773351297143
down	PLEK; FLNA; SWAP70;	GO:0032233~positive regulation of actin filament bundle assembly	3	13	23.0769230769231	0.0112234294762119	0.0480266949343321	1	1	0.865837889870508	0.993627075303383	0.438773351297143
down	DYNC1H1; RC3H1; LSM14A;	GO:0033962~cytoplasmic mRNA processing body assembly	3	13	23.0769230769231	0.0112234294762119	0.0480266949343321	1	1	0.865837889870508	0.993627075303383	0.438773351297143
down	JAK1; STAT5B; GRB2;	GO:0035723~interleukin-15-mediated signaling pathway	3	13	23.0769230769231	0.0112234294762119	0.0480266949343321	1	1	0.865837889870508	0.993627075303383	0.438773351297143
down	PARP1; MPHOSPH8; MBD2;	GO:0044030~regulation of DNA methylation	3	13	23.0769230769231	0.0112234294762119	0.0480266949343321	1	1	0.865837889870508	0.993627075303383	0.438773351297143
down	CCDC71L; ABHD2; ABHD15;	GO:0044255~cellular lipid metabolic process	3	13	23.0769230769231	0.0112234294762119	0.0480266949343321	1	1	0.865837889870508	0.993627075303383	0.438773351297143
down	SOCS3; LEPROT; VHL;	GO:0046426~negative regulation of receptor signaling pathway via JAK-STAT	3	13	23.0769230769231	0.0112234294762119	0.0480266949343321	1	1	0.865837889870508	0.993627075303383	0.438773351297143
down	IGF2R; TSC2; CRIM1;	GO:0048009~insulin-like growth factor receptor signaling pathway	3	13	23.0769230769231	0.0112234294762119	0.0480266949343321	1	1	0.865837889870508	0.993627075303383	0.438773351297143
down	MAVS; LSM14A; TBK1;	GO:0060340~positive regulation of type I interferon-mediated signaling pathway	3	13	23.0769230769231	0.0112234294762119	0.0480266949343321	1	1	0.865837889870508	0.993627075303383	0.438773351297143
down	AP3B1; MAPK1; STK40;	GO:0060425~lung morphogenesis	3	13	23.0769230769231	0.0112234294762119	0.0480266949343321	1	1	0.865837889870508	0.993627075303383	0.438773351297143
down	NPC1; ATP1A1; UBE2L3;	GO:0071383~cellular response to steroid hormone stimulus	3	13	23.0769230769231	0.0112234294762119	0.0480266949343321	1	1	0.865837889870508	0.993627075303383	0.438773351297143
down	ACTN4; RCC2; CORO1C;	GO:1900025~negative regulation of substrate adhesion-dependent cell spreading	3	13	23.0769230769231	0.0112234294762119	0.0480266949343321	1	1	0.865837889870508	0.993627075303383	0.438773351297143
down	ACTN4; LPXN; SND1;	GO:1903506~regulation of nucleic acid-templated transcription	3	13	23.0769230769231	0.0112234294762119	0.0480266949343321	1	1	0.865837889870508	0.993627075303383	0.438773351297143
down	LEPROT; PICALM; GOPC;	GO:2000009~negative regulation of protein localization to cell surface	3	13	23.0769230769231	0.0112234294762119	0.0480266949343321	1	1	0.865837889870508	0.993627075303383	0.438773351297143
down	CALM3; PPP2R5A; PPP1R7; LILRB2;	GO:0035307~positive regulation of protein dephosphorylation	4	26	15.3846153846154	0.0118246597549494	0.0502441407995314	1	1	0.870476898848	0.993627075303383	0.459032004425863
down	EREG; BCL10; THBS1; KCTD20;	GO:0042327~positive regulation of phosphorylation	4	26	15.3846153846154	0.0118246597549494	0.0502441407995314	1	1	0.870476898848	0.993627075303383	0.459032004425863
down	NUP62; RAPGEF1; RASA3; MAPKAP1;	GO:0046580~negative regulation of Ras protein signal transduction	4	26	15.3846153846154	0.0118246597549494	0.0502441407995314	1	1	0.870476898848	0.993627075303383	0.459032004425863
down	SPAG9; ABL1; TCF3; MDM2;	GO:0051149~positive regulation of muscle cell differentiation	4	26	15.3846153846154	0.0118246597549494	0.0502441407995314	1	1	0.870476898848	0.993627075303383	0.459032004425863
down	CDK14; EMD; FAM53B; OTULIN;	GO:0060828~regulation of canonical Wnt signaling pathway	4	26	15.3846153846154	0.0118246597549494	0.0502441407995314	1	1	0.870476898848	0.993627075303383	0.459032004425863
down	PARP1; RAD23B; XPC; GTF2H2;	GO:0070911~global genome nucleotide-excision repair	4	26	15.3846153846154	0.0118246597549494	0.0502441407995314	1	1	0.870476898848	0.993627075303383	0.459032004425863
down	TIMP1; CD44; BMP6; TRIP11; HIF1A; CREB3L2;	GO:0051216~cartilage development	6	58	10.3448275862069	0.0122582726196496	0.0502441407995314	1	1	0.8730105114434	0.993627075303383	0.459032004425863
down	RUNX2; EXT1; DDR2; OSTF1; TRAF6; RUNX3; RUNX1;	GO:0001503~ossification	7	76	9.21052631578947	0.0123298129681542	0.0502441407995314	1	1	0.874336699286304	0.993627075303383	0.459032004425863
down	ABCA1; MSR1; FCER1G; MYH9; AIF1; IGLC2; IGHA1; TRDC; IGLC3;	GO:0006911~phagocytosis, engulfment	9	115	7.82608695652174	0.0125432853026184	0.0507180783531785	1	1	0.875704988330571	0.993627075303383	0.463361912386501
down	MAP2K7; GTF2H2; CIRBP; MAP4K3; CCAR2;	GO:0009411~response to UV	5	42	11.9047619047619	0.0129857907223166	0.0522727069055519	1	1	0.878576152226737	0.993627075303383	0.477565046307747
down	WWP2; CBFA2T2; NFKBIA; BCL6; FBXW7;	GO:0045746~negative regulation of Notch signaling pathway	5	42	11.9047619047619	0.0129857907223166	0.0522727069055519	1	1	0.878576152226737	0.993627075303383	0.477565046307747
down	RB1; PTGS2; ZBTB17; RUNX3; LILRB1;	GO:0045786~negative regulation of cell cycle	5	42	11.9047619047619	0.0129857907223166	0.0522727069055519	1	1	0.878576152226737	0.993627075303383	0.477565046307747
down	CTDSP2; RB1; CCL2; DCUN1D3; BTN2A2;	GO:2000134~negative regulation of G1/S transition of mitotic cell cycle	5	42	11.9047619047619	0.0129857907223166	0.0522727069055519	1	1	0.878576152226737	0.993627075303383	0.477565046307747
down	CSTF1; FIP1L1; SRRM1; CSTF2T; CPSF2; CPSF3;	GO:0031124~mRNA 3'-end processing	6	59	10.1694915254237	0.0131715477623311	0.0522727069055519	1	1	0.880083513272224	0.993627075303383	0.477565046307747
down	PIK3CG; IRAK4; NFAT5; NFATC2;	GO:0001816~cytokine production	4	27	14.8148148148148	0.0132608524746067	0.0522727069055519	1	1	0.880083513272224	0.993627075303383	0.477565046307747
down	CCR7; PTK2B; NINJ1; CIB1;	GO:0001954~positive regulation of cell-matrix adhesion	4	27	14.8148148148148	0.0132608524746067	0.0522727069055519	1	1	0.880083513272224	0.993627075303383	0.477565046307747
down	IL12RB1; MAVS; APOBEC3F; LILRB1;	GO:0002230~positive regulation of defense response to virus by host	4	27	14.8148148148148	0.0132608524746067	0.0522727069055519	1	1	0.880083513272224	0.993627075303383	0.477565046307747
down	NPC1; CTNS; ARRB2; HIPK2;	GO:0007628~adult walking behavior	4	27	14.8148148148148	0.0132608524746067	0.0522727069055519	1	1	0.880083513272224	0.993627075303383	0.477565046307747
down	HEXB; LPCAT1; LPGAT1; AGPAT4;	GO:0008654~phospholipid biosynthetic process	4	27	14.8148148148148	0.0132608524746067	0.0522727069055519	1	1	0.880083513272224	0.993627075303383	0.477565046307747
down	AHR; EIF4EBP2; KSR1; RAPGEF2;	GO:0019933~cAMP-mediated signaling	4	27	14.8148148148148	0.0132608524746067	0.0522727069055519	1	1	0.880083513272224	0.993627075303383	0.477565046307747
down	CLIP1; DCTN1; NUMA1; MAPRE1;	GO:0031116~positive regulation of microtubule polymerization	4	27	14.8148148148148	0.0132608524746067	0.0522727069055519	1	1	0.880083513272224	0.993627075303383	0.477565046307747
down	YWHAB; SAV1; MOB1A; LATS2;	GO:0035329~hippo signaling	4	27	14.8148148148148	0.0132608524746067	0.0522727069055519	1	1	0.880083513272224	0.993627075303383	0.477565046307747
down	ERN1; VEGFA; MAPKAPK2; SPHK1;	GO:0035924~cellular response to vascular endothelial growth factor stimulus	4	27	14.8148148148148	0.0132608524746067	0.0522727069055519	1	1	0.880083513272224	0.993627075303383	0.477565046307747
down	PAFAH1B1; SIRPA; ZMYND11; DUSP10;	GO:0046329~negative regulation of JNK cascade	4	27	14.8148148148148	0.0132608524746067	0.0522727069055519	1	1	0.880083513272224	0.993627075303383	0.477565046307747
down	SKI; ACTB; MAP2K1; BRK1;	GO:0048870~cell motility	4	27	14.8148148148148	0.0132608524746067	0.0522727069055519	1	1	0.880083513272224	0.993627075303383	0.477565046307747
down	IL1A; GAPDH; SRC; CD14;	GO:0050715~positive regulation of cytokine secretion	4	27	14.8148148148148	0.0132608524746067	0.0522727069055519	1	1	0.880083513272224	0.993627075303383	0.477565046307747
down	MAP2K7; NFKB1; MAPK1; MAP3K8;	GO:0051403~stress-activated MAPK cascade	4	27	14.8148148148148	0.0132608524746067	0.0522727069055519	1	1	0.880083513272224	0.993627075303383	0.477565046307747
down	AP3B1; YWHAZ; STK40;	GO:0003016~respiratory system process	3	14	21.4285714285714	0.0133289385029698	0.0522727069055519	1	1	0.880083513272224	0.993627075303383	0.477565046307747
down	ATP2B4; SMARCA4; RAB11FIP4;	GO:0003407~neural retina development	3	14	21.4285714285714	0.0133289385029698	0.0522727069055519	1	1	0.880083513272224	0.993627075303383	0.477565046307747
down	ALG10B; ALG8; ALG2;	GO:0006488~dolichol-linked oligosaccharide biosynthetic process	3	14	21.4285714285714	0.0133289385029698	0.0522727069055519	1	1	0.880083513272224	0.993627075303383	0.477565046307747
down	SRC; SLC9A1; SERPINF1;	GO:0010447~response to acidic pH	3	14	21.4285714285714	0.0133289385029698	0.0522727069055519	1	1	0.880083513272224	0.993627075303383	0.477565046307747
down	B4GALT5; CNTNAP1; B4GALT6;	GO:0022010~central nervous system myelination	3	14	21.4285714285714	0.0133289385029698	0.0522727069055519	1	1	0.880083513272224	0.993627075303383	0.477565046307747
down	THBS1; F2R; HPSE;	GO:0030194~positive regulation of blood coagulation	3	14	21.4285714285714	0.0133289385029698	0.0522727069055519	1	1	0.880083513272224	0.993627075303383	0.477565046307747
down	ATP1A1; SLC9A1; SLC8A1;	GO:0036376~sodium ion export across plasma membrane	3	14	21.4285714285714	0.0133289385029698	0.0522727069055519	1	1	0.880083513272224	0.993627075303383	0.477565046307747
down	CTCF; MTA1; HDAC5;	GO:0040029~regulation of gene expression, epigenetic	3	14	21.4285714285714	0.0133289385029698	0.0522727069055519	1	1	0.880083513272224	0.993627075303383	0.477565046307747
down	B4GALT5; RB1; B4GALT6;	GO:0042551~neuron maturation	3	14	21.4285714285714	0.0133289385029698	0.0522727069055519	1	1	0.880083513272224	0.993627075303383	0.477565046307747
down	ROCK2; ATP2B4; SIRPA;	GO:0045019~negative regulation of nitric oxide biosynthetic process	3	14	21.4285714285714	0.0133289385029698	0.0522727069055519	1	1	0.880083513272224	0.993627075303383	0.477565046307747
down	TNFRSF11B; CSK; P2RX7;	GO:0045779~negative regulation of bone resorption	3	14	21.4285714285714	0.0133289385029698	0.0522727069055519	1	1	0.880083513272224	0.993627075303383	0.477565046307747
down	SPAG9; RB1; MTPN;	GO:0051146~striated muscle cell differentiation	3	14	21.4285714285714	0.0133289385029698	0.0522727069055519	1	1	0.880083513272224	0.993627075303383	0.477565046307747
down	PRKAR1A; RXRA; ARID2;	GO:0060038~cardiac muscle cell proliferation	3	14	21.4285714285714	0.0133289385029698	0.0522727069055519	1	1	0.880083513272224	0.993627075303383	0.477565046307747
down	MYC; FASLG; TBC1D7;	GO:0070848~response to growth factor	3	14	21.4285714285714	0.0133289385029698	0.0522727069055519	1	1	0.880083513272224	0.993627075303383	0.477565046307747
down	NOTCH2; ARL13B; SETDB2;	GO:0070986~left/right axis specification	3	14	21.4285714285714	0.0133289385029698	0.0522727069055519	1	1	0.880083513272224	0.993627075303383	0.477565046307747
down	ETV6; RUNX1; NKAP;	GO:0071425~hematopoietic stem cell proliferation	3	14	21.4285714285714	0.0133289385029698	0.0522727069055519	1	1	0.880083513272224	0.993627075303383	0.477565046307747
down	ATP1A1; PRKACA; SLC8A1;	GO:0086064~cell communication by electrical coupling involved in cardiac conduction	3	14	21.4285714285714	0.0133289385029698	0.0522727069055519	1	1	0.880083513272224	0.993627075303383	0.477565046307747
down	MME; C5AR1; MSR1;	GO:0097242~amyloid-beta clearance	3	14	21.4285714285714	0.0133289385029698	0.0522727069055519	1	1	0.880083513272224	0.993627075303383	0.477565046307747
down	COBL; IQGAP1; CYFIP1;	GO:1900006~positive regulation of dendrite development	3	14	21.4285714285714	0.0133289385029698	0.0522727069055519	1	1	0.880083513272224	0.993627075303383	0.477565046307747
down	ABL1; MAPK1; DNM2;	GO:1903351~cellular response to dopamine	3	14	21.4285714285714	0.0133289385029698	0.0522727069055519	1	1	0.880083513272224	0.993627075303383	0.477565046307747
down	MSN; RDX; VPS11;	GO:1903364~positive regulation of cellular protein catabolic process	3	14	21.4285714285714	0.0133289385029698	0.0522727069055519	1	1	0.880083513272224	0.993627075303383	0.477565046307747
down	OS9; RNF185; SEL1L;	GO:1904380~endoplasmic reticulum mannose trimming	3	14	21.4285714285714	0.0133289385029698	0.0522727069055519	1	1	0.880083513272224	0.993627075303383	0.477565046307747
down	CP; MYC; BMP6; ATP6V1A; ATP6V0D1; HIF1A;	GO:0006879~cellular iron ion homeostasis	6	60	10	0.0141313542326836	0.0553140986077972	1	1	0.886651300684703	0.993627075303383	0.505351293760879
down	CLIC1; HGF; BMP6; BMPR2; RUNX2; DDR2;	GO:0045669~positive regulation of osteoblast differentiation	6	60	10	0.0141313542326836	0.0553140986077972	1	1	0.886651300684703	0.993627075303383	0.505351293760879
down	IGF2R; HGF; C5AR1; TGFBR2; PPARG;	GO:0031100~animal organ regeneration	5	43	11.6279069767442	0.0141469097168445	0.0553140986077972	1	1	0.886651300684703	0.993627075303383	0.505351293760879
down	PTPN6; LILRB2; LILRB1; DLG5; CD274;	GO:0042130~negative regulation of T cell proliferation	5	43	11.6279069767442	0.0141469097168445	0.0553140986077972	1	1	0.886651300684703	0.993627075303383	0.505351293760879
down	ERN1; ZFP36; METTL14; AGO4;	GO:0006402~mRNA catabolic process	4	28	14.2857142857143	0.0148033670006182	0.057621470356402	1	1	0.890300071469414	0.993627075303383	0.526431512506058
down	CTIF; EIF4G3; EIF4G1; EIF4H;	GO:0006446~regulation of translational initiation	4	28	14.2857142857143	0.0148033670006182	0.057621470356402	1	1	0.890300071469414	0.993627075303383	0.526431512506058
down	SKAP2; LAX1; IKZF3; HDAC5;	GO:0042113~B cell activation	4	28	14.2857142857143	0.0148033670006182	0.057621470356402	1	1	0.890300071469414	0.993627075303383	0.526431512506058
down	EREG; IL1A; NUP62; SPHK1;	GO:0045840~positive regulation of mitotic nuclear division	4	28	14.2857142857143	0.0148033670006182	0.057621470356402	1	1	0.890300071469414	0.993627075303383	0.526431512506058
down	LIG3; LIG4; POLM; SPHK1;	GO:0071897~DNA biosynthetic process	4	28	14.2857142857143	0.0148033670006182	0.057621470356402	1	1	0.890300071469414	0.993627075303383	0.526431512506058
down	RB1; CSNK2A2; TMBIM6; AATF;	GO:2001234~negative regulation of apoptotic signaling pathway	4	28	14.2857142857143	0.0148033670006182	0.057621470356402	1	1	0.890300071469414	0.993627075303383	0.526431512506058
down	SOD2; ATP1A1; PTGS2; PPARG; ACSM3; P2RX4;	GO:0008217~regulation of blood pressure	6	61	9.83606557377049	0.0151387902864222	0.0588831156513675	1	1	0.893188626898908	0.993627075303383	0.537957942442101
down	TULP3; BTG2; RING1; BMPR2; TSHZ1; HIPK2; BHLHE40; HES6;	GO:0009952~anterior/posterior pattern specification	8	99	8.08080808080808	0.0153159282384815	0.0595276793280876	1	1	0.894229516929871	0.993627075303383	0.543846695872784
down	PARP1; XRCC6; RPA2; RPA1; TERF1;	GO:0000723~telomere maintenance	5	44	11.3636363636364	0.0153757111068972	0.0596266415841875	1	1	0.894229516929871	0.993627075303383	0.544750818066082
down	CCDC88A; PPP1R9B; TLR7; FNIP2; CORO1C;	GO:0001932~regulation of protein phosphorylation	5	44	11.3636363636364	0.0153757111068972	0.0596266415841875	1	1	0.894229516929871	0.993627075303383	0.544750818066082
down	ATF3; MAPK1; MTOR; RRAGA; SH3GLB1;	GO:0034198~cellular response to amino acid starvation	5	44	11.3636363636364	0.0153757111068972	0.0596266415841875	1	1	0.894229516929871	0.993627075303383	0.544750818066082
down	TRPT1; ZBTB8OS; TSEN15;	GO:0006388~tRNA splicing, via endonucleolytic cleavage and ligation	3	15	20	0.0156437918563259	0.059776717855697	1	1	0.896309811585408	0.993627075303383	0.546121919464802
down	FOXO1; CREBBP; SPHK1;	GO:0006473~protein acetylation	3	15	20	0.0156437918563259	0.059776717855697	1	1	0.896309811585408	0.993627075303383	0.546121919464802
down	CCL2; VCP; CTBP2;	GO:0019079~viral genome replication	3	15	20	0.0156437918563259	0.059776717855697	1	1	0.896309811585408	0.993627075303383	0.546121919464802
down	WDR1; RAC2; RHOU;	GO:0030865~cortical cytoskeleton organization	3	15	20	0.0156437918563259	0.059776717855697	1	1	0.896309811585408	0.993627075303383	0.546121919464802
down	UFL1; SRC; RUNX1;	GO:0033146~regulation of intracellular estrogen receptor signaling pathway	3	15	20	0.0156437918563259	0.059776717855697	1	1	0.896309811585408	0.993627075303383	0.546121919464802
down	PTPN6; ADAM9; CIB1;	GO:0033630~positive regulation of cell adhesion mediated by integrin	3	15	20	0.0156437918563259	0.059776717855697	1	1	0.896309811585408	0.993627075303383	0.546121919464802
down	PDPK1; ARRB2; IRAK3;	GO:0034122~negative regulation of toll-like receptor signaling pathway	3	15	20	0.0156437918563259	0.059776717855697	1	1	0.896309811585408	0.993627075303383	0.546121919464802
down	TLR4; BCL10; TLR7;	GO:0045416~positive regulation of interleukin-8 biosynthetic process	3	15	20	0.0156437918563259	0.059776717855697	1	1	0.896309811585408	0.993627075303383	0.546121919464802
down	CCP110; CCDC88A; BBS4;	GO:0045724~positive regulation of cilium assembly	3	15	20	0.0156437918563259	0.059776717855697	1	1	0.896309811585408	0.993627075303383	0.546121919464802
down	PNPLA6; GDE1; GDPD1;	GO:0046475~glycerophospholipid catabolic process	3	15	20	0.0156437918563259	0.059776717855697	1	1	0.896309811585408	0.993627075303383	0.546121919464802
down	TGFBR2; JARID2; SAV1;	GO:0060044~negative regulation of cardiac muscle cell proliferation	3	15	20	0.0156437918563259	0.059776717855697	1	1	0.896309811585408	0.993627075303383	0.546121919464802
down	PARP1; BMP6; DAB2;	GO:0060391~positive regulation of SMAD protein signal transduction	3	15	20	0.0156437918563259	0.059776717855697	1	1	0.896309811585408	0.993627075303383	0.546121919464802
down	SMARCA4; DAB2; NCOR2;	GO:0060766~negative regulation of androgen receptor signaling pathway	3	15	20	0.0156437918563259	0.059776717855697	1	1	0.896309811585408	0.993627075303383	0.546121919464802
down	ROCK2; ROCK1; METTL14;	GO:0061157~mRNA destabilization	3	15	20	0.0156437918563259	0.059776717855697	1	1	0.896309811585408	0.993627075303383	0.546121919464802
down	ATP2B4; MTOR; CHP1;	GO:0070885~negative regulation of calcineurin-NFAT signaling cascade	3	15	20	0.0156437918563259	0.059776717855697	1	1	0.896309811585408	0.993627075303383	0.546121919464802
down	RIPK2; ASPH; NLRC4;	GO:0097202~activation of cysteine-type endopeptidase activity	3	15	20	0.0156437918563259	0.059776717855697	1	1	0.896309811585408	0.993627075303383	0.546121919464802
down	CNOT1; ZFP36; ZFP36L1;	GO:1900153~positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay	3	15	20	0.0156437918563259	0.059776717855697	1	1	0.896309811585408	0.993627075303383	0.546121919464802
down	NF1; LILRB2; PAIP2;	GO:1900271~regulation of long-term synaptic potentiation	3	15	20	0.0156437918563259	0.059776717855697	1	1	0.896309811585408	0.993627075303383	0.546121919464802
down	PARP1; PPM1F; DVL3;	GO:1903827~regulation of cellular protein localization	3	15	20	0.0156437918563259	0.059776717855697	1	1	0.896309811585408	0.993627075303383	0.546121919464802
down	PDPK1; HMGB1; FGFR1;	GO:1905564~positive regulation of vascular endothelial cell proliferation	3	15	20	0.0156437918563259	0.059776717855697	1	1	0.896309811585408	0.993627075303383	0.546121919464802
down	SOCS3; SOCS6; OSM; PAK2; NEDD9; E4F1;	GO:0040008~regulation of growth	6	62	9.67741935483871	0.01619492691116	0.0616743810544337	1	1	0.900725130854301	0.993627075303383	0.563459028388943
down	TNFRSF11B; CA2; ARSB; MAPK1; TGFBR2; PPARG;	GO:0043627~response to estrogen	6	62	9.67741935483871	0.01619492691116	0.0616743810544337	1	1	0.900725130854301	0.993627075303383	0.563459028388943
down	VEGFA; ENG; TGFBR2; PLXND1;	GO:0001569~branching involved in blood vessel morphogenesis	4	29	13.7931034482759	0.0164545450545726	0.0616743810544337	1	1	0.903070769215901	0.993627075303383	0.563459028388943
down	AHCYL1; EGR2; CALR; CHP1;	GO:0006611~protein export from nucleus	4	29	13.7931034482759	0.0164545450545726	0.0616743810544337	1	1	0.903070769215901	0.993627075303383	0.563459028388943
down	PRDM1; RARA; MTOR; PAFAH1B1;	GO:0007281~germ cell development	4	29	13.7931034482759	0.0164545450545726	0.0616743810544337	1	1	0.903070769215901	0.993627075303383	0.563459028388943
down	B4GALT5; ST3GAL2; B3GNT7; B4GALT6;	GO:0018146~keratan sulfate biosynthetic process	4	29	13.7931034482759	0.0164545450545726	0.0616743810544337	1	1	0.903070769215901	0.993627075303383	0.563459028388943
down	THBS1; DAB2; CREBBP; HIPK2;	GO:0030511~positive regulation of transforming growth factor beta receptor signaling pathway	4	29	13.7931034482759	0.0164545450545726	0.0616743810544337	1	1	0.903070769215901	0.993627075303383	0.563459028388943
down	SLC9A3R1; ABL1; SMAD3; BTG2;	GO:0045930~negative regulation of mitotic cell cycle	4	29	13.7931034482759	0.0164545450545726	0.0616743810544337	1	1	0.903070769215901	0.993627075303383	0.563459028388943
down	PDPK1; ABL1; F2R; CXCL9;	GO:0051281~positive regulation of release of sequestered calcium ion into cytosol	4	29	13.7931034482759	0.0164545450545726	0.0616743810544337	1	1	0.903070769215901	0.993627075303383	0.563459028388943
down	TLR4; RIPK2; HMGB1; CCR7; PTK2B; HIPK2; TRAF6;	GO:0046330~positive regulation of JNK cascade	7	81	8.64197530864197	0.0166019661578688	0.0616743810544337	1	1	0.903070769215901	0.993627075303383	0.563459028388943
down	MAPK1; STX4; STX3; PTK2B; NPTN;	GO:0060291~long-term synaptic potentiation	5	45	11.1111111111111	0.0166737313016762	0.0616743810544337	1	1	0.903070769215901	0.993627075303383	0.563459028388943
down	POLR2D; SKI; LIG4; RBPJ; REST; BCL9L;	GO:0035019~somatic stem cell population maintenance	6	63	9.52380952380952	0.0173008062726221	0.0625758516952855	1	1	0.908067998768875	0.993627075303383	0.571694891687954
down	NDUFS8; STK25; TOR1A; ATRN; ABL1; PTGS2; GCLM; ATOX1;	GO:0006979~response to oxidative stress	8	102	7.84313725490196	0.0178202157891473	0.0643651868974606	1	1	0.910733187863794	0.993627075303383	0.588042312727978
down	KIF3B; TACC1; PCNT; DCTN2; DYNC1H1;	GO:0007052~mitotic spindle organization	5	46	10.8695652173913	0.0180424354915552	0.064909188563489	1	1	0.913336982658781	0.993627075303383	0.593012328558568
down	ARID1A; APAF1; TYROBP; SRC; KDM2B;	GO:0030900~forebrain development	5	46	10.8695652173913	0.0180424354915552	0.064909188563489	1	1	0.913336982658781	0.993627075303383	0.593012328558568
down	ERN1; BMPR2; PROK2;	GO:0001935~endothelial cell proliferation	3	16	18.75	0.0181700894309537	0.064909188563489	1	1	0.913336982658781	0.993627075303383	0.593012328558568
down	CCR1; PTK2B; HIF1A;	GO:0030502~negative regulation of bone mineralization	3	16	18.75	0.0181700894309537	0.064909188563489	1	1	0.913336982658781	0.993627075303383	0.593012328558568
down	CIRBP; DYNC1H1; ATXN2L;	GO:0034063~stress granule assembly	3	16	18.75	0.0181700894309537	0.064909188563489	1	1	0.913336982658781	0.993627075303383	0.593012328558568
down	PHLPP1; MAP4K4; RAPGEF1;	GO:0046328~regulation of JNK cascade	3	16	18.75	0.0181700894309537	0.064909188563489	1	1	0.913336982658781	0.993627075303383	0.593012328558568
down	ACTN4; RARA; RXRA;	GO:0048384~retinoic acid receptor signaling pathway	3	16	18.75	0.0181700894309537	0.064909188563489	1	1	0.913336982658781	0.993627075303383	0.593012328558568
down	BCR; CCR7; CARD11;	GO:0048872~homeostasis of number of cells	3	16	18.75	0.0181700894309537	0.064909188563489	1	1	0.913336982658781	0.993627075303383	0.593012328558568
down	NLRP3; NLRC4; CARD8;	GO:0050713~negative regulation of interleukin-1 beta secretion	3	16	18.75	0.0181700894309537	0.064909188563489	1	1	0.913336982658781	0.993627075303383	0.593012328558568
down	RHOA; CAMK1D; PREX1;	GO:0050773~regulation of dendrite development	3	16	18.75	0.0181700894309537	0.064909188563489	1	1	0.913336982658781	0.993627075303383	0.593012328558568
down	MAP1A; DCTN1; CHMP2B;	GO:0070050~neuron cellular homeostasis	3	16	18.75	0.0181700894309537	0.064909188563489	1	1	0.913336982658781	0.993627075303383	0.593012328558568
down	SOCS3; JAK1; CTR9;	GO:0070102~interleukin-6-mediated signaling pathway	3	16	18.75	0.0181700894309537	0.064909188563489	1	1	0.913336982658781	0.993627075303383	0.593012328558568
down	CFLAR; DNM2; FOXO1;	GO:0071732~cellular response to nitric oxide	3	16	18.75	0.0181700894309537	0.064909188563489	1	1	0.913336982658781	0.993627075303383	0.593012328558568
down	SLC9A1; SLC8A1; SLC9A7;	GO:0098719~sodium ion import across plasma membrane	3	16	18.75	0.0181700894309537	0.064909188563489	1	1	0.913336982658781	0.993627075303383	0.593012328558568
down	RNF40; FBXW7; OSBPL7;	GO:1901800~positive regulation of proteasomal protein catabolic process	3	16	18.75	0.0181700894309537	0.064909188563489	1	1	0.913336982658781	0.993627075303383	0.593012328558568
down	RRAGA; PIH1D1; SIK3;	GO:1904263~positive regulation of TORC1 signaling	3	16	18.75	0.0181700894309537	0.064909188563489	1	1	0.913336982658781	0.993627075303383	0.593012328558568
down	CSF2RB; COX15; CHST11; MAFB;	GO:0007585~respiratory gaseous exchange by respiratory system	4	30	13.3333333333333	0.0182165172193582	0.0649415100870692	1	1	0.913336982658781	0.993627075303383	0.593307618984855
down	DNMT1; AEBP2; JARID2; MPHOSPH8;	GO:0045814~negative regulation of gene expression, epigenetic	4	30	13.3333333333333	0.0182165172193582	0.0649415100870692	1	1	0.913336982658781	0.993627075303383	0.593307618984855
down	SKI; CHSY1; GLG1; RARA;	GO:0060349~bone morphogenesis	4	30	13.3333333333333	0.0182165172193582	0.0649415100870692	1	1	0.913336982658781	0.993627075303383	0.593307618984855
down	NDUFS8; NDUFB5; NDUFB10; NDUFV1; OXA1L; NDUFAF3;	GO:0032981~mitochondrial respiratory chain complex I assembly	6	64	9.375	0.0184574402395682	0.0657554193633831	1	1	0.91408317300409	0.993627075303383	0.600743518983978
down	NQO2; CREB1; PTGS2; MAP1A; EIF4EBP2; PAIP2; SYT11;	GO:0007613~memory	7	83	8.43373493975904	0.0185722981749863	0.0661194112623146	1	1	0.91408317300409	0.993627075303383	0.604068960086214
down	NUP62; LATS2; RARA; PPARA; PPARG;	GO:0009755~hormone-mediated signaling pathway	5	47	10.6382978723404	0.0194832155047838	0.0693150301781115	1	1	0.91571112872484	0.993627075303383	0.633264232071303
down	PRDM1; METTL18; GSTO1; METTL23; SMYD4; PRDM8;	GO:0032259~methylation	6	65	9.23076923076923	0.0196658089838389	0.0699169143409059	1	1	0.916520728132101	0.993627075303383	0.638763064159647
down	CALM3; PRKACA; SLC8A1; MDM2;	GO:0002027~regulation of heart rate	4	31	12.9032258064516	0.0200912030740305	0.071041621724455	1	1	0.917407111815014	0.993627075303383	0.649038425155927
down	SND1; ERI1; CNOT9; CNOT11;	GO:0031047~gene silencing by RNA	4	31	12.9032258064516	0.0200912030740305	0.071041621724455	1	1	0.917407111815014	0.993627075303383	0.649038425155927
down	CFLAR; THBS1; CALR; HSF1;	GO:0033574~response to testosterone	4	31	12.9032258064516	0.0200912030740305	0.071041621724455	1	1	0.917407111815014	0.993627075303383	0.649038425155927
down	ABL1; PTK2B; SRC; HCK;	GO:0038083~peptidyl-tyrosine autophosphorylation	4	31	12.9032258064516	0.0200912030740305	0.071041621724455	1	1	0.917407111815014	0.993627075303383	0.649038425155927
down	RIPK2; NFKBIA; MAPK1; IRAK3;	GO:0043330~response to exogenous dsRNA	4	31	12.9032258064516	0.0200912030740305	0.071041621724455	1	1	0.917407111815014	0.993627075303383	0.649038425155927
down	SPTLC2; ASAH1; CERS2; P2RX7;	GO:0046513~ceramide biosynthetic process	4	31	12.9032258064516	0.0200912030740305	0.071041621724455	1	1	0.917407111815014	0.993627075303383	0.649038425155927
down	CFLAR; ICAM1; SERPINF1; FOXO1;	GO:0071549~cellular response to dexamethasone stimulus	4	31	12.9032258064516	0.0200912030740305	0.071041621724455	1	1	0.917407111815014	0.993627075303383	0.649038425155927
down	KIF3B; FLNA; RHOA; GOLGA2;	GO:0090307~mitotic spindle assembly	4	31	12.9032258064516	0.0200912030740305	0.071041621724455	1	1	0.917407111815014	0.993627075303383	0.649038425155927
down	TNFSF15; TLR6; TRAF6;	GO:0007250~activation of NF-kappaB-inducing kinase activity	3	17	17.6470588235294	0.0209091237222597	0.0733367111981277	1	1	0.919306505421257	0.993627075303383	0.670006432662316
down	TMBIM6; ITPR1; PACS2;	GO:0032469~endoplasmic reticulum calcium ion homeostasis	3	17	17.6470588235294	0.0209091237222597	0.0733367111981277	1	1	0.919306505421257	0.993627075303383	0.670006432662316
down	TGFBR2; HIF1A; CCDC134;	GO:0035162~embryonic hemopoiesis	3	17	17.6470588235294	0.0209091237222597	0.0733367111981277	1	1	0.919306505421257	0.993627075303383	0.670006432662316
down	PTPN6; ABI1; WASF2;	GO:0035855~megakaryocyte development	3	17	17.6470588235294	0.0209091237222597	0.0733367111981277	1	1	0.919306505421257	0.993627075303383	0.670006432662316
down	SLC9A3R1; MSN; RHOA;	GO:0045198~establishment of epithelial cell apical/basal polarity	3	17	17.6470588235294	0.0209091237222597	0.0733367111981277	1	1	0.919306505421257	0.993627075303383	0.670006432662316
down	APOBEC3F; MPHOSPH8; APOBEC3A;	GO:0045869~negative regulation of single stranded viral RNA replication via double stranded DNA intermediate	3	17	17.6470588235294	0.0209091237222597	0.0733367111981277	1	1	0.919306505421257	0.993627075303383	0.670006432662316
down	SON; RBM42; KHDRBS1;	GO:0048024~regulation of mRNA splicing, via spliceosome	3	17	17.6470588235294	0.0209091237222597	0.0733367111981277	1	1	0.919306505421257	0.993627075303383	0.670006432662316
down	SLC9A1; HGSNAT; CHP1;	GO:0051259~protein complex oligomerization	3	17	17.6470588235294	0.0209091237222597	0.0733367111981277	1	1	0.919306505421257	0.993627075303383	0.670006432662316
down	ZFP36; ZFP36L1; RC3H1;	GO:0061158~3'-UTR-mediated mRNA destabilization	3	17	17.6470588235294	0.0209091237222597	0.0733367111981277	1	1	0.919306505421257	0.993627075303383	0.670006432662316
down	TFE3; PTGS2; METRNL;	GO:0090336~positive regulation of brown fat cell differentiation	3	17	17.6470588235294	0.0209091237222597	0.0733367111981277	1	1	0.919306505421257	0.993627075303383	0.670006432662316
down	MAP2K7; MAPK1; NABP2;	GO:1904355~positive regulation of telomere capping	3	17	17.6470588235294	0.0209091237222597	0.0733367111981277	1	1	0.919306505421257	0.993627075303383	0.670006432662316
down	SRC; MCL1; PDK4;	GO:2000811~negative regulation of anoikis	3	17	17.6470588235294	0.0209091237222597	0.0733367111981277	1	1	0.919306505421257	0.993627075303383	0.670006432662316
down	ICAM1; MTOR; MTHFR; RHOA;	GO:0043200~response to amino acid	4	32	12.5	0.0220803121091412	0.0747472614824021	1	1	0.921395838388123	0.993627075303383	0.682893263127134
down	ATP1A1; PTPRC; PPP3CA; DUSP4; PRUNE1; PHOSPHO1; DUSP10;	GO:0016311~dephosphorylation	7	87	8.04597701149425	0.0229935457833058	0.0771186361792728	1	1	0.922520863831821	0.993627075303383	0.704558214761842
down	FURIN; RPL7L1; SUPT6H;	GO:0001825~blastocyst formation	3	18	16.6666666666667	0.0238614410148754	0.0793655587552844	1	1	0.924953351277653	0.993627075303383	0.725086168020542
down	ATP1A1; SLC9A1; SLC8A1;	GO:0006883~cellular sodium ion homeostasis	3	18	16.6666666666667	0.0238614410148754	0.0793655587552844	1	1	0.924953351277653	0.993627075303383	0.725086168020542
down	EOMES; SKI; EXT1;	GO:0021772~olfactory bulb development	3	18	16.6666666666667	0.0238614410148754	0.0793655587552844	1	1	0.924953351277653	0.993627075303383	0.725086168020542
down	IRF8; NCOA6; TET2;	GO:0030099~myeloid cell differentiation	3	18	16.6666666666667	0.0238614410148754	0.0793655587552844	1	1	0.924953351277653	0.993627075303383	0.725086168020542
down	ARID1A; TRIP4; DDX54;	GO:0030520~intracellular estrogen receptor signaling pathway	3	18	16.6666666666667	0.0238614410148754	0.0793655587552844	1	1	0.924953351277653	0.993627075303383	0.725086168020542
down	TGFBR2; SMAD3; BMPR2;	GO:0032924~activin receptor signaling pathway	3	18	16.6666666666667	0.0238614410148754	0.0793655587552844	1	1	0.924953351277653	0.993627075303383	0.725086168020542
down	SRC; RHOA; PTK2B;	GO:0043149~stress fiber assembly	3	18	16.6666666666667	0.0238614410148754	0.0793655587552844	1	1	0.924953351277653	0.993627075303383	0.725086168020542
down	NFKBIA; PTK2B; CTR9;	GO:0045638~negative regulation of myeloid cell differentiation	3	18	16.6666666666667	0.0238614410148754	0.0793655587552844	1	1	0.924953351277653	0.993627075303383	0.725086168020542
down	ST6GAL1; ST3GAL2; ST8SIA4;	GO:0097503~sialylation	3	18	16.6666666666667	0.0238614410148754	0.0793655587552844	1	1	0.924953351277653	0.993627075303383	0.725086168020542
down	RAB29; CHP1; TBK1;	GO:1901214~regulation of neuron death	3	18	16.6666666666667	0.0238614410148754	0.0793655587552844	1	1	0.924953351277653	0.993627075303383	0.725086168020542
down	PDPK1; VEGFA; JAK1;	GO:1903672~positive regulation of sprouting angiogenesis	3	18	16.6666666666667	0.0238614410148754	0.0793655587552844	1	1	0.924953351277653	0.993627075303383	0.725086168020542
down	RAB11B; VPS39; ANKRD27;	GO:1990126~retrograde transport, endosome to plasma membrane	3	18	16.6666666666667	0.0238614410148754	0.0793655587552844	1	1	0.924953351277653	0.993627075303383	0.725086168020542
down	FOXO1; PID1; COQ7;	GO:2000377~regulation of reactive oxygen species metabolic process	3	18	16.6666666666667	0.0238614410148754	0.0793655587552844	1	1	0.924953351277653	0.993627075303383	0.725086168020542
down	ICAM1; CALM3; PPP3CA; PPP1R9B;	GO:0001975~response to amphetamine	4	33	12.1212121212121	0.024185345349612	0.0802891846892853	1	1	0.924953351277653	0.993627075303383	0.733524442754222
down	CTNS; ATP6V1B2; ATP6V1A; VCP;	GO:0046034~ATP metabolic process	4	33	12.1212121212121	0.024185345349612	0.0802891846892853	1	1	0.924953351277653	0.993627075303383	0.733524442754222
down	SGPL1; FGFR1; ANKRD11; P2RX7;	GO:0048705~skeletal system morphogenesis	4	33	12.1212121212121	0.024185345349612	0.0802891846892853	1	1	0.924953351277653	0.993627075303383	0.733524442754222
down	ELL; WDR81; SPRED1; CHP1; PCIF1;	GO:0010923~negative regulation of phosphatase activity	5	50	10	0.0242507901827773	0.0804040193591828	1	1	0.924953351277653	0.993627075303383	0.7345735758046
down	RPA2; RPA1; SLX4; RNF168; DCLRE1C;	GO:0036297~interstrand cross-link repair	5	50	10	0.0242507901827773	0.0804040193591828	1	1	0.924953351277653	0.993627075303383	0.7345735758046
down	SOCS3; OSM; VEGFA; TNFRSF1A; CD40; HSF1;	GO:0042531~positive regulation of tyrosine phosphorylation of STAT protein	6	69	8.69565217391304	0.0250350541155857	0.0829514952641022	1	1	0.926297002276671	0.993627075303383	0.757847393452859
down	DCTN3; PAFAH1B1; EML4; SRRD;	GO:0007017~microtubule-based process	4	34	11.7647058823529	0.0264075976169398	0.0871668136665549	1	1	0.929138660559452	0.993627075303383	0.796358671082053
down	JUN; MAPK1; AGAP3; CAMKK2;	GO:0034614~cellular response to reactive oxygen species	4	34	11.7647058823529	0.0264075976169398	0.0871668136665549	1	1	0.929138660559452	0.993627075303383	0.796358671082053
down	PTK2B; DVL3; TLR6; TRAF6;	GO:0043507~positive regulation of JUN kinase activity	4	34	11.7647058823529	0.0264075976169398	0.0871668136665549	1	1	0.929138660559452	0.993627075303383	0.796358671082053
down	PICALM; ABI1; TRAK1; SDC2;	GO:0048813~dendrite morphogenesis	4	34	11.7647058823529	0.0264075976169398	0.0871668136665549	1	1	0.929138660559452	0.993627075303383	0.796358671082053
down	TGFBR2; RBPJ; BMPR2; SAV1;	GO:0060412~ventricular septum morphogenesis	4	34	11.7647058823529	0.0264075976169398	0.0871668136665549	1	1	0.929138660559452	0.993627075303383	0.796358671082053
down	OTUD7B; BAP1; USP9X; OTUD5;	GO:0071108~protein K48-linked deubiquitination	4	34	11.7647058823529	0.0264075976169398	0.0871668136665549	1	1	0.929138660559452	0.993627075303383	0.796358671082053
down	HMGB1; XRCC6; RPA1; IGHMBP2; NONO; POLM;	GO:0006310~DNA recombination	6	70	8.57142857142857	0.0265156020149185	0.0874125981668282	1	1	0.929138660559452	0.993627075303383	0.798604165780976
down	RIPK2; EPB41; MARK3; HIPK2; PLXND1; RAPGEF2;	GO:0032092~positive regulation of protein binding	6	70	8.57142857142857	0.0265156020149185	0.0874125981668282	1	1	0.929138660559452	0.993627075303383	0.798604165780976
down	ABCA1; NFKBIA; EEPD1;	GO:0010875~positive regulation of cholesterol efflux	3	19	15.7894736842105	0.0270268991929395	0.0882055094512216	1	1	0.93070286705871	0.993627075303383	0.805848227484791
down	NPC1; MSR1; STARD3;	GO:0030301~cholesterol transport	3	19	15.7894736842105	0.0270268991929395	0.0882055094512216	1	1	0.93070286705871	0.993627075303383	0.805848227484791
down	NBR1; DDR2; PHOSPHO1;	GO:0030500~regulation of bone mineralization	3	19	15.7894736842105	0.0270268991929395	0.0882055094512216	1	1	0.93070286705871	0.993627075303383	0.805848227484791
down	BBS4; FAM49B; SSH1;	GO:0030837~negative regulation of actin filament polymerization	3	19	15.7894736842105	0.0270268991929395	0.0882055094512216	1	1	0.93070286705871	0.993627075303383	0.805848227484791
down	RARA; MTOR; SIRT2;	GO:0031641~regulation of myelination	3	19	15.7894736842105	0.0270268991929395	0.0882055094512216	1	1	0.93070286705871	0.993627075303383	0.805848227484791
down	EGR2; HGF; ITGAX;	GO:0031643~positive regulation of myelination	3	19	15.7894736842105	0.0270268991929395	0.0882055094512216	1	1	0.93070286705871	0.993627075303383	0.805848227484791
down	BMP6; SMAD3; RUNX2;	GO:0032332~positive regulation of chondrocyte differentiation	3	19	15.7894736842105	0.0270268991929395	0.0882055094512216	1	1	0.93070286705871	0.993627075303383	0.805848227484791
down	CAT; RARA; PPARG;	GO:0033189~response to vitamin A	3	19	15.7894736842105	0.0270268991929395	0.0882055094512216	1	1	0.93070286705871	0.993627075303383	0.805848227484791
down	TMED2; TRAF3IP1; CHST11;	GO:0036342~post-anal tail morphogenesis	3	19	15.7894736842105	0.0270268991929395	0.0882055094512216	1	1	0.93070286705871	0.993627075303383	0.805848227484791
down	JAK1; SMARCA4; STAT5B;	GO:0038111~interleukin-7-mediated signaling pathway	3	19	15.7894736842105	0.0270268991929395	0.0882055094512216	1	1	0.93070286705871	0.993627075303383	0.805848227484791
down	MTHFD2; MTHFR; DHFR2;	GO:0046655~folic acid metabolic process	3	19	15.7894736842105	0.0270268991929395	0.0882055094512216	1	1	0.93070286705871	0.993627075303383	0.805848227484791
down	ERP29; RHBDF2; DPH3;	GO:0050709~negative regulation of protein secretion	3	19	15.7894736842105	0.0270268991929395	0.0882055094512216	1	1	0.93070286705871	0.993627075303383	0.805848227484791
down	GCNT1; ROCK1; SELPLG;	GO:0050901~leukocyte tethering or rolling	3	19	15.7894736842105	0.0270268991929395	0.0882055094512216	1	1	0.93070286705871	0.993627075303383	0.805848227484791
down	CALM3; PRKACA; P2RX4;	GO:0055117~regulation of cardiac muscle contraction	3	19	15.7894736842105	0.0270268991929395	0.0882055094512216	1	1	0.93070286705871	0.993627075303383	0.805848227484791
down	ROCK2; GCLM; ROCK1;	GO:0097746~regulation of blood vessel diameter	3	19	15.7894736842105	0.0270268991929395	0.0882055094512216	1	1	0.93070286705871	0.993627075303383	0.805848227484791
down	ABL1; NOTCH2; PTK2B;	GO:2000249~regulation of actin cytoskeleton reorganization	3	19	15.7894736842105	0.0270268991929395	0.0882055094512216	1	1	0.93070286705871	0.993627075303383	0.805848227484791
down	TRIO; MBP; ARSB; LIG4; JARID2; B3GNT5; PDGFC; TPP1; GBA2;	GO:0007417~central nervous system development	9	133	6.76691729323308	0.0276431146864292	0.0882490885703951	1	1	0.932364836464172	0.993627075303383	0.806246367648142
down	ABHD2; RARA; RXRA; PPARG; PPARA;	GO:0043401~steroid hormone mediated signaling pathway	5	52	9.61538461538462	0.0278116125372666	0.0882490885703951	1	1	0.932364836464172	0.993627075303383	0.806246367648142
down	SLC30A4; TLR2; MBP; CCL4; AHR; SLC7A11;	GO:0009636~response to toxic substance	6	71	8.45070422535211	0.0280530317528401	0.0882490885703951	1	1	0.932364836464172	0.993627075303383	0.806246367648142
down	RAB29; CFLAR; CCL2; MLH1; SERPINB9; ST13; IKZF3;	GO:0009617~response to bacterium	7	92	7.60869565217391	0.0294762264852594	0.0926040340212007	1	1	0.936021169156189	0.993627075303383	0.846033282254257
down	UBE2R2; UBE2Q2; RFFL; RNF34; RNF115;	GO:0070936~protein K48-linked ubiquitination	5	53	9.43396226415094	0.0297097583393837	0.0932814822077518	1	1	0.936021169156189	0.993627075303383	0.852222469570803
down	EREG; FOXO3; PTK2B;	GO:0001556~oocyte maturation	3	20	15	0.0304047223338029	0.0948350764834115	1	1	0.93803845615868	0.993627075303383	0.866416154308412
down	SOD2; PREX1; NCF4;	GO:0006801~superoxide metabolic process	3	20	15	0.0304047223338029	0.0948350764834115	1	1	0.93803845615868	0.993627075303383	0.866416154308412
down	PIAS4; RFFL; CARD8;	GO:0010804~negative regulation of tumor necrosis factor-mediated signaling pathway	3	20	15	0.0304047223338029	0.0948350764834115	1	1	0.93803845615868	0.993627075303383	0.866416154308412
down	CYFIP1; RHOU; RAC2;	GO:0030031~cell projection assembly	3	20	15	0.0304047223338029	0.0948350764834115	1	1	0.93803845615868	0.993627075303383	0.866416154308412
down	SRC; TERF1; GNL3L;	GO:0032211~negative regulation of telomere maintenance via telomerase	3	20	15	0.0304047223338029	0.0948350764834115	1	1	0.93803845615868	0.993627075303383	0.866416154308412
down	NF1; SPRED1; P2RX7;	GO:0043409~negative regulation of MAPK cascade	3	20	15	0.0304047223338029	0.0948350764834115	1	1	0.93803845615868	0.993627075303383	0.866416154308412
down	FOXO3; PAFAH1B1; BBS4;	GO:0048854~brain morphogenesis	3	20	15	0.0304047223338029	0.0948350764834115	1	1	0.93803845615868	0.993627075303383	0.866416154308412
down	TLR4; CD14; FASLG;	GO:0070266~necroptotic process	3	20	15	0.0304047223338029	0.0948350764834115	1	1	0.93803845615868	0.993627075303383	0.866416154308412
down	SIRT2; HDAC7; HDAC5;	GO:0070932~histone H3 deacetylation	3	20	15	0.0304047223338029	0.0948350764834115	1	1	0.93803845615868	0.993627075303383	0.866416154308412
down	APOBEC3A; TET2; APOBEC3F;	GO:0080111~DNA demethylation	3	20	15	0.0304047223338029	0.0948350764834115	1	1	0.93803845615868	0.993627075303383	0.866416154308412
down	TET2; CTR9; RTF1;	GO:0080182~histone H3-K4 trimethylation	3	20	15	0.0304047223338029	0.0948350764834115	1	1	0.93803845615868	0.993627075303383	0.866416154308412
down	TPP1; MTOR; P2RX7; USE1;	GO:0030163~protein catabolic process	4	36	11.1111111111111	0.0312079250314756	0.0972821203732362	1	1	0.93803845615868	0.993627075303383	0.888772422000322
down	CCR1; CCR5; CACNA1D; PPP3CA; ITPR1; CALCRL;	GO:0006816~calcium ion transport	6	74	8.10810810810811	0.0330136690982803	0.102114335609029	1	1	0.942521316164218	0.993627075303383	0.932919687934337
down	GOLGA2; NEK6; TUBGCP2; MAPRE2; MAPRE1;	GO:0051225~spindle assembly	5	55	9.09090909090909	0.0337457095875232	0.102114335609029	1	1	0.94487986845065	0.993627075303383	0.932919687934337
down	CAT; RARA; FGFR1; SMAD3;	GO:0001657~ureteric bud development	4	37	10.8108108108108	0.0337875868487867	0.102114335609029	1	1	0.945021372705767	0.993627075303383	0.932919687934337
down	ADA; MME; PPARG; CCDC134;	GO:0001890~placenta development	4	37	10.8108108108108	0.0337875868487867	0.102114335609029	1	1	0.945021372705767	0.993627075303383	0.932919687934337
down	PARP1; RPA2; RPA1; GTF2H2;	GO:0006296~nucleotide-excision repair, DNA incision, 5'-to lesion	4	37	10.8108108108108	0.0337875868487867	0.102114335609029	1	1	0.945021372705767	0.993627075303383	0.932919687934337
down	CTNS; NFE2L1; SLC7A11; GSR;	GO:0006749~glutathione metabolic process	4	37	10.8108108108108	0.0337875868487867	0.102114335609029	1	1	0.945021372705767	0.993627075303383	0.932919687934337
down	ULK1; SRC; HSF1; TRAF3IP1;	GO:0031333~negative regulation of protein-containing complex assembly	4	37	10.8108108108108	0.0337875868487867	0.102114335609029	1	1	0.945021372705767	0.993627075303383	0.932919687934337
down	CFLAR; BCL2L11; HSF1; PPP1R9B;	GO:0071392~cellular response to estradiol stimulus	4	37	10.8108108108108	0.0337875868487867	0.102114335609029	1	1	0.945021372705767	0.993627075303383	0.932919687934337
down	RIPK2; TLR2; C5AR1; LYZ; NLRP3; P2RX7; TBK1;	GO:0050830~defense response to Gram-positive bacterium	7	95	7.36842105263158	0.0339044466111054	0.102114335609029	1	1	0.945021372705767	0.993627075303383	0.932919687934337
down	RB1; ANKRD11; P2RX4;	GO:0001894~tissue homeostasis	3	21	14.2857142857143	0.0339935522374545	0.102114335609029	1	1	0.945021372705767	0.993627075303383	0.932919687934337
down	XIAP; TKFC; RNF135;	GO:0045088~regulation of innate immune response	3	21	14.2857142857143	0.0339935522374545	0.102114335609029	1	1	0.945021372705767	0.993627075303383	0.932919687934337
down	SMAD3; LIMS1; LIMS2;	GO:0045216~cell-cell junction organization	3	21	14.2857142857143	0.0339935522374545	0.102114335609029	1	1	0.945021372705767	0.993627075303383	0.932919687934337
down	KHDRBS1; UHMK1; POLR2D;	GO:0045948~positive regulation of translational initiation	3	21	14.2857142857143	0.0339935522374545	0.102114335609029	1	1	0.945021372705767	0.993627075303383	0.932919687934337
down	IL18RAP; LAMP1; STAT5B;	GO:0045954~positive regulation of natural killer cell mediated cytotoxicity	3	21	14.2857142857143	0.0339935522374545	0.102114335609029	1	1	0.945021372705767	0.993627075303383	0.932919687934337
down	RBM10; RBM42; PTBP3;	GO:0048025~negative regulation of mRNA splicing, via spliceosome	3	21	14.2857142857143	0.0339935522374545	0.102114335609029	1	1	0.945021372705767	0.993627075303383	0.932919687934337
down	CUX1; ANKRD27; RAB21;	GO:0050775~positive regulation of dendrite morphogenesis	3	21	14.2857142857143	0.0339935522374545	0.102114335609029	1	1	0.945021372705767	0.993627075303383	0.932919687934337
down	CALM3; PTK2B; HIF1A;	GO:0051000~positive regulation of nitric-oxide synthase activity	3	21	14.2857142857143	0.0339935522374545	0.102114335609029	1	1	0.945021372705767	0.993627075303383	0.932919687934337
down	SKI; SERPINF1; GNB1; MERTK; LPCAT1;	GO:0060041~retina development in camera-type eye	5	56	8.92857142857143	0.0358849445258336	0.106328783893488	1	1	0.947721433770641	0.993627075303383	0.971423016138973
down	IPO8; POLR2D; NUP62; EIF4G1; POM121;	GO:0060964~regulation of gene silencing by miRNA	5	56	8.92857142857143	0.0358849445258336	0.106328783893488	1	1	0.947721433770641	0.993627075303383	0.971423016138973
down	APAF1; LIMS1; SMAD3; ZFP36L1; PDGFD;	GO:0071560~cellular response to transforming growth factor beta stimulus	5	56	8.92857142857143	0.0358849445258336	0.106328783893488	1	1	0.947721433770641	0.993627075303383	0.971423016138973
down	TAF4; ICAM1; VEGFA; MMP19;	GO:0001541~ovarian follicle development	4	38	10.5263157894737	0.0364876490600609	0.107869328928552	1	1	0.948678875561582	0.993627075303383	0.985497482616078
down	TPM3; VIM; MYL6; TPM4;	GO:0030049~muscle filament sliding	4	38	10.5263157894737	0.0364876490600609	0.107869328928552	1	1	0.948678875561582	0.993627075303383	0.985497482616078
down	PARP1; RPA2; RPA1; GTF2H2;	GO:0033683~nucleotide-excision repair, DNA incision	4	38	10.5263157894737	0.0364876490600609	0.107869328928552	1	1	0.948678875561582	0.993627075303383	0.985497482616078
down	SLC9A1; VDAC2; SLC9A7; SLC9A8;	GO:0098656~anion transmembrane transport	4	38	10.5263157894737	0.0364876490600609	0.107869328928552	1	1	0.948678875561582	0.993627075303383	0.985497482616078
down	ACADVL; FOXO1; ARRDC3;	GO:0001659~temperature homeostasis	3	22	13.6363636363636	0.0377914970386778	0.110968609896106	1	1	0.950646499924254	0.993627075303383	1
down	ANKRD17; CCDC88A; EHMT2;	GO:0006275~regulation of DNA replication	3	22	13.6363636363636	0.0377914970386778	0.110968609896106	1	1	0.950646499924254	0.993627075303383	1
down	CAPN2; MYH9; PLEKHO1;	GO:0007520~myoblast fusion	3	22	13.6363636363636	0.0377914970386778	0.110968609896106	1	1	0.950646499924254	0.993627075303383	1
down	THBS1; SERPINF1; VASH1;	GO:0010596~negative regulation of endothelial cell migration	3	22	13.6363636363636	0.0377914970386778	0.110968609896106	1	1	0.950646499924254	0.993627075303383	1
down	CD2; IL18R1; SLAMF7;	GO:0030101~natural killer cell activation	3	22	13.6363636363636	0.0377914970386778	0.110968609896106	1	1	0.950646499924254	0.993627075303383	1
down	MAPK1; SMAD3; MAP2K1;	GO:0030878~thyroid gland development	3	22	13.6363636363636	0.0377914970386778	0.110968609896106	1	1	0.950646499924254	0.993627075303383	1
down	ICAM1; ITGAV; ADAM9;	GO:0033627~cell adhesion mediated by integrin	3	22	13.6363636363636	0.0377914970386778	0.110968609896106	1	1	0.950646499924254	0.993627075303383	1
down	BCL6; CCDC125; KCTD10;	GO:0035024~negative regulation of Rho protein signal transduction	3	22	13.6363636363636	0.0377914970386778	0.110968609896106	1	1	0.950646499924254	0.993627075303383	1
down	HK1; TKFC; GNPTAB;	GO:0046835~carbohydrate phosphorylation	3	22	13.6363636363636	0.0377914970386778	0.110968609896106	1	1	0.950646499924254	0.993627075303383	1
down	STX7; STX4; STX3;	GO:0048278~vesicle docking	3	22	13.6363636363636	0.0377914970386778	0.110968609896106	1	1	0.950646499924254	0.993627075303383	1
down	PID1; FEZ1; POLDIP2;	GO:0070584~mitochondrion morphogenesis	3	22	13.6363636363636	0.0377914970386778	0.110968609896106	1	1	0.950646499924254	0.993627075303383	1
down	CALR; CDK9; MDM2;	GO:0071157~negative regulation of cell cycle arrest	3	22	13.6363636363636	0.0377914970386778	0.110968609896106	1	1	0.950646499924254	0.993627075303383	1
down	RBM3; PABPC4; DHX8; DDX54; HNRNPUL1;	GO:0006396~RNA processing	5	57	8.7719298245614	0.0381058346777369	0.111765678300712	1	1	0.952645866943422	0.993627075303383	1
down	BCL2L11; CA2; RUNX2; ANKRD11; TRAF6;	GO:0042475~odontogenesis of dentin-containing tooth	5	57	8.7719298245614	0.0381058346777369	0.111765678300712	1	1	0.952645866943422	0.993627075303383	1
down	RAC2; PDIA3; NCF4; PDIA6; NHLRC2; GSR;	GO:0045454~cell redox homeostasis	6	77	7.79220779220779	0.0385099347737048	0.112823934817622	1	1	0.953825919656442	0.993627075303383	1
down	GSR; CAT; PTGS2; GSTO1; KDM3B; PARK7;	GO:0098869~cellular oxidant detoxification	6	77	7.79220779220779	0.0385099347737048	0.112823934817622	1	1	0.953825919656442	0.993627075303383	1
down	JUN; MAPK1; PPP5C; HSF1;	GO:0071276~cellular response to cadmium ion	4	39	10.2564102564103	0.0393084274946218	0.11509860904605	1	1	0.953825919656442	0.993627075303383	1
down	DNM2; RAB10; GOPC;	GO:0006893~Golgi to plasma membrane transport	3	23	13.0434782608696	0.0417961770427063	0.117561616161136	1	1	0.961093164758587	0.993627075303383	1
down	PEA15; SLC37A2; SLC50A1;	GO:0008643~carbohydrate transport	3	23	13.0434782608696	0.0417961770427063	0.117561616161136	1	1	0.961093164758587	0.993627075303383	1
down	BCR; MYO9B; CDC42SE1;	GO:0035023~regulation of Rho protein signal transduction	3	23	13.0434782608696	0.0417961770427063	0.117561616161136	1	1	0.961093164758587	0.993627075303383	1
down	PTPRC; PRKACA; PTPRJ;	GO:0035584~calcium-mediated signaling using intracellular calcium source	3	23	13.0434782608696	0.0417961770427063	0.117561616161136	1	1	0.961093164758587	0.993627075303383	1
down	HMGB1; IL12RB1; STAT5B;	GO:0042104~positive regulation of activated T cell proliferation	3	23	13.0434782608696	0.0417961770427063	0.117561616161136	1	1	0.961093164758587	0.993627075303383	1
down	SRC; PRKACA; HDAC5;	GO:0043393~regulation of protein binding	3	23	13.0434782608696	0.0417961770427063	0.117561616161136	1	1	0.961093164758587	0.993627075303383	1
down	TLR2; PPARG; MTOR;	GO:0048714~positive regulation of oligodendrocyte differentiation	3	23	13.0434782608696	0.0417961770427063	0.117561616161136	1	1	0.961093164758587	0.993627075303383	1
down	CCL2; PTGS2; PTK2B;	GO:0051968~positive regulation of synaptic transmission, glutamatergic	3	23	13.0434782608696	0.0417961770427063	0.117561616161136	1	1	0.961093164758587	0.993627075303383	1
down	SLC8A1; CACNA1D; MICU1;	GO:0070509~calcium ion import	3	23	13.0434782608696	0.0417961770427063	0.117561616161136	1	1	0.961093164758587	0.993627075303383	1
down	RAB29; B3GAT3; PCNT;	GO:0090316~positive regulation of intracellular protein transport	3	23	13.0434782608696	0.0417961770427063	0.117561616161136	1	1	0.961093164758587	0.993627075303383	1
down	CALR; MAP2K1; SMC6;	GO:0090398~cellular senescence	3	23	13.0434782608696	0.0417961770427063	0.117561616161136	1	1	0.961093164758587	0.993627075303383	1
down	NLRC3; HDAC7; NLRP3;	GO:1901223~negative regulation of NIK/NF-kappaB signaling	3	23	13.0434782608696	0.0417961770427063	0.117561616161136	1	1	0.961093164758587	0.993627075303383	1
down	CAT; ICAM1; CD14; RARA; EEF2; RHOA; PTK2B;	GO:0045471~response to ethanol	7	100	7	0.0422261166248693	0.118706860759881	1	1	0.961093164758587	0.993627075303383	1
down	CREB1; MAPK1; PPP1R9B; SLC7A11;	GO:0035094~response to nicotine	4	40	10	0.0422500554564533	0.118710128862013	1	1	0.961093164758587	0.993627075303383	1
down	AKAP5; FPR2; GNAL; AKAP12; RIC8A;	GO:0007193~adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway	5	59	8.47457627118644	0.0427945344212772	0.120045809151613	1	1	0.961093164758587	0.993627075303383	1
down	CD63; NIPBL; RRAGA; SCYL1; PRPF19;	GO:0034613~cellular protein localization	5	59	8.47457627118644	0.0427945344212772	0.120045809151613	1	1	0.961093164758587	0.993627075303383	1
down	NPC1; CHMP2A; SRGAP2; PARK7; CHMP4B;	GO:0060548~negative regulation of cell death	5	59	8.47457627118644	0.0427945344212772	0.120045809151613	1	1	0.961093164758587	0.993627075303383	1
down	BMP6; PTGS2; AIF1; RHOA; ADAM9;	GO:0051384~response to glucocorticoid	5	60	8.33333333333333	0.0452631166428268	0.126792903705259	1	1	0.965271830692319	0.993627075303383	1
down	HMGB1; SIRT2; HDAC5; PCGF1;	GO:0006342~chromatin silencing	4	41	9.75609756097561	0.0453124888838297	0.126792903705259	1	1	0.965271830692319	0.993627075303383	1
down	PSMA7; PSMB7; PSMB4;	GO:0010499~proteasomal ubiquitin-independent protein catabolic process	3	24	12.5	0.0460047679179647	0.126792903705259	1	1	0.966100126277259	0.993627075303383	1
down	PTGS2; QKI; MYO5A;	GO:0042759~long-chain fatty acid biosynthetic process	3	24	12.5	0.0460047679179647	0.126792903705259	1	1	0.966100126277259	0.993627075303383	1
down	CD40; IRF8; LYST;	GO:0042832~defense response to protozoan	3	24	12.5	0.0460047679179647	0.126792903705259	1	1	0.966100126277259	0.993627075303383	1
down	ABCA1; GNAL; CXCL9; CALCRL; ADGRG5; ADGRE2; ADGRE3;	GO:0007189~adenylate cyclase-activating G protein-coupled receptor signaling pathway	7	103	6.79611650485437	0.0478017982526665	0.126792903705259	1	1	0.969890356198024	0.993627075303383	1
down	PTK2B; NCOA6; MMP19; TIMP1;	GO:0009725~response to hormone	4	42	9.52380952380952	0.0484955117401	0.126792903705259	1	1	0.969910234802001	0.993627075303383	1
down	ACSL4; GLUD1; SIRT3; SERP1;	GO:0032024~positive regulation of insulin secretion	4	42	9.52380952380952	0.0484955117401	0.126792903705259	1	1	0.969910234802001	0.993627075303383	1
down	TLR2; THBS1; ABHD2; NCOA1;	GO:0032570~response to progesterone	4	42	9.52380952380952	0.0484955117401	0.126792903705259	1	1	0.969910234802001	0.993627075303383	1
